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ABSTRACT
Mohammadi, Shahin Ph.D., Purdue University, December 2016. Cell Type-specific
Analysis of Human Interactome and Transcriptome.
Major Professor: Ananth
Grama.
Cells are the fundamental building block of complex tissues in higher-order organisms. These cells take different forms and shapes to perform a broad range of
functions. What makes a cell uniquely eligible to perform a task, however, is not
well-understood; neither is the defining characteristic that groups similar cells together to constitute a cell type. Even for known cell types, underlying pathways that
mediate cell type-specific functionality are not readily available. These functions, in
turn, contribute to cell type-specific susceptibility in various disorders.
In this dissertation, I propose a novel measure of similarity between cells and utilize it to identify de novo cell types. I show that my method allows us to uncover
novel cancer subtypes. Furthermore, by constructing underlying pathways that drive
progression of these subtypes, I show that we can pinpoint diagnostic biomarkers and
potential therapeutic targets. Then, I develop a method to dissect the cell type composition of complex tissues. Using this snapshot of what tissues/cell types look like,
I create a framework for constructing tissue/cell type-specific interactomes to shed
light on the systems-level understanding of cellular functions. I use these networks
to uncover brain-specific pathways that are involved in Alzheimer’s and Parkinson’s
diseases. Finally, I provide evidence for the conservation of these interactomes across
distant species, even down to unicellular organisms, such as yeast.

1

1 INTRODUCTION
Human cells, while inheriting a similar genetic code, exhibit distinct morphological
and functional characteristics and group together uniquely to form complex tissues.
Uncovering biochemical processes that drive the transformation of a totipotent cell
into various cell types and ultimately tissues is essential to our understanding of living
systems. Understanding this complex machinery determines how tissues differ in
terms of their anatomy, physiology, morphology, and, more importantly, how various
cellular control mechanisms contribute to the observed similarities/ differences.
A fundamental challenge in understanding cellular biology is to classify cells according to their common functions. This allows us to study cell types as a whole, and
to extend our understanding to the behavior of individual cells. Traditionally, cells
are classified into a few hundred different cell types according to their morphological properties and cell cell surface markers. However, emerging knowledge suggests
that seemingly identical cell types may exhibit varying transcriptional characteristics,
leading to vastly different functions. This, in turn, motivates the development of new
approaches for defining refined groupings of cells.
With the availability of single cell transcriptomic data, there is an unprecedented
opportunity to analyze and model cellular processes at a resolution that was not
possible before. These technologies have the potential to radically redefine our view
of cell type identity. However, there are a number of challenges to realize the potential
of these datasets. The first major challenge is to define what makes a pair of cells
similar. This similarity is at the very core of any algorithm that aims to find groups of
similar tissue, and by extension, coherent cell types. To this end, my first attempt was
to develop a method for uncovering true similarity between cells, while accounting for
biological and technical noise. In this framework, I aim to remove the common part of
the identity of cells to boost their distinguishing (informative) signals. To this end, I
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project cellular signatures to a suitably regularized orthogonal subspace, which allows
better identification of cells, as well as their similarities. I show that this reduction
step enhances the signal-to-noise ratio (SNR) for known markers. Moreover, I show
that repeated application of subspace reduction within groups of cell types allows us
to identify highly specific markers.
Armed with a measure of cell-to-cell similarities, the next logical objective is to
group coherent cells to identify de novo cell types. To this end, we need to account
for a few important considerations. First, there are extremely important but very
rare cells, such as circulating tumor cells, the identity of which is of considerable
significance. Traditional clustering algorithms typically fail to capture such trends,
and there is a need to develop specific tools that are robust to the sampling density of
cells. Another key challenge is that even after identifying a cell type, it is unclear what
distinguishes a cell type from other cell types. Transcriptional regulatory networks
(TRNs) are at the heart of this differentiating process. As such, understanding cell
type-specific TRNs has the potential to unlock cell type identity. To address these
issues, I developed a method that uses our measure of cell-to-cell similarity as a
kernel, and constructs a geometric representation of the functional space of cells. This
representation characterizes principal functions that are performed by cells. I then
couple this geometric approach with a new statistical framework to reconstruct the
underlying transcriptional regulatory networks that mediate characteristic behavior
of each cell type.
Once we have characterized a cell-type, the next step is to analyze how various
cell types come together to form complex tissues. A fundamental question then is to
deconvolve complex tissues to identify their constituting cell types and their relative
fractions. This has applications in the removal of contaminants (e.g., surrounding
cells) from tumor biopsies, as well as in monitoring changes in the cell population
in response to treatment or infection. This problem is known as source separation
in the signal processing community and has attracted considerable attention. In this
dissertation, I focused on one specific problem in this area: knowing individual cell
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types profiles, can we identify the composition of these cell types in a given tissue? To
answer this question, I performed a comprehensive study to investigate the effect of
different loss functions, constraints on the solution, preprocessing and data filtering,
feature selection, and regularization on deconvolution quality. I developed prescriptive
recipes that yield the best performance and showed how these recipes could be used
in practice.
The next question I address is how various cell types and tissues come together
at a system level? How do various gene products interact? What are the emergent
properties of these complex interactions? To answer these questions, I developed a
method for constructing accurate tissue/cell type-specific networks. This approach
formulates network inference as a suitably regularized convex optimization problem.
The objective function of the optimization problem has two terms – the first term
corresponds to a diffusion kernel that propagates activity of genes through interactions (network links). The second term is a regularizer that penalizes differences
between transcriptional and functional activity scores. I use these functional activity
scores to compute tissue-specificity of each edge in the global interactome, which I
show, through a number of validation tests, are significantly better than state-ofthe-art methods in the field. Finally, I couple these networks with Prize-Collecting
Steiner Tree (PCST) method to identify novel disease/tissue-specific pathways that
drive neurodegenerative disorders. This method is platform-independent and can be
applied directly to single-channel, double-channel, and RNA-Seq expression datasets.
Finally, I addressed the problem of transferrability of molecular mechanisms across
organisms. Budding yeast, S. cerevisiae, has been used extensively as a model organism for studying cellular processes in evolutionarily distant species, including humans.
However, The extent to which a unicellular organism, such as yeast, can be used to
model tissue-specific processes has never been assessed. To answer this question, I
developed a novel framework to systematically quantify the suitability of yeast as
a model organism for different human tissues. To this end, I first used network
alignment to map human tissue-specific networks to the yeast interactome. Then, I
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devised a statistical model to assign an empirical p-value to each alignment, assessing the overall suitability of yeast to model the systems biology of each tissue. My
framework not only helps in classifying human tissues/cell types as either compatible
with the yeast model or not, but also provides missing functional elements in yeast
for each tissue. These functional constructs can further be utilized to engineer humanized yeast models that mimic the biology of specific human tissues, and can be
used as high-throughput, tissue-specific model to study different diseases.
In summary, my dissertation extends our understanding of the identity of human cell types, their functional pathways, their composition in complex tissues, and
their conservation across evolution. In the what follows I will address each of these
questions in sequential order in each chapter of this dissertation.
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2 BIOLOGICAL BACKGROUND
2.1 Genes, RNAs, Proteins – And How We Measure Them in Bulk Tissues
The central dogma of biology describes the flow of genetic information within
cells – the genetic code, represented in DNA molecules, is first transcribed to an
intermediate construct, called messenger RNA (mRNA), which in turn translates
into proteins. These proteins are the functional workhorses of the cell. Genes, defined
as the minimal coding sections of the DNA, contain the recipe for making proteins.
These instructions are utilized dynamically by the cell to adapt to different conditions.
The amounts of various proteins in a cell can be measured at a time point. This
corresponds to the level of protein expression. This process is limited by the availability of high-quality antibodies that can specifically target each protein. The amount
of active mRNA in a cell, however, can be measured at the genome scale using highthroughput technologies such as microarrays and RNASeq. The former is an older
technology that relies on the binding affinity of complementary base pairs (alphabets
used in the DNA/RNA molecules), while the latter is a newer technique, using next
generation sequencing (NGS). This technique estimates gene expression based on the
overlap of mRNA fragments with known genomic features. Since microarrays have
been used for years, extensive databases from different studies are publicly available.
RNASeq datasets, in comparison, are relatively smaller but growing rapidly in scale
and coverage. Both of these technologies provide reliable proxies for the amount of
proteins in cells, with RNASeq being more sensitive, especially for lowly expressed
genes.
The expression level of genes is tightly regulated in different stages of cellular
development, as well as in response to environmental changes. In addition to these
biological variations due to cellular state, intermediate steps in each technology in-

6
troduce technical variations in repeated measurement of gene expression in the same
cell-type. To enhance reproducibility of measurements, one normally includes multiple instances of the same cell-type in each experiment, known as technical replicates.
The expression profiles from these experiments provide a snapshot of the cell under
different conditions. In addition to the biological variation of genes within the same
cell type, there is an additional level of variation when we look across different cell
types.

2.2 From Bulk Tissue Measurements to Single Cell RNA-Seq (scRNA-Seq)
Traditionally, biological samples are disaggregated and measured in bulk. However, different tissues typically consist of a heterogeneous population of cells of different type and at different fractions. An important example is the tumor microenvironment. In this case, not only we have immune, stromal, and cancerous cells all
mixed in the tumor biopsy, but also the tumor samples themselves consist of different
subtypes.
Many different groups have focused their energy to develop technologies capable
of measuring RNA quantities at the single cell level. A major challenge to achieve
this goal is the limited RNA quantity at single cell level. The total amount of RNA in
a single cell is in order of picograms, whereas most recent RNA-seq technologies need
at least tens of nanograms to be able to measure RNA levels. To compensate for this
gap, amplification techniques before performing RNA-Seq are mandatory. Another
challenge is to isolate single cells from bulk tissue without perturbing their expression
profile. Furthermore, different techniques may have biases towards different ends of
RNA or according to the specific sequence of it. Finally, the maximum length of RNAs
that each method can measure can vary across methods. Methods such as SmartSeq [151], and its successor Smart-Seq2 [144], aim to sequence the whole length of
genes. On the other hand, more recently developed methods, such as InDrop [92] and
DropSeq [114], sacrifice full-length coverage to gain of significantly higher throughput.
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These methods are under constant development, with microfluidics and emulsionbased techniques being at the leading front of this development.

2.3 Cell Type Specificity – Ubiquitously Expressed Versus Highly Selective Genes
Proteins are basic workhorses of living cells. Their overall quantity is tightly
regulated across different tissues and cell-types to manifest tissue-specific biology and
pathobiology. These regulatory controls orchestrate cellular machinery at different
levels of resolution, including, but not limited to, gene regulation [62, 120], epigenetic
modification [24,121], alternative splicing [19,46], and post-translational modifications
[77, 194]. Transcriptional regulation is a fundamental component of this hierarchical
regulation, which has been widely used to study context-specific phenotypes. In the
context of human tissues/ cell types, genes can exhibit varying levels of specificity
in their expression. They can be broadly classified as (i) tissue-specific (unique to
one cell-type); (ii) tissue-selective (shared among coherent groups of cell-types); and
(iii) housekeeping (utilized in all cell-types). Housekeeping genes comprise a subset of
human genes that are universally expressed across all tissues and are responsible for
maintaining core cellular functions needed by all tissues, including translation, RNA
processing, intracellular transport, and energy metabolism [23, 39, 172]. These genes
are under stronger selective pressure, compared to tissue-specific genes, and evolve
more slowly [221]. In contrast, certain genes are specifically or preferentially expressed
in one, or a set of biologically relevant tissue types [22, 23, 181, 206]. These marker
genes are critical for distinguishing various cells. In fact, cell surface markers have
long been used to sort different subsets of immune cells. Tissue-specific/selective genes
have significant applications in drug discovery, as they have been shown to be more
likely drug targets [40]. Tissue-specific transcription factors (tsTFs) are significantly
implicated in human diseases [123, 150], including cancers [197].
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2.4 Adding Cell Type-specificity to Biological Networks
The majority of human proteins do not work in isolation but take part in pathways,
complexes, and other functional modules. These complex interactions are typically
represented as a graph. This graph can be undirected, in the case of protein-protein
interaction networks (PINs), or directed, as in transcriptional regulatory networks
(TRNs). In PINs, each node represents a protein and each edge indicates a physical
interaction between a pair of proteins. These interactions are measured in vitro by
technologies such as yeast two-hybrid (Y2H) or affinity purificationmass spectrometry
(AP/MS). The basic premise of these technologies is to assess if two proteins can
interact. That is conditioned on if they are both expressed at high enough levels,
co-localized, and post-translationally modified (if needed). As such, PINs provide a
superset of all possible interactions that can happen in the cell. Of course, this set
also contains a lot of false negatives since not all pairs of proteins are systematically
measured for interactions, and even if they have been, there is a high false positive
rate associated with these technologies as well (especially with AP/MS). In TRNs,
each node can be either a transcription factor (TF) (a protein) or a target gene (TG).
Interactions are regulatory interactions and are directed. If a protein is linked to a
gene if means that it regulates the expression of that genes. This regulation can be
either positive, or activation, or negative, or inhibition.
In context-specific networks, we add a spatial and/or temporal context to these
networks. What this information provides is a realistic snapshot of what is going on
inside a specific cell type at a given moment (that the data was captured). Perturbations that impact interacting interfaces of proteins are significantly enriched among
tissue-specific, disease-causing variants [155, 157, 208]. Additionally, disease-related
protein complexes tend to be over-expressed in tissues in which defects cause pathology [103]. In terms of topology, tissue-specific genes typically reside in the periphery
of the interactome, are enriched among signaling and cell surface receptors, and highly
associated with the onset of tissue-specific disorders [216].
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3 A BIOLOGICALLY-INSPIRED KERNEL TO MEASURE SIMILARITY OF
CELLS
3.1 Background
An embryonic stem cell encapsulates all of the genetic information needed to develop an individual; it differentiates into various cell types, which group together to
shape tissues, combine to constitute organs, and assemble into organ systems. Various differentiated tissues/ cell types, while inheriting a similar genetic code, exhibit
unique anatomical and physiological features. Traditionally, these cell types/ tissues have been classified using their high-level phenotypic characterizations, such as
location and morphology. However, more recently, single-cell technologies have revealed an unprecedented heterogeneity among what were, until recently, believed to
be identical cell types [162]. This heterogeneity is achieved through systematic control
of cellular machinery at different levels, including transcriptional, translational, and
post-translational regulations, to orchestrate tissue-specific functions and dynamic
responses to environmental stimuli.
Transcriptional regulation is among the best-studied aspects of this control. It
is manifested in the observed differences in expression levels of genes across tissues.
Housekeeping genes constitute the subset of the transcriptome that is universally
expressed in human tissues. These genes are responsible for core cellular functions [23,
39, 172], and their corresponding pathways, are essential to all cells for their normal
activity. However, they are not informative, with respect to the identity of cells, nor
do they provide any power to classify cells into coherent groups of cell types. In
contrast, certain genes are specifically or preferentially expressed in one, or a set of
biologically relevant tissue types [22, 23, 181,206]. These marker genes are critical for
distinguishing various cells. In fact, cell surface markers have long been used to sort
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different subsets of immune cells. These genes play a crucial role in the physiology
and the pathophysiology of human tissues. Many of the known disease genes are
tissue-specific and are under/ over-expressed in the specific tissue(s) where the gene
defect causes pathology [60, 103].
The use of transcriptomic profile as a genome-scale phenotype to identify unique
cell types has attracted considerable attention [186]. However, identifying transcriptionally related cell types and their key marker genes remains a challenging task. One
of the complicating factors in this paradigm is the hierarchical relationships among
cell types. At the highest level, all cells are highly similar due to the expression of
housekeeping genes. These genes are typically expressed at high levels and strongly
impact the computed cell-cell distances (using any of the existing distance measures).
After peeling this common layer, cell types split into groups with common functionality, which can be represented using the community affiliation graph model [215].
Here, we can model common functionalities such as “affiliations”, which are used
to annotate cell types. However, these affiliations are not known a priori. Furthermore, cell types are not uniformly spaced and form a hierarchical structure linking
them together. As we move deeper into this hierarchy, shared functionalities become
more detailed, and distances among cell types reduce – necessitating use of rigorous
statistical models and methods to assess the “proximity” of cell types.
In this chapter, I propose an iterative, multi-step process to simultaneously identify groups of similar cell types as well as their characteristic marker genes that are
specifically expressed within each group of cell types. The two main operators in
my framework are subspace reduction, in which we identify the unique signature of a
given expression domain, and clustering, in which we group similar tissues/ cell types
in the reduced space to define new expression domains. In this framework, I make an
implicit assumption that genes do not work alone, but rather, as part of functional
pathways. These pathways can be viewed as barcodes that uniquely identify their
corresponding cell types/ tissues.
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Motivated by these considerations, I develop a novel algorithm for de novo identification of cell types and their corresponding markers. I show that this subspace
reduction step significantly enhances the signal-to-noise ratio (SNR) for markers, and
that repeated application of reduction step within known groups of cells can identify
their markers. Next, I show that, in the absence of known groupings, my method can
automatically identify similar cell types using a clustering algorithm. I use this as a
hierarchical prior for characterizing the expression domain of genes. Finally, I show
that my method is able to reconstruct highly accurate models of tissue-specific transcriptional regulatory networks (tsTRN). my framework is particularly well-suited for
applications in single-cell analysis, in which the true identity of cell types, as well as
their corresponding markers, is critical.

3.2 Materials and Methods
3.2.1 Datasets
Gene Expression Profiles
In my experiments, I used two separate datasets derived from different technologies. The first dataset, which I will refer to as immune cell types, is the expression
profile of 38 distinct subpopulations of hematopoietic cells measured using Affymetrix
GeneChip microarray [130]. This dataset consists of the gene expression of 12, 074
genes in a total of 211 samples. The second dataset contains a comprehensive compendium of 675 cancer cell lines [93]. The origin of these cell lines can be classified
into 17 different tissues. I will focus on these 17 distinct groups, but collectively refer
to this dataset as the cancer cell lines dataset.

Gold Standard Marker Genes
To evaluate identified markers and the impact of adjustment, I collected marker
genes from two independent studies. For immune cell types, I adopted the LM22
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dataset from Newman et al. [129]. First, for each cell type in LM22, I identified genes
that are highly expressed. Then, I computed the mean expression of these markers in
each of the immune cell types in my dataset. I constructed a weighted bipartite graph
between cell types in these two datasets and identified matches using a maximumweight bipartite matching algorithm [102], followed by manual assessment. Table 3.1a
shows the final results for the immune marker set.
For the cancer cell lines dataset, I downloaded the gold standard tissue-specific
markers from the Human Protein Atlas (HPA) [193]. I manually matched ten different tissues of origin to the markers in HPA, and limited my focus on the markers that
have both transcriptomic and proteomic evidence. Among these ten, pancreas markers were not significantly expressed in the pancreas-originated cell lines, and thus I
removed this from my set. The final set consists of nine tissues, shown in Table 3.1b.

Transcriptional Regulatory Network (TRN)
I collected transcription factor (TF) – target gene (TG) interactions from the
RegNetwork database [110], which aggregates data from 25 different databases. This
dataset contains a total of 151, 214 regulatory interactions between 1, 408 TFs and
20, 230 TGs.

3.2.2 Identifying the Shared Subspace among a Group of Tissues
A given set of tissues/ cell-types typically share a common set of genes/ pathways,
while specializing through preferential genes that control and regulate this core shared
set. I represent the raw transcriptional signature of these tissues using a matrix
T ∈ Rng ×nt , in which rows correspond to genes and columns correspond to various
tissues. We are interested in finding the subspace of common genes, and to use it to
adjust the transcriptional signatures. When the given set includes all, or majority
of, human cell-types, the shared subspace represents the signature of housekeeping
genes.
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Table 3.1: Number of markers for different cell types and tissues used for validating
cell similarity kernel
(a) Immune cell types
LM22 cell type

mapped cell type

number of markers

B cells naive

Naive B-cells

118

B cells memory

Mature B-cell class able to switch

106

Plasma cells

Mature B-cells

109

T cells CD8

CD8+ Effector Memory

142

T cells CD4 naive

Naive CD4+ T-cell

121

T cells CD4 memory activated

CD4+ Effector Memory

107

NK cells activated

Mature NK cell CD56+ CD16+ CD3-

109

Monocytes

Monocyte

104

Dendritic cells activated

Myeloid Dendritic Cell

121

Eosinophils

Eosinophill

159

Neutrophils

Granulocyte (Neutrophilic Metamyelocyte)

140

(b) Cancer cell lines

cell line origin

number of markers

brain

336

colo-rectal

72

kidney

158

liver

185

lung

56

ovary

35

stomach

77

urinary bladder

27

skin

133

There are a number of methods for approximating this common signature in T ,
the simplest of which would be to compute the mean of its columns. An alternate

14
approach involves decomposing T into sum of rank-one matrices, using methods such
as singular value decomposition (SVD) or non-negative matrix under-approximation
(NMU). The general goal of these methods is to represent T as a sum of outer products
of vectors. More formally, I write T as follows:
T = Ur Σr Vr =

r
X

σi ui vi T ,

(3.1)

i=1

where r ≤ min(ng , nt ) is the rank of the approximation. In the SVD formulation, ui
and vi vectors are called left and right singular vectors, respectively. These vectors
constitute an orthonormal basis, that is, both ui uTj = δij and vi vjT = δij for all i and
j. Additionally, for any r, an SVD is the optimal rank-r approximation of T . When
all entries of T are positive, Perron-Frobenius theorem ensures that all entries of the
both left and right singular vectors are positive. However, the first residual matrix,
R1 = M − σ1 u1 v1 T , can, and typically does, contain negative elements to ensure
orthonormality. On the other hand, the NMU formulation does not ensure orthonormality, but, rather enforces an additional constraint on the optimization problem,
which is that Rk should consist of only positive elements. Unfortunately, while SVD
has an optimal solution, the additional non-negativity constraint of NMU makes its
computation non-convex, though heuristics exist to approximate the solution.
Here, I use a rank-one approximation of matrix T , that is r = 1, to identify
a unique signature that closely represents the common signature in T . I use the
first singular vector of matrix T , after z -score normalization, as a proxy for the
housekeeping signature throughout my study.
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3.2.3 Adjusting Transcriptional Signatures to Control for the Effect of Shared Subspace
Let us denote the transcriptional profile of the ith tissue by Ti . In order to compute
the raw transcriptional similarity between each given pair of tissues, I compute the
Pearson’s correlation as follows:
Pn

− t¯i )(tkj − t¯j )
pPn
¯ 2
¯ 2
k=1 (tki − ti )
k=1 (tkj − tj )

rTi Tj = pPn

k=1 (tki

(3.2)

where, n represents the total number of genes, tki and tkj are the expression levels
of the k th gene in the ith and j th tissues, respectively. Similarly, t̄i and t̄j represent
the average expression levels of genes in the corresponding tissues. Let Zi denote
the Z -score normalized version of Ti , defined as

Ti −µ(Ti )
.
σ(Ti )

I refer to Zi as the raw

transcriptional signature of tissue i. Using this formulation, I can simplify the raw
transcriptional similarity as the normalized dot product of raw transcriptional signatures:
rTi Tj =

Zi Zj
n

(3.3)

The raw transcriptional similarity of tissues is artificially inflated due to the ubiquitous expression of housekeeping genes across all tissues. To control for this effect,
I first define housekeeping transcriptional signature, denoted by vector S, as the left
singular vector of matrix Z. Using this notation, I revise my similarity scores by
computing the partial Pearson’s correlation between Ti and Tj , after controlling for
the effect of S as follows:
rT T − rT S rTj S
rTi Tj •S = q i j qi
2
2
1 − rT
1 − rT
iS
jS

(3.4)

As before, we can rewrite this using the Z -score formulation. Let us denote the
adjusted transcriptional profile of tissue i as Yi = Zi − rTi S S. I define the adjusted
transcriptional signature of tissue i as Ẑi =

Yi −µ(Yi )
.
σ(Yi )

Finally, we can rewrite the

adjusted transcriptional similarity as:
rTi Tj •S =

Ẑi Ẑj
n

(3.5)

16
I use this approach to remove the shared subspace of a given set of expression profiles,
and to construct the corresponding adjusted transcriptional signatures. Significantly
positive transcriptional similarities in this framework are indicators of shared tissuespecific pathways. I use these adjusted transcriptional signatures in my study to
identify marker genes. However, when applying methods that rely on the positivity
of the input expression matrix, one can use the sigmoid transform of these scores as
follows:
p̂ki =

1
1 + e−ẑki

(3.6)

Please note that this transformation, when applied to the raw transcriptional signatures, is equivalent to the previously known softmax normalization:
pki =
=

1
1 + e−zki
1
−(

1+e

tki −µ(Ti )
)
σ(Ti )

(3.7)

This normalization is known to remove the effect of outliers, while preserving a linear
relationship for mid-range values.

3.2.4 Computing Signal-to-Noise Ratio (SNR)
Signal-to-Noise Ratio (SNR) is a commonly used measure for evaluating the quality of a desired signal by comparing the power of the signal to the power of (undesired)
noise. I define the desired signal as the expression of marker genes in their corresponding tissue/ cell type of origin. Similarly, I define noise as the expression of the rest of
the genes in that cell type. Let us assume there are k replicas of a given tissue/ cell
type, and a total of n genes, represented in a matrix A ∈ Rn×k . We are also given a
subset S of rows that are designated as markers. I compute the power of signal as:
Psignal =

kA(S,:)k2F
|S|

. The numerator can be also expressed as k vec(A(S, :)) k22 , where

the vec operator vectorizes a matrix by stacking up its columns. Similarly, we can
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compute the power of noise as: Psignal =

kA(S 0 ,:)k2F
|S 0 |

, where S 0 = {1..n} \ S. Then, we

can compute SNR as:
SN R = 10log10 (

Psignal
),
Pnoise

(3.8)

which is in unit of decibels (dB).

3.2.5 Assessing the Significance of Marker Detection Methods
I use the hypergeometric p-value as a statistical measure of the overlap among
sets. A typical use case for this formulation is in over-representation analysis (ORA).
The classical approach to this problem is to select a predefined cutoff l to identify topranked genes, and then to compute the enrichment p-value using the hypergeometric
distribution. Let us denote the total number of gene products by N . Given a set of
known gene annotations (true positives) of size A, I encode these annotations using
a binary vector λ = λ1 , λ2 , ...λN ∈ {0, 1}N . Let the random variable T denote the
number of positive genes in the target set, if we distribute genes randomly. In this
formulation, the hypergeometric p-value is defined as:
p-value(T = bl (λ)) = P rob(bl (λ) ≤ T )
= HGT (bl (λ)|N, A, l)
min(A,l)

=

X C(A, t)C(N − A, l − t)
C(N, l)

t=bl (λ)

(3.9)
where HGT is the tail of hypergeometric distribution and bl (λ) =

Pl

i=1

λi counts the

total number of true positives in top-l observations. The drawback of this approach
is that we need a predefined cutoff value, l. To remedy this, Eden et al. [43] propose
a two-step process for computing the exact enrichment p-value, called mHG p-value,
without the need for a predefined cutoff value of l. First, an optimal cutoff value is
chosen among all possible values of 1 ≤ l ≤ N . The computed value for this optimal
cutoff is called the minimum hypergeometric (mHG) score, and is defined as:
mHG(λ) = min1≤l≤N HGT (bl (λ)|N, A, l)

(3.10)
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Next, a dynamic programming (DP) method is used to compute the exact p-value of
the observed mHG score, in the state space of all possible λ vectors of size N having
exactly A ones (please refer to Eden et al. [43] for algorithmic details, and Eden [42]
for an efficient implementation).

3.2.6 Combining Individual p-values to Compute a Meta p-value
When we compute individual p-values for each tissue/ cell type, we then need
to combine them in order to define a meta p-value that can be used to assess each
selection. To combine a set of computed p-values, I use the Fisher’s method [49].
P
This method computes a statistic S = −2 ki=1 ln(pi ) for a set of k given p-values pi .
Then, I can use χ2 test with 2k degrees of freedom to assess the significance of the
meta-analysis, assuming that pi s are independent.

3.3 Results and Discussion
In this section, I validate the following hypotheses: (i) a single level of adjustment
(reducing the effect of housekeeping genes) enhances the signal-to-noise ratio (SNR);
(ii) repeated application of the reduction process over groups of cell types allows us to
recover cell type-specific markers; (iii) automatic identification of putative cell types
using label propagation based clustering yields reliable grouping of cell types; and (iv)
cluster-specific, adjusted signatures yield highly accurate models of cell type/ tissuespecific transcriptional regulatory circuits. All of these hypothesis are validated using
known cell type groupings and markers.

3.3.1 Adjusting for the Effect of Housekeeping Genes Enhances Signal-to-Noise Ratio (SNR) for the Known Marker Genes
I hypothesize that the global expression of housekeeping genes, which are universally expressed genes that perform core cellular functions, masks the true signal from
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tissue-specific markers. Thus, adjusting for this common signature should enhance
the signal-to-noise ratio (SNR) of marker detection methods. To systematically evaluate my hypothesis, I compute SNR using Equation 3.8, for immune cells and cancer
cell line markers, respectively. The results of this adjustment are presented in Figure 3.1. In the two cases shown, we observe a significant improvement over the raw
expressions. However, we note that in the cancer cell line dataset, there are cases in
which the power of non-marker genes is stronger than the power of marker genes, thus
the negative dB values. This effect is remedied in all cases after adjustment, which
suggests that the proposed adjustment process deflates housekeeping gene expression
effectively, but does not negatively influence the expression of marker genes.

3.3.2 Iterative Application of Adjustment Process Identifies Markers That are Comparable or Better Than the t-test
In this experiment, I quantify the extent to which highly expressed genes in the
adjusted profile can be used to identify tissue/ cell type-specific markers. I apply
the same adjustment process to each group of cells/tissues, after adjusting for housekeeping effect. The result is a single shared signature for each group of cell types/
tissues. I rank genes according to their expression level in this signature and assess
the over-representation of known markers among the higher ranked elements in this
list. I use mHG p-values, introduced in Section 3.2.5, to assess the significance of
each case. Similarly, I compute the mHG p-values for results of one-sided and twosided t-tests, which correspond to the most commonly used methods for identifying
differentially expressed genes. my final results are presented in Figure 3.2. For the
immune cell dataset, the iterative adjustment process yields superior results in every
single case. However, in the cancer cell line datasets, the results are more varied. In
this case, I removed ovary from my study, since none of the methods had significant
p-values. To systematically evaluate different methods, I use Fisher’s method [49] to
combine individual p-value into a meta p-value, the details of which are presented in
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Figure 3.1.: SNR enhancement for marker genes after the adjustment process for
housekeeping genes

Section 3.2.6. This results in the combined p-values of 2.5 × 10−197 , 2 × 10−185 , and
8.1 × 10−150 , for my method, one-sided t-test, and two-sided t-test, respectively.
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In summary, in both cases my method significantly outperforms the standard ttest but, more importantly, as I show in the next section, it does not depend on a
predefined grouping and can automatically identify relevant expression domains.
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Figure 3.2.: Significance of marker predictions using two-step adjustment process
compared to the standard t-test.

22
3.3.3 Adjusted Cell Type Signatures Identify Groups of Similar Tissues/Cell Types
Having established that iterative application of the adjustment process can identify marker genes within given groups of cells, I now study whether these groups
can be identified from the data directly. Given a compendium of cells, this would
allow us to automatically identify major subgroups corresponding to cell types, as
well as key marker genes associated with each group. In order to evaluate if such
structure exists in the adjusted data, I perform bi-clustering on the similarity matrix
between tissues/ cell types. I compute similarities using Pearson’s correlation, after
adjusting expression profiles for the effect of housekeeping genes. Figure 3.3 shows
the clustered heat-map of samples in each of my datasets. Each coherent group of
samples is marked according to the majority of cell types/ tissues in the group. For
the immune cell dataset, B-cell (mature) and hematopoietic stem cell (HSC) are two
of the largest coherent groups, followed by erythrocyte (ERY), granulocyte/monocyte
progenitor (GMP), and granulocyte (GRAN). In the cancer cell line dataset, lymphoid
tissues comprise the largest coherent group, followed by lung, skin, colo-rectal, and
breast groups. These groups are the major separable clusters at the first level of hierarchy. The size of each group is related to the total number of samples for that
tissue/ cell type, whereas consistency within the group is related to the homogeneity
of cell types. For example, lymphoid tissues exhibit three separate subtypes in the
heat-map, which correspond to bone marrow, lymph node and blood.
I use a recent method proposed by Gaiteri [52] to automatically identify these
separable groups. This algorithm is a modification of the label propagation clustering
that corrects for the global frequency of labels, which in turn allows it to identify
more refined clusters. I compute similarity matrices before and after adjustment, and
remove all negative entries after computing the correlation scores. Next, I match
each identified cluster to known groups in each dataset. I first construct a weighted
bipartite graph between clusters on one side and known groups of cell types on the
other, by assigning a hypergeometric p-value to the size of their overlap. I then use
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(a) Immune cell types

(b) Cancer cell lines

Figure 3.3.: Heatmap of tissue/cell type similarities after the adjustment process for
housekeeping genes

a maximum-weight bipartite matching algorithm [102] to compute the best match
for each cluster. I rank each tissue/ cell type according to the best matched cluster,
i.e., how well identified clusters capture each group. Table 3.2 summarizes the set of
tissues/ cell types in each dataset best matched to the identified set of clusters. Interestingly, all major separable groups in the cancer cell line dataset are captured by at
least one cluster. In addition, brain and pancreatic tissues both have a corresponding
cluster, even though in the heat-map, they were not distinguishable from the rest
of tissues. On the other hand, for immune cell types, clusters cover a majority of
separable cell types, with the exception of GMP, which is a heterogeneous group by
itself consisting of a group of progenitor cells in the myeloid branch. Memory T-cells
are also strongly connected in the heat-map, but are split into different groups, with
the groups themselves being fairly homogeneous. We note that, in general, known
tissues in the cancer cell lines dataset are better represented by their clusters than
the immune cell types, in terms of their overlap p-value. I hypothesize that this phenomena is due to higher underlying similarity among immune cell types that is not
separable using only one level of clustering.
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Table 3.2: Significance of matching known functional groups to the clusters identified
using the new cell similarity kernel
(a) Immune cell types

−log10 (p − val)

Celltype
Hematopoietic stem cell

8.36

Erythroid

7.63

Mature B-cell class able to switch

4.90

CD4+ Central Memory

4.34

Granulocyte (Neutrophil)

3.88

Basophils

3.60
(b) Cancer cell lines

Cellline origin

−log10 (p − val)

lymphoid

120.02

skin

51.45

breast

38.86

colo-rectal

38.43

brain

13.17

lung

11.85

pancreas

11.75

In order to assess the performance of my method, I applied the same procedure on
each of the clusters, representing major cell types, to identify more refined clusters,
where each cluster represents a sub-cell type. In addition to the cell type hierarchy
identified using adjusted/unadjusted transcriptional signatures, I also identified cell
types using SNN Cliq method [213], which is shown to outperform both k-means and
DBSCAN methods in identifying cell types. Figure 3.4 compares the final clustering
results, using NMI and Purity measures, which are two of the most well-used ex-
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trinsic measures to evaluate clustering results. It can be seen that in all case, label
propagation clustering using adjusted signature outperforms the other two methods.
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Figure 3.4.: Performance of different methods for de novo identification of cell types
using Label Propagation

In summary, label propagation applied to the similarity scores after adjustment
for housekeeping genes can automatically identify groups of cell types/ tissues with
coherent functions/ expression. These groups can be used as a hierarchical prior to
define the expression domain of tissue/ cell type-specific genes and their corresponding
pathways, as I demonstrate in the next section.

3.3.4 Putting the Pieces Together: Automated Identification of Cell Types and Their
Characteristic Markers
I have, thus far, shown that adjusted transcriptional signatures are capable of
identifying highly accurate cell-type markers. Furthermore, being accurate representations of cell type/ tissue-specific functionality, these signatures are better suited
to quantifying cell type-cell type and tissue-tissue similarities. These similarities, in
turn, can be used to identify coherent groups of cell types/ tissues. Here, I show
that highly expressed genes within identified clusters are enriched with tissue/ cell
type-specific pathways. I select the top three clusters that correspond to top three
best-covered tissues of origin in the cell lines dataset as my test cases. First, I ap-
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ply the adjustment process over each cluster, instead of known groups. I then filter
each cluster signature vector to select anything above z-score threshold of 1.96. I
use these three genesets and performed GO enrichment analysis over each one of
them using the GOsummaries package in R/Bioconductor [95]. This package relies on the g:Profiler [153] package to identify and summarize enriched terms using
their hierarchical relationships, but also generates a word cloud of the final, simplified results. Figure 3.5 shows the enrichment for the top three clusters in the cancer
cell line dataset, which are lymphoid, skin, and breast, respectively. I note that the
annotations of each cluster are consistent with the matched pair of known groups.
Furthermore, each cluster is highly enriched with respect to related tissue-specific
functions. This validates the fact that the grouping/ marker detection process is able
to automatically identify cell types/ tissues, and to identify highly specific markers.

3.3.5 Adjusted Signatures Predict Tissue-specific Transcriptional Regulatory Networks
Tissue/ cell type-specific transcription factors (tsTFs) are significantly implicated
in various human disorders [123, 150], including cancers [197]. Having established
that adjusted signatures can be used to identify marker genes from among identified
clusters, I now construct core regulatory networks responsible, in each tissue, for
defining its identity. I focus on the same set of tissues as in Section 3.3.4. For
each tissue, I first identify the set of transcription factors that are highly expressed,
specifically in that tissue. I then assign a p-value to each of these TFs by looking at
their target genes. I identify how many total targets each TF has, how many of them
are expressed (above z-score of 1.96), and how many total genes are expressed in the
adjusted signature. Using these statistics, I compute the p-value of tissue-specificity
for each selected TF using the tail of hypergeometric distribution. A TF is deemed
signficant in a given tissue if it is specifically expressed highly in that tissue, after the
iterative adjustment process, and has a significantly large number of targets that are
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Figure 3.5.: Enrichment of top-ranked genes in the top three clusters in cancer cell
lines dataset using new similarity measure for cells

also highly expressed. I identify a minimal set of 12, 14 and 8 TFs for lymphoid, skin,
and breast tissues, respectively. I then construct the tissue-specific transcriptional
regulatory network (tsTRN) as the bipartite graph consisting of the selected TFs,
together with their highly expressed gene targets. For breast, GRHL1 just has a
self-loop, whereas, in skin network, NDN TF is only connected to NGFR. I exclude
these two TFs from further study. Figure 4.7 shows three networks corresponding to
the tsTRN of these tissues.
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Functional enrichment analysis of identified TFs shows a very significant and very
relevant set of functions. Myb is a known proto-oncogene and its over-expression plays
a key role in development of chronic B-lymphocytic leukemia (B-CLL) [198]. On the
other hand, POU2F2, SPI1, MEF2C, MYB, IRF4, IRF8, IKZF3, and HCLS1 are
all involved in the hematopoiesis (GO:0030097 p-val = 3.6 × 10−9 ). Among these
genes, SPI1 has the highest connectivity in the constructed lymphoid-specific TRN
(Figure 3.6a). This TF regulates gene expression during myeloid and B-lymphoid cell
development. In skin-specific TRN (Figure 3.5b), TFAP2A has the highest connectivity, but CTNNB1 has a higher centrality. Interestingly, a subset of TFs in this
network, LEF1,CTNNB1, and ALX1, are known to be involved in the positive regulation of epithelial to mesenchymal transition (p-val = 3.2 × 10−6 ). This suggests that
the skin-specific network can be used to identify new targets for trans-differentiation.
Finally, breast-specific TRN is centered around Estrogen Receptor 1 (ESR1), Androgen Receptor (AR), and Forkhead Box A1 (FOXA1) TFs. These TFs, together with
progesterone receptor (PGR), constitute the core of the steroid hormone mediated
signaling pathway (p-val = 9.4 × 10−7 ), and essential for sexual development and
reproductive function. In summary, these tsTRNs, identified automatically from the
given cell type/ tissue-specific transcriptome, capture highly relevant functionalities
that are fundamental to the core identity of each cell type. I conclude that, my framework can identify hypothesized groups of related cells, identify their common markers,
and construct the underlying circuits that regulate the context-specific machinery.
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Figure 3.4.: Tissue-specific transcriptional regulatory network (tsTRN) of top 3 clusters identified in the cancer cell lines dataset
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4 DE NOVO IDENTIFICATION OF CELL TYPES FROM SINGLE-CELL
TRANSCRIPTOME
4.1 Background
Complex tissues consist of heterogeneous populations of interacting cells that are
specialized to perform different functions. With rapid growth in single cell transcriptomic technologies, the observed diversity of known cell types has greatly expanded.
What were once believed to be homogeneous groups of cells can now viewed as ecosystems of varying cell types [186]. In tumor microenvironments, for example, immune,
stromal, and cancerous cells coexist, cooperate, and compete for resources. The exact composition of these cells, as well as their molecular makeup, have significant
impact on diagnosis, prognosis, and treatment of cancer patients [129]. Single cell
technologies have already been proven useful for dissecting this complex microenvironment [156]. Using the rapidly growing datasets of single cell gene expression
profiles, a key challenge is to identify de novo cell types directly from genome-wide
transcriptomic phenotypes [176]. An important problem in cell type identification is
the existence of rare but key cell types, such as circulating tumor cells [145]. Beyond
identifying cell types, it is also import to identify factors that distinguish them from
other cell types.
I propose a new method, called Archetypal-analysis for cell type identificaTION
(ACTION), to identify cell types from single cell expression datasets. My method is
robust to biological noise, identifies a wide range of cell types with varying relative
populations, and provides a novel mechanism for constructing transcriptional regulatory networks (TRN) that mediate characteristic behaviors of each cell type. At the
core of my method is a biologically-inspired metric for similarity of cells, as characterized by their transcriptional profiles. This metric accounts for specificity of marker
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genes and defines a signature for each cell that is robust to noise. At the same time,
it is sensitive enough to capture weak cell type-specific signals. This metric helps us
construct a geometric representation for the space of principal functions, which are
groups of distinguishing functions that are uniquely performed by specialized cells.
In this space, assigning cells to their closest principal function accurately identifies
cell types. Finally, I develop a statistical framework to identify key marker genes, as
well as transcription factors that are responsible for mediating the observed expression of these markers. I use these regulatory elements to construct cell type-specific
transcriptional regulatory networks.
My method provides a flexible approach for directly mapping characteristic transcriptional regulatory networks of cells from the raw transcriptomic data. I apply
my method to the problem of subtyping Melanoma patients and identify a coherent subclass, which closely resembles noninvasive tumors [201]. For this subclass, I
characterized key marker genes, as well as their underlying pathways. This analysis
highlights a MITF-associated regulatory network and suggests a potential mechanism
for distinguishing invasive and proliferative types of melanoma.
Significance. A few methods have been proposed for the problem of cell type identification [65, 70, 82, 96, 117, 213, 219]. A common theme underlying these methods is
to cluster coherent cells as putative cell types [176]. At the core of these clustering
methods is a similarity measure that defines relationships among cells. A majority
of prior methods rely on classical measures such as correlation or Euclidean distance
to define such relationships. However, this approach is confounded by ubiquitously
and highly expressed levels of housekeeping genes. Cell type-specific markers, on the
other hand, have a weaker signal in comparison. This, in turn, causes a majority
of traditional techniques to be driven by biological noise contributed by housekeeping genes [125]. To overcome this, methods – such as ACTION – that are robust
to biological noise but are sensitive enough to identify cell type-specific signals are
critically needed. Once the identity of a cell has been established, it is unclear what
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Figure 4.1.: Five main components of ACTION

distinguishes it from other cell types. Transcriptional regulatory networks (TRNs)
are important aspects of this differentiation process. Understanding cell type-specific
TRNs has the potential to explain distinguishing mechanisms underlying observed
transcriptional phenotypes. ACTION is among the first set of methods to directly
infer cell type-specific networks from single cell expression datasets.

4.2 Materials and Methods
4.2.1 Datasets
Single cell gene expression datasets For all my studies, I rely on the following
datasets collected from publicly available sources:
Immune (from Supplementary Material) : Comprehensive qPCR based assay
of 1522 immune cells. This dataset spans 30 different types of stem, progenitor,
and fully differentiated cells [67].
Melanoma (GEO: GSE72056) : This dataset measures the expression profile of
4,645 malignant, immune, and stromal cells isolated from 19 freshly procured
human melanoma tumors. These cells are classified into 7 major types [183].
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MouseBrain (GEO: GSE60361) : This dataset contains the expression profile
of 3005 cells from the mouse cortex and hippocampus. These cells classify into
7 major types, including astrocytes-ependymal, endothelial-mural, interneurons,
microglia, oligodendrocytes, pyramidal CA1, and pyramidal SS [219].
Pollen (SRA: SRP041736) : This is a small, but commonly used dataset that
contains different cell types in developing cerebral cortex. It consists of 301
cells that classify into 11 distinct cell types [146].
Immune subtype markers I collected immune cell markers for 22 subclasses from
a recent paper [129]. This dataset contains a total of 547 markers, spanning 7 different
T-cell subtypes, B-cells, NK cells, and myeloid derived subclasses. This dataset is
collected and heavily curated from publicly available databases.
Transcriptional Regulatory Network (TRN) I collect transcription factor (TF)
– target gene (TG) interactions from the RegNetwork database [110], which aggregates data from 25 different databases. This dataset contains a total of 151, 214
regulatory interactions between 1, 408 TFs and 20, 230 TGs.

4.2.2 Overview of Prior Methods for Cell-type Identification
Various methods have been developed to tackle the problem of cell type identification. SNN-Cliq [213] computes a similarity graph among cells, referred to as
shared nearest neighbor (SNN). It then uses a graph-based clustering algorithm to
identify dense subgraphs. TSCAN [82] starts by grouping genes with similar expression patterns into “modules” and represents all cells in this reduced space. It
then performs principal component analysis (PCA) over the module space to further
reduce dimensions. Finally, cells are clustered by fitting a mixture of multivariate normal distributions to the data, with the number of components estimated using the
Bayesian Information Criterion (BIC). SCUBA [117] first uses k-means with gap
statistic to cluster data along an initial binary tree by analyzing bifurcation events
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for time-course data. Then,it refines the tree using a maximum likelihood scheme.
BackSPIN [219] is based on SPIN algorithm, which permutes correlation matrix of
cell types to extract its underlying structure. BackSPIN then couples it with a divisive splitting procedure to identify clusters from the ordered similarity matrix. Two
methods are specifically designed to identify rare cell types. RaceID [65] uses k-means
to first cluster cells, with the number of clusters identified using gap statistic. Then,
it identifies rare cell types as outliers that are not explained by an appropriate noise
model, accounting for both biological and technical variations. GiniClust [83] aims
to identify marker genes that are specific to rare cell types using the concept of Gini
index. Then, it computes distances between cell types in this reduced subspace and
uses DBSCAN clustering algorithm to identify cell types. In addition to these methods, there are approaches that visualize cell types on a continuous spectrum in a given
space. Haghverdi et al. [68] proposed to use diffusion maps to model the continuous
spectrum of cells. On the other hand, Korem et al. [96], adopted a previously developed method, called Pareto task inference (ParTI) method [70], and applied it
to single cell datasets.

4.2.3 Overview and Justification for ACTION ’s Components
In the following sections, I describe various components of ACTION, as shown
in Figure 4.1. I first explain exactly how the metric, illustrated in Figure 4.4a, is
computed from a matrix of raw cell expression profile data (Step 1 in the overview).
Next, I explain how ACTION identifies the principal functions of a set of cells,
assuming it knows the number of principal functions (Step 3 in the overview). I
use an elbow method based on the quality of the principal functions to choose the
actual number of principal functions (Step 2 in the overview). Finally, I explain how
to estimate the transcriptional regulatory network for a specific principal function
(Step 5) by orthogonalizing the functional space of cells (Step 4).
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4.2.4 Step 1: A Biologically-inspired Metric for Similarity of Cells
Justification The transcriptome of each cell consists of genes that are expressed at
different levels and have different specificity with respect to the underlying cell types.
Housekeeping genes are the subset of genes responsible for mediating core cellular
functions, such as translation, transcription, and DNA repair. These functions are
needed by all cells to function properly, which result in ubiquitous expression of these
genes across all cell types [45]. While fundamental to cellular function, these genes
are not informative with respect to the identity of cells. That is, the fact that a
housekeeping gene is expressed in a cell does not provide any information regarding
its cell type. On the other hand, cell type-specific genes are preferentially expressed
in one or a few selected group of cell types to perform cell type-specific functions.
Unlike housekeeping genes, cell type-specific genes are highly relevant for grouping
cells according to their common functions. My goal here is to define a similarity
measure between cells that suppresses the noise contributed by housekeeping genes
and enhances the signal contained in cell type-specific genes.
Suppressing housekeeping genes To suppress the ubiquitously high expression
of housekeeping genes, I adopt a method that I developed recently for bulk tissue
measurements and extend it to single cell analysis [125]. The core of this method
is to project a standardized representation of expression profiles of cells onto the
orthogonal subspace of housekeeping genes. Let us denote given expression profiles
of cells using matrix X ∈ Rm×n , where each row corresponds to a gene and each
column represents a cell. I use the shorthand xi to denote the expression profile of
ith cell. In addition, let us denote the signature vector of housekeeping genes by v.
As a first order estimate, housekeeping signature is computed by taking the average
P
expression over all cells: v = n1 ni=1 xi . This choice is optimal in a least-square
sense when the chance of observing a gene is uniform across all cells. Then, I z -score
normalize the profile of each cell: z i =

xi −µi
,
σi

where µi and σi are the mean and

sample standard deviation of the entries in the ith cell profile. Similarly, I z -score
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normalize the signature vector of housekeeping genes, v, to create a new vector z v .
Finally, I project out the impact of the housekeeping gene expressions on each cell’s
profile as follows:
=
z⊥
i


z v z Tv 
zi.
I−
kz v k22

(4.1)

This operation projects zi to the orthogonal complement of the space spanned by the
housekeeping genes. I then concatenate the column vectors z ⊥
i to create a matrix
Z ⊥.
Enhancing signal from cell type-specific genes Next, to enhance the signal
contributed by preferentially expressed genes, I propose an information theoretic
approach, which in essence is similar to the one used previously for marker detection [160]. The idea is to use Shannon’s entropy to measure the informativeness of
gene expressions. If a gene is uniformly expressed across cells, it contains less information as opposed to the case in which it is selectively expressed in a few cells.
To this end, I first shift all entries of Z ⊥ by its minimum value to ensure positivity.
Then, I normalize this shifted matrix to construct a new matrix P, in which every
row has sum one. Let pj be the row vector associated with the jth gene. Then, I
P
compute the entropy of pj as: H(j) = − j pji log(pji ), where pji is an entry in the
matrix P. Finally, I use these entropy values as a basis to boost contributions from
the most informative genes. To this end, I compute a scaling factor for each gene as
follows. First, I partition genes as either informative or noninformative by finding
the location of the most rapid shift in uniformity values, which resembles a L-shaped
curve. Let us denote the entropy of the gene on the edge of this partition by H ∗ .
Then for each gene j, I define a scaling factor as sj = H ∗ /H(j). Finally, I compute
the kernel matrix as follows:

K = (Z ⊥ )T diag(w)Z ⊥

(4.2)
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where function diag() creates a diagonal matrix from elements of a given vector,
and each entry wi = s2j . In this formulation, if I denote Q = diag(c)Z ⊥ , then
K = QT Q defines a dot-product kernel.

4.2.5 Steps 2 and 3: A Geometric Approach to Identify Principal Functions (Representing Pure Cell Types)
Transcriptional profiles of cells that perform multiple functions can be represented
using a limited repertoire of principal functions. The functional space of cells, thus,
can be represented by a low-dimensional geometric construct.
The convex hull of a given set of points is the minimum volume polytope that
encloses all points. This can be envisioned as a rubber band fitting to the outermost points. The functional space of cells that perform multiple functions can be
represented using a limited repertoire of principal functions, which has recently been
shown to be embedded within a reduced convex hull [70]. The corners, or archetypes,
of this space represent principal functions, associated with specialized groups of cells.
Identifying the enclosing convex hull in high-dimensional space is computationally
expensive and susceptible to noise and overfitting. As an alternative, I seek a limited
number of points on the convex hull that enclose as many points as possible, while
being resilient to noise and outliers. To this end, I first use the successive projection
algorithm (SPA) to identify k transcriptional profiles as initial corners for the covering
convex hull, each of which corresponds to a pure cell that is specialized to perform a
set of unique principal functions. Then, I use principal convex hull algorithm (PCHA)
combined with my distance kernel to adjust these corners by allowing others cells to
contribute to the identity of each archetype/corner. This is combined with a standard
model selection technique to estimate the number of principal functions.
A quick sketch of my procedure is as follows. I expand on this description in
subsequent sections. For each k = 1, . . . , Kmax , (i) identify potential “pure”
cells: use SPA on the raw expression data X to find k pure cells that are near
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extreme points of the functional space; and (ii) adjust the corners: initialize PCHA
using the profiles of those k cells and iterate using the kernel K. Then let V (k) be
the PCHA objective function with k archetypes. Finally after all models have been
adjusted, (iii) estimate the number of cell types from V (k) such that it balances
the number of cells and the total explained variance.

Estimating “pure” Cells As Extreme Corners of the Functional Subspace of Cells
Given a raw expression matrix X, I aim to identify an “optimal” set S of k “pure
cells.” These cells can be viewed as extreme corners of the convex hull of the functional
space of cells, and all other samples can be written as convex combinations of these
basis vectors. Under a strict assumption, known as separability, I seek to identify k
columns such that X = X(:, S)H, where S is the selected column subspace of matrix
X and H is non-negative. This means that every column of X is a non-negative linear
combination of a subset S of all columns. In terms of cells, this means that every
cell’s expression profile is a combination of a few cells. However, this is a very strong
assumption that rarely holds in real data. A relaxation of this assumption, referred to
as near-separability, seeks to estimate X ≈ X(:, S)H+N, where the noise is bounded:
kN(:, j)k2 ≤ ε. This decomposition is known as near-separable Nonnegative Matrix
Factorization (NMF). The Successive Projection Algorithm (SPA) is an efficient algorithm for solving near-separable NMF with provable performance guarantees [57].


σmin (W)
If ε satisfies the technical condition ε ≤ O √
, then:
kκ2 (W)



min kX − X(:, S)Hk ≤ O κ (W)
0≤H

2

(4.3)

More recently, other techniques have been developed to enhance the robustness
of SPA to noise [58]. These methods are based on the fact that premultiplying matrix X by an orthogonal matrix Q preserves its separability. Thus, by carefully
choosing matrix Q, I can enhance the conditioning of the problem. Here, I use the
prewhitening technique, which uses SVD decomposition of matrix X to estimate a
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noise-reduced approximation matrix. Algorithm 1 presents the SPA algorithm combined with prewhitening technique that I use to estimate a set of k cells.
Input: X ∈ Rm×n : expression profile of cells
Output: S: selected subset of columns in matrix X
1:

[Uk , Σk , Vk ] = SVD(X, k)

2:

e = Σ−1 UT X = VT {Prewhitening}
X
k
| k{z k}
Q

3:

e ⇒ Initialize
S = {}, R = X

4:

for i = {1, · · · , k} do

5:

α = argmaxj kr j k2 {r j is the jth column}

6:

β = R(:, α)

7:

R ← (I −

8:

S ← S ∪ {β}

9:

ββ T
)R
βT β

{Orthogonal Projection}

end for
Algorithm 1: SPA algorithm with prewhitening

Adjusting Selected Corners to Allow Contributions From All Cells
Archetypal-analysis (AA) [35] can be viewed as a generalization of near-separable
NMF. While in near-separable NMF all columns are represented using k columns in
X, in AA this constraint is relaxed to be a convex combination of all columns in X.
Formally, I can formulate AA as follows:
minimize
C,H,α

kX − XCHk

subject to kC(:, i)k1 = 1.

(4.4)

kH(:, i)k1 = 1.
0 ≤ C, 0 ≤ H
Near-separable NMF is a special case of AA in which C has exactly k nonzeros and
none of the columns have more than one element. The matrix W = XC here stores
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Figure 4.2.: Example of running PCHA algorithm

the archetypes. Joint column stochasticity of C and H indicates that archetypes are
convex combinations of data points, and each data point can be represented as convex
combination of archetypes.
There is an algorithm, called Principal Convex Hull Analysis (PCHA), to solve
the above problem. The intuition behind PCHA is to fit a polytope to the data
points, which approximates the optimal polytope containing as many data points as
possible. Figure 4.2 illustrates this phenomena.
I use a kernelized version of PCHA algorithm that minimizes the objective:
trace(−XT XCH − HT CT XT X + HT CT XT XCH)

(4.5)

in which I directly provide the ACTION kernel K as XT X and initialize C based on
the solution to SPA.

4.2.6 Estimating the Total Number of Archetypes Needed to Represent All Cell
Types
A key challenge in all parametric methods is to identify the optimal configuration
for associated parameters. In my formulation, the total number of archetypes (corner points) must be provided by the user or directly estimated from the data. To
automatically identify this number, one can use various measures of “goodness” to
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assess overall performance as I increase the number of archetypes. A balance between
the number of archetypes and the goodness of solution provides an optimal compromise. I use variance explained by the fit as a measure to find the optimal number of
archetypes. For each archetype count (up to a max value), I fit a convex hull to the
data and compute explained variance.
The explained variance has an elbow-shape, meaning that it starts increasing
rapidly, then it plateaus. The corner of this L-curve is an optimal choice for the
number of archetypes. To find this point automatically, I fit a piecewise linear model
to the data with two split points. This allows us to distinguish both rapid and more
gradual shift patterns in the L-curve. Formally:




m1 c + b1 , for 0 ≤ c < ci



f (c) = m2 c + b2 , for ci ≤ c < cj





m3 c + b3 , for c < cj ≤ cmax

(4.6)

where c is the archetype count and ci and cj are two free parameters. I evaluate
every pair of (ci , cj ); 1 ≤ ci < cj ≤ cmax and fit a minimum least squares fit to each
piece. The configuration with minimum overall error is selected as cbest
and cbest
.
i
j
For this specific configuration, let m2 and m3 represent the slope of the second and
the third linear fits. Then, if

m2
m3

is less that or equal to a user-defined parameter

thresholdmin , then I select the first split point (cbest
). Otherwise, I have a rapidly
i
shifting curve and the slopes of second and third segments are very close. Thus, I
select the second split point as the choice of k. Figure 4.3 illustrates an example
of fitting process. The pink dots represent the explained variance for archetypal fits
with increasing number of archetypes. Green lines show the piecewise linear fit to the
data. The optimal number of archetypes is selected according to bestj in this case,
which is nine.
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Figure 4.3.: Illustration of identification of total number of functions for the Pollen
dataset

4.2.7 Steps 4 and 5: Constructing the Transcriptional Regulatory Network Corresponding to Each Archetype
Each archetype represents a principal function performed by a group of cells.
However, what makes these functions unique and the functional specializations they
represent is not clear from the archetype signatures. To identify marker genes in
each archetype, and to shed light on the underlying network regulating the observed
transcriptional phenotype, I developed a novel approach based on orthogonalizing the
space of principal functions.

Archetype orthogonalization to Identify Cell Type-specific Markers
A key factor in analyzing principal functions represented by each archetype is to
identify what distinguishes one archetype from others. To identify shared and unique
aspects represented by each archetype, I present a new method, called arechetype
orthogonalization. The idea is to remove effects that are shared with any other
archetypes before analyzing a given archetype.
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Recall the result of PCHA is C and H. The result XC represents the archetypes
in the space of gene expression profiles. Let us denote the vector representation of
archetype i by ai and let A be the matrix of all archetypes. Let A−i denote the
matrix of archetypes without the ith column. Then our goal is to project ai into the
subspace orthogonal to the columns spanned by A−i . This can be computed as:


T
−1 T
a⊥
=
I
−
A
(A
A
)
A
(4.7)
i
−i
−i −i
−i ai
For each archetype, I can sort all genes according to their “residual expression” after
orthogonalization.

Identifying Cell Type-specific Transcriptional Regulatory Network (TRN)
Given residual expression vectors for each archetype, I can identify key regulatory
circuits responsible for the observed transcriptional phenotype. I construct induced
subgraphs of the global transcriptional regulatory network (TRN), which drive characteristic behavior of each cell type. First, I order all genes according to their residual
expression for a given archetype. Then, for each transcription factor (TF), I identify
the over-representation of its target genes (TGs) among top-ranked genes with respect
to that archetype. To this end, I use minimum hypergeometric (mHG) p-value. This
method is nonparametric, in the sense that I do not need to predefine a fixed cut. Let
us represent the total number of genes by m. Given a set of target genes, of size T ,
I construct a binary vector of true positives (targets) as λ = [λ1 , λ2 , ...λm ] ∈ {0, 1}m .
Let the random variable Z denote the number of target genes among a fixed number
of l top-ranked genes, if I distribute genes randomly. In this formulation, I can express
the p-value in terms of the hypergeometric distribution:
p-value(Z = bl (λ)) = Prob(bl (λ) ≤ Z)
= HGT(bl (λ)|m, T, l)
min(T,l) T  m−T 
X x l−x

=
m
x=bl (λ)

l

(4.8)
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where HGT is the tail of hypergeometric distribution and bl (λ) =

Pl

i=1

λi counts the

total number of true positives in top-l observations. The drawback of this approach is
that I still need a predefined cutoff value, l. To remedy this, Eden et al. [43] proposed
a two-step process for computing the exact enrichment p-value, called mHG p-value,
without the need for a predefined cutoff value of l. First, an optimal cutoff value is
chosen among all possible values of 1 ≤ l ≤ N . The computed value for this optimal
cutoff is called the minimum hypergeometric (mHG) score, and is defined as:
mHG(λ) =

min p-value(Z = bl (λ))

1≤l≤m

(4.9)

Next, a dynamic programming (DP) method is used to compute the exact p-value of
the observed mHG score, in the state space of all possible λ vectors of size m having
exactly T ones.
I use this formulation to identify significant transcription factors based on the
number of target genes (TGs) with high residual expression. This, in turn, splits
TGs of each TF into top vs bottom-ranked genes. I then select all significant TFs,
together with their top-ranked target genes and construct a node-weighted induced
subgraph of the global TRN, which represents the cell type-specific TRN.

4.3 Results and Discussion
The ACTION framework consists of three major components, shown in Figure 4.1:
(i) A robust measure of cell-to-cell similarity, (ii) A geometric approach for identification of principal functions, and (iii) a statistical framework for constructing cell-type
specific transcriptional regulatory networks (TRNs). My cell-to-cell similarity metric
is rooted in the notion that functional roles of a cell form an embedded hierarchy,
with successively refined set of tissue-specific functions. When used with a classic
clustering algorithm such as k-means, ACTION metric surpasses all other measures
of cell similarity in identifying cell types. The next component of my method is a
geometric approach for identifying principal functions of cells, each represented by
an archetype (corner) of the convex hull in the functional space of cells. Finally,
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Figure 4.4.: Evaluation of ACTION Similarity Metric

ACTION uses a novel method that utilizes the geometric view of cell functions to
construct the transcriptional regulatory network (TRN) that mediates characteristic
behavior of each cell type. In what follows, I describe, validate, and discuss each
component in detail.

4.3.1 Component 1: Measuring Cell-to-cell Similarity
An essential component of any method for identifying cell types is the ability to
quantify similarity between individual cells. Most prior methods rely on traditional
measures, such as Euclidean distance, that are not specifically targeted towards transcriptomic profiles. In contrast, I define a similarity metric, or formally a kernel,
specifically designed for measuring similarity between cells [125]. My approach is
based on the observation that housekeeping genes, while not informative of cell type
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identity, significantly impact traditional measures of cell similarity due to their ubiquitous and high expression levels. Suppressing these genes significantly enhances the
signal-to-noise ratio (SNR) in expression profiles, allowing us to extract a stronger
cell type-specific signal.
Novel methodology my method starts by projecting transcriptional signatures to
the orthogonal subspace spanned by housekeeping genes. I then boost the contribution of cell type-specific genes using an information theoretic approach. Finally, I
combine these two measures to define a robust measure of cell-to-cell similarity. This
approach is illustrated in Figure 4.4. The mathematical models underlying the metric
are described in the Methods section.
Validation To establish the superiority of my metric, I compare it against one measure specifically designed for single cell analysis, SIMLR, and two general measures:
multidimensional scaling (MDS), and Isomap. SIMLR [205], combines a number of
distance metrics to learn a joint similarity score that maximizes the block diagonal
structure of the resulting matrix. Both MultiDimensional Scaling (MDS) and Isomap
are nonlinear dimension reduction techniques. The former method projects points into
a low-dimensional space, such that distances between samples are preserved to the
extent possible. The latter method first computes the nearest neighborhood graph of
data points. It then uses shortest path between vertices as a measure of distance between them. Finally it uses MDS to embed these distances in a low-dimensional space.
After projecting the data to a lower dimension space in either MDS or Isomap, one
can use linear correlation in the transformed subspace to measure similarity between
cells. While ACTION is a non-parametric method, other methods need additional
input. For SIMLR, I need to provide the true number of cell types. In order to give
the other methods the best chance at competing with ACTION, I evaluate them using
ten different values for dimension of projected subspace (from 5 to 50 with increments
of 5) and report the best results obtained over all configurations.
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To assess the quality of computed similarities between cells, I use each of the four
measures to cluster cells and identify cell types. Each cluster is assumed to represent
a unique cell type, and the clusters are determined using the commonly used kernel
k-means algorithm. I compare the computed cell types with the true (known) cell
types in terms of Normalized Mutual Information (NMI) and Adjusted Rand Index
(ARI). Normalized Mutual Information is an information theoretic measure that is
zero for random clustering (when the identified clustering contains no information
about true cell types), and one for a clustering that perfectly matches a given gold
standard. The ARI measure is also between zero and one; however, it evaluates the
cases in which a given pair of cells are either co-clustered in both true and identified,
or classified separately in both.
In each case, I perform 100 independent clusterings with random initialization
and report the average of NMI and ARI scores as quality measures (relative ordering
of results is robust with respect to other aggregating functions, such as median or
max). These experiments are independently performed for each dataset. Figures 4.4bd present the performance of the cell type identification technique operating with
different similarity measures, both in terms of their clustering quality (NMI and
ARI) and total running time.
Discussion of results on similarity metric To evaluate performance of each
similarity metric, I analyzed four different datasets, which are listed in Section 5.2.1.
These datasets have different number of cells, ranging from hundreds to thousands,
span a wide range of normal and cancerous cells, and are measured using different
single cell technologies.
For both MouseBrain and Pollen datasets, ACTION metric significantly outperforms other metrics in terms of both NMI and ARI measures. For the Melanoma
dataset, ACTION has significantly better NMI, but there is a tie between ACTION,
MDS, and SIMLR with respect to the ARI measure. Finally, for the Immune dataset,
there is a tie between ACTION, MDS, and SIMLR for both measures. In all studies,
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Figure 4.5.: Performance of ACTION in identifying cell types

t-test with p-val ≤ 10−2 has been used to assess significance of difference between
observed NMI/ARI values. In summary, my results demonstrate that in all cases ACTION metric is either significantly better or at least as good as any other methods.
Thus establishes the ACTION metric as a fast, nonparametric, and accurate method
for computing similarity among single cells. I use this measure throughout the rest
of my study. I note however, that my overall framework is flexible with respect to
choice of other similarity metrics.

4.3.2 Component 2: A Geometric View to Identify Discrete Cell Types
Novel methodology Using the ACTION metric as a measure of similarity between
cells, I develop a new method for identifying de novo cell types in a given experiment.
My method is based on a geometric interpretation of cellular functions. Each cell is
a data-point in a high-dimensional space. My method identifies “extreme” corners
in this space, and each cell is characterized by its distance to every corner. The
corners identified by ACTION represent “pure” cells that are specialized to perform
a principal function. This is in contrast to methods such as unsupervised clustering
(e.g., k-medoids) that identify the most common centers. My focus on identifying the
extreme points (and thus, principal functions), allows us to better identify rare cell
types.
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Validation. Each corner or archetype represents a principal function. I first validate these by considering each archetype as a characteristic cell type. I then identify the type of each cell by determining the closest archetype and assigning this
type. I compare my method to four recently proposed methods: SCUBA [117],
SNNCliq [213], single-cell ParTI [70, 96], and TSCAN [82]. Details of these methods
are given in the methods section. Clique size and density of quasi cliques of SNN Cliq
are left as default parameters (k = 3 and r = 0.7). Increasing clique size k did not
improve performance, but significantly increased the running time. With these parameters, SNNCliq did not terminate in 72h for the largest dataset (Melanoma), after
which I stopped the experiment. I present a comprehensive analysis of the results for
all other combinations of datasets/methods.
Discussion of results on cell-type identification. Figure 4.5 shows comparative
performance of different methods in predicting cell types in various datasets. In
all cases, except ARI for the Melanoma dataset, ACTION yields superior results
compared to the state-of-the-art methods for cell-type identification. In general,
NMI measure exhibits lower range of variation across methods, whereas ARI has
a higher range of variability. To further investigate the difference between ParTI and
ACTION on the Melanoma dataset, I manually evaluated each archetype identified
in these methods. My results indicate that the source of difference is that ACTION
identifies more refined subtypes of T-cells and subclasses of tumor cells, whereas
ParTI combines these subtypes/classes. These subgroup details are missing from
the annotations provided for the dataset by authors. Combining cell types that are
classified as different subtypes of T-cells or subclasses of tumor cells significantly
enhances the computed performance measures of ACTION in this dataset. This is
shown using gray boxes in the corresponding figure.
Analysis and validation of the principal functions. While cells can be classified based on their closest archetype, they can also be viewed on a continuum [70].
To illustrate this continuous view, I use the distance from each archetype as a low-
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dimensional embedding of the cells. I use the Fielder embedding, followed by adjustment using Stochastic Neighbor Embedding (SNE) method to visualize this lowdimensional embedding in Figure 4.6. Each archetype is marked with a text labeled
(A1, . . . , A11) point and assigned a unique color. Each point corresponds to a cell.
I interpolate its color using its distance to all archetypes to highlight the continuous
nature of the data. The labels for the groups are based on three sources. First, I perform enrichment analysis on the cells assigned to each archetype. Then, I use markers
provided in the original datasets to identify the cell type-specific expression in each
archetype. Finally, I use markers from LM22 dataset [129] to classify subtypes of
immune cells.
Figure 4.6 illustrates the ability of my method to identify both isolated cell-types
with specialized principal functions, as well as cells with a combination of functions.
As an example, different subclasses of T-cell constitute a spectrum with the corners
(or archetypes) representing specialized functions that are performed by a pure T-cell
subtype. In addition to given cell types, I also find an additional archetype, A6, which
links between T-cells and B-cells and I hypothesize to be a lymphocyte progenitor.
In terms of tumor cells, many of the patients form their own archetypes. The
two exceptions to this rule, A5 and A10, define a “MITF axis”, which is shown in
the subfigure (MITF is one of the transcription factors known be related to various
types of Melanoma [183,201]). Archetype A5 is enriched in five patients with varying
degrees of expression for MITF from mid to high. I collectively refer to patients
in Archetype A5 as MITF-associated patients. Archetype A10, on the other hand,
contains patients 81 and 82, both of who have low levels of MITF. In what follows, I
construct the transcriptional regulatory network responsible for mediating observed
phenotype of MITF-associated patients in A5.
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Figure 4.6.: A continuous view of cell types in the Melanoma dataset identifies subclasses of immune cells and highlights a MITF-related “axis”

4.3.3 Component 3: Constructing Subclass-specific Transcription Regulatory Network of MITF-associated Patients
Novel Methodology I propose a new method to construct regulatory pathways responsible for mediating phenotypes associated with each archetype. To this end, I first
perform an archetype orthogonalization (details described in Section 4.2.7), to compute residual expression and identify marker genes that are unique to the archetype.
Then, I rank all genes according to their residual expression. Finally, I project these
scores to the transcriptional regulatory network (TRN) to find key transcription fac-
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Figure 4.7.: The transcriptional regulatory network (TRN) for MITF-associated
Melanoma patients highlights a number of genes that have not previously been associated with Melanoma – along with some known markers

tors (TFs) responsible for mediating the observed transcriptional phenotype. For each
TF, I assess the over-representation of its targets among top-ranked genes (according
to the residual expression score). I use a dynamic programming algorithm [43] to assign exact p-values to each TF. For each TF, its “top ranked” target genes, according
to the cut that yields the minimum hypergeometric score, are also selected as part of
the regulatory network.
I apply this technique to identify regulatory pathways of MITF-associated samples. A p-value threshold of 0.05 is used to identify significant TFs. The final constructed network is presented in Figure 4.7. This network consists of six key transcription factors (in yellow), 85 target genes (in green/purple). Purple nodes are target
genes that are jointly regulated by two TFs. I marked enriched functions of each
group in the figure, accordingly, and highlighted elements that are already known to
be associated with Melanoma.
Validation MITF is one of the best-characterized markers for Melanoma, and is
also used in the original paper to classify patients [183]. It is notable here that my
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method identified MITF directly using data from the activity of its targets. Furthermore, since these transcription factors are identified based on the activity of their
target, they are “related” to the subclasses, however, the mechanism of their control
can be diverse.
Among other factors, BHLHE40 has the highest number of activated targets. This
factor, among other functions, regulates M-MITF, a melanocyte-restricted isoform of
MITF, and potently reduces expression of MITF under hypotoxic conditions [48].
Angiogenesis, or growth of blood vessels, is a hallmark of cancer. MEOX2 plays
multiple roles in this process. At low levels, it activates nuclear factor-κB (NK-κB), a
proangiogenic signaling pathway, whereas in high doses, it has an inhibitory role [27].
Similarly, TSG101 plays different roles depending on the context. In fibroblasts,
it acts as a tumor suppressor gene, whereas it has a tumor-enhancing role in some
epithelial tumors. This bidirectional regulation is postulated to be through expression
of MMP-9 in different cell types [159]. The role of other factors is less-studied.
Experimental evidence To further validate my results, I use the transcriptome
of 10 patients with invasive and proliferative melanoma subtypes from Verfaillie et
al. [201]. Proliferative subtype is characterized by high levels of MITF, as well as
SOX10 and PAX3. In contract, invasive subtype is known to have low levels of
MITF and high levels of epithelial-to-mesenchymal (EMT) transcription factor ZEB1,
and is associated with metastatic dissemination. Nodes in my MITF -associatied
TRN resemble the proliferative subtype. Thus, I use marker genes for this class to
validate my results. There are a total of 770 marker genes for the proliferative subtype
and among 91 total genes in my network, 8 genes coincide with them (p-value =
0.01). These genes include DCT, MITF, PAX3, PPFIBP2, PRKCZ, TP53, TYR,
and TYRP1, all of which have high residual expression compared to all other nodes.
Beside the MITF subnetwork, TP53, PRKCZ, and PPFIBP2 are also enriched in
this set. Interestingly, a key factor involved in the invasive subtype, MEOX2, is also
identified as a node in my network. As mentioned earlier, depending on the level
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of its expression, this gene can play different roles for proliferative versus invasive
subclasses.
Collectively, these results illustrate the effectiveness of the ACTION in identifying
novel cancer subtypes, their underlying regulatory network, and characteristic markers. This, in turn, presents new avenues for diagnosis and prognosis of melanoma
patients, as well as new therapeutic targets for further investigation.
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5 SEPARATING CELL TYPES AND THEIR RELATIVE PERCENTAGES
FROM COMPLEX TISSUES
5.1 Background
Source separation, or deconvolution, is the problem of estimating individual signal components from their mixtures. This problem arises when source signals are
transmitted through a mixing channel and the mixed sensor readings are observed.
Source separation has applications in a variety of fields. One of its early applications
is in processing audio signals [136, 173, 204, 218]. Here, mixtures of different sound
sources, such as speech or music, are recorded simultaneously using several microphones. Various frequencies are convolved by the impulse response of the room and
the goal is to separate one or several sources from this mixture. This has direct applications in speech enhancement, voice removal, and noise cancellation in recordings
from populated areas. In hyperspectral imaging, the spectral signature of each pixel
is observed. This signal is the combination of pure spectral signatures of constitutive
elements mixed according to their relative abundance. In satellite imaging, each pixel
represents sensor readings for different patches of land at multiple wavelengths. Individual sources correspond to reflectances of materials at different wavelengths that
are mixed according to the material composition of each pixel [57, 113, 131, 134, 203].
Beyond these domains, deconvolution has applications in removing noise from
biomedical sensors. Tracing electrical current in the brain is widely used as a proxy
for spatiotemporal patterns of brain activity. These patterns have significant clinical
applications in diagnosis and prediction of epileptic seizures, as well as characterizing different stages of sleep in patients with sleep disorders. Electroencephalography
(EEG) and magnetoencephalography (MEG) are two of the most commonly used
techniques for cerebral imaging. These techniques measure voltage fluctuations and

58
changes in the electromagnetic fields, respectively. Superconducting QUantum Interference Device (SQUID) sensors used in the latter technology are susceptible to magnetic coupling due to geometry and must be shielded carefully against magnetic noise.
Deconvolution techniques are used to separate different noise sources and to ameliorate the effect of electrical and magnetic coupling in these devices [72, 179, 199, 220].
At a high level, mixing channels can be classified as: (i) linear or nonlinear,
(ii) instantaneous, delayed, or convolutive, and (iii) over/under determined. When
neither the sources nor the mixing process is available, the problem is known as
blind source separation (BSS). This problem is highly under-determined in general,
and additional constraints; such as independence among sources, sparsity, or nonnegativity; are typically enforced on the sources in practical applications. A new
class of methods has been developed recently, known as semi or guided BSS [72,
136, 173, 204]. In these methods, additional information is available a priori on the
approximate behavior of either sources or the mixing process. In this chapter, I focus
on the class of over-determined, linear instantaneous (LI) mixing processes, for which
a deformed prior on sources is available. In this case, the parameters of the linear
mixer, as well as the true identity of the original sources are to be determined.
In the context of molecular biology, deconvolution methods have been used to
identify constituent cell-types in a tissue, along with their relative proportions. The
inherent heterogeneity of tissue samples makes it difficult to identify separated, celltype specific signatures, i.e., the precise gene expression levels for each cell-type. Relative changes in cell proportions, combined with variations attributed to the changes
in the biological conditions, such as disease state, complicate identification of true biological signals from mere technical variations. Changes in tissue composition are often
indicative of disease progression or drug response. For example, coupled depletion
of specific neuronal cells with the gradual increase in the glial cell population is indicative of neurodegenerative disorders. An increasing proportion of malignant cells,
as well as a growing fraction of tumor infiltrating lymphocytes (TIL) compared to
surrounding cells, directly influence tumor growth, metastasis, and clinical outcomes
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for patients [100,129]. Deconvolving tissue biopsies allows further investigation of the
interaction between tumor and micro-environmental cells, along with its role in the
progression of cancer.
The expression level of genes, which is a proxy for the number of present copies
of each gene product, is one of the most common source factors used for separating
cell-types and tissues. In the linear mixing model, the expression of each gene in a
complex mixture is estimated as a linear combination of the expression of the same
gene in the constitutive cell-types. In silico deconvolution methods for separating
complex tissues can be coarsely classified as either full deconvolution, in which both
cell-type specific expressions and the percentages of each cell-type are estimated, or
partial deconvolution methods, where one of these data sources is used to compute
the other [164]. These two classes loosely relate to BSS and guided-BSS problems.
Note that in cases where relative abundances are used to estimate cell-type-specific
expressions, the problem is highly under-determined. In the complementary case of
computing percentages from noisy expressions of purified cells, the problem is highly
over-determined. In the former case, I typically have only a handful of known cell
types with known percentages, and I need to estimate unknown expression values for
thousands of genes. In the latter case, I use known expression values of all genes
(or a selected subset that is typically much larger than the number of cell types) to
compute percentages of a small population of constituting cells. Thus, in the case
of an over-determined system, the key is to select the most reliable features that
satisfy the linearity assumption. I provide an in-depth review of recent deconvolution
methods in Section 5.2.3.
In contrast to computational methods, a variety of experimental cell separation
techniques have been proposed to enrich samples for cell-types of interest. However,
these experimental methods not only involve significant time, effort, and expense,
but may also result in insufficient RNA abundance for further quantification of gene
expression. In this case, amplification steps may introduce technical artifacts into
the gene expression data. Furthermore, sorting of cell-types must be embedded in
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the experiment design for the desired subset of cells, and any subsequent separation
is infeasible. Computational methods, on the other hand, are capable of sorting
mixtures at different levels of resolution and for arbitrary cell-type subsets of interest.
The organization of the remainder of the chapter is as follows: The formal definition of the deconvolution problem and its relationship to linear regression is defined
in Section 5.2.2. Sections 5.2.2 and 5.2.2 review different choices and examples of
the objective function used in regression. An overview of computational methods for
biological deconvolution is provided in Section 5.2.3. Datasets and evaluation measures used in this study are described in Sections 5.2.1 and 5.2.4, respectively. The
effect of the loss function, constraint enforcement, range filtering, and feature selection choices on the performance of deconvolution methods is evaluated systematically
in Sections 5.3.1-5.3.5.

5.2 Materials and Methods
5.2.1 Datasets
In Vivo Mixtures With Known Percentages
I use a total of five datasets with known mixtures. I use CellMix to download and
normalize these datasets [54], which uses the soft format data available from Gene
Expression Omnibus (GEO).
• BreatBlood [61] (GEO ID: GSE29830 ): Breast and blood from human specimens are mixed in three different proportions and each of the mixtures is measured three times, with a total of nine samples.
• CellLines [2] (GEO ID: GSE11058 ): Mixture of human cell lines Jurkat (T
cell leukemia), THP-1 (acute monocytic leukemia), IM-9 (B lymphoblastoid
multiple myeloma) and Raji (Burkitt B-cell lymphoma) in four different concentrations, each of which is repeated three times, resulting in a total of 12
samples.
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• LiverBrainLung [165] (GEO ID: GSE19830 ): This dataset contains three
different rat tissues, namely brain, liver, and lung tissues, which are mixed in
11 different concentrations with each mixture having three technical replicates,
for a total of 33 samples.
• RatBrain [101] (GEO ID: GSE19380 ): This contains four different cell-types,
namely rat’s neuronal, astrocytic, oligodendrocytic and microglial cultures, and
two replicates of five different mixing proportions, for a total of 10 samples.
• Retina [166] (GEO ID: GSE33076 ): This dataset pools together retinas from
two different mouse lines and mixed them in eight different combinations and
three replicates for each mixture, resulting in a total of 24 samples.

Mixtures With Available Cell-sorting Data Through Flow-cytometry
For this experiment, I use two datasets available from Qiao et al. [148]. I directly download these datasets from the supplementary material of the paper. These
datasets are post-processed by the supervised normalization of microarrays (SNM)
method to correct for batch effects. Raw expression profiles are also available for
download under GEO ID GSE40830. This dataset contains two sub-datasets:
• PERT Uncultured: This dataset contains uncultured human cord blood mono
nucleated and lineage depleted (Lin-) cells on the first day.
• PERT Cultured: This dataset contains culture-derived lineage-depleted human blood cells after four days of cultivation.
Table 5.1 summarizes overall statistics related to each of these datasets.

5.2.2 Deconvolution: Formal Definition
I introduce formalisms and notation used in discussing different aspects of in silico
deconvolution of biological signals. I focus on models that assume linearity, that is,
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Table 5.1: Summary statistics of each dataset for deconvolution
# features

# samples

# references

BreastBlood

54675

9

2

CellLines

54675

12

4

LiverBrainLung

31099

33

3

PERT Cultured

22215

2

11

PERT Uncultured

22215

4

11

RatBrain

31099

10

4

Retina

22347

24

2

Dataset

the expression signature of the mixture is a weighted sum of the expression profile for
its constitutive cell-types. In this case, sources are cell-type specific references and
the mixing process is determined by the relative fraction of cell-types in the mixture.
I first introduce the mathematical constructs used:
• M ∈ Rn×p : Mixture matrix, where each entry M(i, j) represents the raw expression of gene i, 1 ≤ i ≤ n, in heterogeneous sample j, 1 ≤ j ≤ p. Each
sample, represented by m, is a column of the matrix M, and is a combination
of gene expression profiles from constituting cell types in the mixture.
• H ∈ Rn×r : Reference signature matrix for the expression of primary cell types,
with multiple biological/technical replicates for each cell-type. In this matrix,
rows correspond to the same set of genes as in M, columns represent replicates and there is an underlying grouping among columns that collects profiles
corresponding to the same cell-type.
• G ∈ Rn×q : Reference expression profile, where the expression of similar celltypes in matrix H is represented by the average value.

63
• C ∈ Rq×p : Relative proportions of each cell-type in the mixture sample. Here,
rows correspond to cell-types and columns represent samples in mixture matrix
M.
Using this notation, I can formally define deconvolution as an optimization problem that seeks to identify “optimal” estimates for matrices G and C, denoted by Ĝ
and Ĉ, respectively. Since G and/or C are not known a priori, I use an approximation that is based on the linearity assumption. In this case, I aim to find Ĝ and
Ĉ such that their product is close to the mixture matrix, M. Specifically, given a
function δ that measures the distance between the true and approximated solutions,
also referred to as the loss function, I aim to solve:
min δ(ĜĈ, M)

(5.1)

0≤Ĝ,Ĉ

In partial deconvolution, either C or G, or their noisy representation, is known a
priori and the goal is to find the other unknown matrix. When matrix G, referred
to as the reference profile, is known, the problem is over-determined and I seek to
distinguish features (genes) that closely conform to the linearity assumption, from the
rest of the (variable) genes. In this case, I can solve the problem individually for each
mixture sample. Let us denote by m and ĉ the expression profile and estimated celltype proportion of a mixture sample, respectively. Then, I can rewrite Equation 5.1
as:
min δ(Gĉ, m)
0≤ĉ

(5.2)

This formulation is essentially a linear regression problem, with an arbitrary loss function. On the other hand, in the case of full deconvolution, I can still estimate C in a
column-by-column fashion. However, estimating G is highly under-determined and I
must use additional sources to restrict the search space. One such source of information is the variation across samples in M, depending on the cell-type concentrations
in the latest estimated value of C. In general, most regression-based methods for full
deconvolution use an iterative scheme that starts from either noisy estimates of G
and C, or a random sample that satisfies given constraints on these matrices, and
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successively improves over this initial approximation. This iterative process can be
formalized as follows:
Ĉ ← argmin(δ(ĜĈ − M))

(5.3)

0≤Ĉ

Ĝ ← (argmin(δ(ĈT ĜT − M)T ))T
0≤Ĝ

Please note that the updating Ĝ is typically row-wise (for each gene), whereas updating Ĉ is column-wise (for each sample). Non-negative matrix factorization (NMF) is
a dimension reduction technique that aims to factor each column of the given input
matrix as a nonnegative weighted sum of non-negative basis vectors, with the number of basis vectors being equal or less than the number of columns in the original
matrix. The alternating non-negative least squares formulation (ANLS) for solving
NMF can be formulated using the framework introduced in Equation 5.3. There are
additional techniques for solving NMF, including the multiplicative updating rule and
the hierarchical alternating least squares (HALS) methods, all of which are special
cases of block-coordinate descent [91]. Two of the most common loss functions used
in NMF are the Frobenius and Kullback-Leibler (KL) divergence [91].
In addition to non-negativity (NN), an additional sum-to-one (STO) constraint is
typically applied over columns of the matrix Ĉ, or the sample-specific vector ĉ. This
constraint restricts the search space, which can potentially enhance the accuracy of
the results. It also simplifies the interpretation of values in ĉ as relative percentages.
Finally, another fundamental assumption that is mostly neglected in prior work is the
similar cell quantity (SCQ) constraint. The similar cell quantity assumption states
that all reference profiles and corresponding mixtures must be normalized to ensure
that they represent the expression level of the “same number of cells.” If this constraint
is not satisfied, differences in the cell-type counts directly affect concentrations by
rescaling the estimated coefficients to adjust for the difference.

65
In this chapter, I focus on different loss functions (δ functions), as well as the
role of constraint enforcement strategies, in estimating ĉ. These constitute the key
building blocks of both partial and full deconvolution methods.

Choice of Objective Function
In linear regression, often a slightly different notation is used, which I describe
here. I subsequently relate it to the deconvolution problem. Given a set of samples,
k
{(xi , yi )}m
i=1 , where xi ∈ R and yi ∈ R, the regression problem seeks to find a

function f (x) that minimizes the aggregate error over all samples. Let us denote
the fitting error by ri = yi − f (xi ). Using this notation, I can write the regression
problem as:
argmin
f ∈F

m
X

L(ri )

(5.4)

i=1

where the loss function L measures the cost of estimation error. I focus on the class
of linear functions, that is fw (x) = wT x, for which I have ri = yi − wT xi . In this
formulation, yi corresponds to the expression level of a gene in the mixture, vector
xi is the expression level of the same gene in the reference cell types, and w is the
fraction of each cell-type in the mixture. I can represent {xi }m
i=1 in a compact form
by matrix X, in which row i corresponds to xi .
In cases where the number of parameters is greater than the number of samples,
minimizing Equation 5.4 directly can result in over-fitting. Furthermore, when features (columns of X) are highly correlated, the solution may change drastically in
response to small changes in the samples, particularly among the correlated features.
This condition, known as multicollinearity, can result in inaccurate estimates, in which
coefficients of similar features are vastly different. To remedy these problems, I can
add a regularization term that incorporates additional constraints (such as sparsity
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or flatness) to enhance the stability of results. I re-write the problem with the added
regularizer as:
argmin{
w∈Rk

m
X

L(yi − wT xi ) +

i=1

λR(w) }
| {z }
Regularizer

(5.5)

{z
}
Overall loss
where the λ parameter controls the relative importance of estimation error versus
|

regularization. There are different choices and combinations for the loss function L
and regularizer function R, which I describe in the following sections.

Choice of Loss Functions
There are a variety of options for suitable loss functions. Some of these functions
are known to be asymptotically optimal for a given noise density, whereas others may
yield better performance in practice when assumptions underlying the noise model
are violated. I summarize the most commonly used set of loss functions:
• If I assume that the underlying model is perturbed by Gaussian white noise,
the squared or quadratic loss, denoted by L2 , is known to be asymptotically
optimal. This loss function is used in classical least squares regression and is
defined as:
L2 (ri ) = ri2 = (yi − wT xi )2
• Absolute deviation loss, denoted by L1 , is the optimal choice if noise follows a
Laplacian distribution. Formally, it is defined as:
L1 (ri ) = |ri | = |yi − wT xi |
Compared to L2 , the choice of L1 is preferred in the presence of outliers, as it
is less sensitive to extreme values
(M )

• Huber’s loss function, denoted by Lhuber , is a parametrized combination of L1
and L2 . The main idea is that L2 loss is more susceptible to outliers, while
it is more sensitive to small estimation errors. To combine the best of these
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two functions, I can define a half-length parameter M , which I use to transition
from L2 to L1 . More formally:
(M )

LHuber (ri ) =



ri2 ,

if |ri | ≤ M


M (2|ri | − M ), otherwise
• The loss function used in support vector regression (SVR) is the -insensitive
loss, denoted by L()
 . Similar to Huber loss, there is a transition phase between
small and large estimation errors. However, -insensitive loss does not penalize
the errors that are smaller than a threshold. Formally, I define -insensitive loss
as:
L()
 (ri ) = max(0, |ri | − )


0,
if |ri | ≤ 
=

|ri | − , otherwise
Figure 5.1 provides a visual representation of these loss functions, in which I use
M = 1 and  =

1
2

for the Huber and -insensitive loss functions, respectively. Note

that for small residual values, |ri | ≤ M = 1, Huber and square loss are equivalent.
However, outside this region Huber loss becomes linear.

Choice of Regularizers
When the reference profile contains many cell-types that may not exist in mixtures, or in cases where constitutive cell-types are highly correlated, regularizing the
objective function can sparsify the solution or enhance the conditioning of the problem. I describe two commonly used regularizers here:
• The norm-2 regularizer is used to shrink the regression coefficient vector w to
ensure that it is as flat as possible. A common use of this regularizer is in
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Comparisson of different loss functions (ε = 0.75, M = 1.00)
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1

Figure 5.1.: Comparison of different loss functions
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conjunction with L2 loss to remedy the multicollinearity problem in classical
least squares regression. This regularizer is formally defined as:
k
X

R2 (w) =k w k22 =

wi2 .

(5.6)

i=1

• Another common regularizer is the norm-1 regularizer, which is used to enforce
sparsity over w. Formally, it can be defined as:
R1 (w) =k w k1 =

k
X

|wi |.

(5.7)

i=1

In addition to these two regularizers, their combinations have also been introduced
in the literature. One such example is elastic net, which uses a convex combination
of the two, that is Relastic (w) = αR1 (w) + (1 − α)R2 (w). Another example is group
Lasso, which, given a grouping G among cell-types, enforces flatness among members
of the group, while enhancing the sparsity pattern across groups. This regularizer
P
function can be written as Rgroup = Gi L2 (w(Gi )), where w(Gi ) is the weight of
cell-types in the ith group.

Examples of Objective Functions Used In Practice
Ordinary Least Squares (OLS) The formulation of OLS is based on squared loss,
L2 . Formally, I have:
m
m
X
X
minw {
L2 (ri )} = minw { (yi − wT xi )2 }
i=1

i=1

= minw k y − Xw k22
where row i of the matrix X, also known as the design matrix, corresponds to
xi . This formulation has a closed form solution given by:
ŵ = (XT X)−1 XT y
In this formulation, I can observe that norm-2 regularization is especially useful in cases where the matrix X is ill-conditioned and near-singular, that is,
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columns are dependent on each other. By shifting XT X towards the identity
matrix, I ensure that the eigenvalues are farther from zero, which enhances the
conditioning of the resulting combination.
Ridge Regression One of the main issues with the OLS formulation is that the
design matrix, X, should have full column rank k. Otherwise, if I have highly
correlated variables, the solution suffers from the multicollinearity problem.
This condition can be remedied by incorporating a norm-2 regularizer. The
resulting formulation, known as ridge regression, is as follows:
minw {

m
X

L2 (ri ) + λR2 (w)}

i=1

= minw k y − Xw k22 +λ k w k22
Similar to OLS, I can differentiate w.r.t. w to find the close form solution for
Ridge regression given by:
ŵ = (XT X + λI)−1 XT y
Least Absolute Selection and Shrinkage Operator (LASSO) Combining the
OLS with a norm 1 regularizer, we have the LASSO formulation:
minw {

m
X

L2 (ri ) + λR1 (w)}

i=1

= minw k y − Xw k22 +λ k w k1
This formulation is especially useful for producing sparse solutions by introducing zero elements in vector w. However, while being convex, it does not have a
closed form solution.
Robust Regression It is known that L2 (r) is dominated by the largest elements
of the residual vector r, which makes it sensitive to outliers. To remedy this
problem, different robust regression formulations have been proposed that use
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alternative loss functions. Two of the best-known formulations are based on the
L1 and Lhuber loss functions. The L1 formulation can be written as:
minw {

m
X

L1 (ri )} = minw {

i=1

m
X

|yi − wT xi |}

i=1

= minw k y − Xw k1
However, for the Huber loss function, while it can be defined similarly, it is
usually formulated as an alternative convex Quadratic Program (QP):
1
minx,z,t { k z k22 +M 1T t}
2
Subject to: − t ≤ Xw − y − z ≤ t

(5.8)

which can be solved more efficiently using the following equivalent QP variant
[116]:
1
minx,z,r,s { k z k22 +M 1T (r + s)}
2

Xw − y − z = r − s
Subject to:

0 ≤ r, s

(5.9)

In both of these formulations, the scalar M corresponds to half-length parameter
of the Huber’s loss function.
Support Vector Regression In machine learning, Support Vector Regression (SVR)
is a commonly used technique that aims to find a regression by maximizing the
margins around the estimated separator hyperplane from the closest data points
on each side of it. This margin provides the region in which estimation errors are
ignored. SVR has been recently used to deconvolve biological mixtures, where
it has been shown to outperform other methods [129]. One of the variants of
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SVR is -SVR, in which parameter  defines the margin, or the -tube. The
primal formulation of -SVR with linear kernel can be written as [196]:
m
X
1
−
2
minw,ξ+i ,ξ−i { k w k2 +C
(ξ +
i + ξ i )}
2
i=1




yi − w · xi ≤  + ξ +

i


Subject to: −( + ξ −
i ) ≤ yi − w · xi





−
0 ≤ ξ +
i , ξi

(5.10)

in which, given the unit norm assumption introduced in Section 5.2.2, I assume
that b = 0. The dual problem for the primal in Equation 5.10 can be written
in matrix form as:
n
1T (α+ − α− )

maxα+ ,α−

y



−1T (α+ + α− )
o
−(α+ − α− )T K(α+ − α− )


1T (α+ − α− ) = 0
Subject to:

0 ≤ α+ , α− ≤ C
In this formulation, 1 is a vector of all ones,

(5.11)

is the element-wise product, and

K is the kernel matrix defined as K = XXT . The dual formulation is often
used to solve -SVR, because it can be easily extended to use different kernel
functions to map xi to a d-dimensional non-linear feature space. Additionally,
when m  k, such as the case of high-dimensional feature spaces, it provides a
better way to solve the SVR problem. However, the primal problem provides a
more straightforward interpretation. In addition, in the case where k  m, it
provides superior performance. To show the similarity with Equation 5.5, I can
rewrite Equation 5.10 using the -insensitive loss function as follows:
minw {

m
X
i=1

where λ =

1
2C

[170].

L (yi − wT xi ) + λR2 (w)}

(5.12)
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5.2.3 Overview of Prior In Silico Deconvolution Methods
A majority of existing deconvolution methods fall into two groups – they either
use a regression-based framework to compute G, C, or both; or perform statistical inference over a probabilistic model. Abbas et al. [2] present one of the early
regression-based methods for estimating C. This method is designed to identify celltype concentrations from a known reference profile of immune cells. Their method
is based on Ordinary Least Squares (OLS) regression and does not consider either
non-negativity or sum-to-one constraints explicitly, but rather it enforces these constraints implicitly after the optimization procedure. An extension of this approach is
proposed by Qiao et al. [148], which uses non-negative least squares (NNLS) to explicitly enforce non-negativity as part of the optimization. Gong et al. [61] present a
quadratic programming (QP) framework to explicitly encode both constraints in the
optimization problem formulation. They also propose an extension to this method,
called DeconRNASeq, which applies the same QP framework to RNASeq datasets.
More recently Newman et al. [129] propose robust linear regression (RLR) and νSVR regression instead of L2 based regression, which is highly susceptible to noise.
Digital cell quantification (DCQ) [5] is another approach designed for monitoring the
immune system during infection. Compared to prior methods, DCQ forces sparsity
by combining R2 and R1 regularization into an elastic net. This regularization is
essential for successfully identifying the subset of active cells at each stage, given the
larger number of cell-types included in their panel (213 immune cell sub-populations).
In contrast to these techniques, Shen-Orr et al. [165] propose a method, call csSAM,
which is specifically designed to identify genes that are differentially expressed among
purified cell-types. The core of this method is regression over matrix C to estimate
matrix G.
Full regression-based methods correspond to unsupervised approaches in the sense
that they do not rely on either G or C. They are either fully ab initio, or they use
variations of block-coordinate descent to successively identify better estimates for
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both C and G [91]. Venet et al. [200] present one of the early methods in this class,
which uses an NMF-like method coupled with a heuristic to decorrelate columns of G
in each iteration. Repsilber et al. [154] propose an algorithm called deconf, which uses
alternating non-negative least squares (ANLS) for solving NMF, without the decorrelation step of Vennet et al., while implicitly applying constraints on C and G at
each iteration. Inspired by the work of Pauca et al. on hyperspectral image deconvolution [134], Zuckerman et al. [225] propose an NMF method based on the Frobenius
norm for gene expression deconvolution. They use gradient descent to solve for C
and G at each step, which converges to a local optimum of the objective function.
Given that the expression domain of cell-type specific markers is restricted to unique
cells in the reference profile, Gaujoux et al. [53] present a semi-supervised NMF (ssNMF) method that explicitly enforces an orthogonality constraint at each iteration
over the subset of markers in the reference profile. This constraint both enhances the
convergence of the NMF algorithm, and simplifies the matching of columns in the
estimated cell-type expression to the columns of the reference panel, G. The Digital
Sorting Algorithm (DSA) [222] works as follows: if concentration matrix C is known
a priori, it directly uses quadratic programming (QP) with added constraints on the
lower/upper bound of gene expressions to estimate matrix G. Otherwise, if fractions
are also unknown, it uses the average expression of given marker genes that are only
expressed in one cell-type, combined with the STO constraint, to estimate concentrations matrix C first. Population-specific expression analysis (PSEA) [101] performs a
linear least squares regression to estimate quantitative measures of cell-type-specific
expression levels, in a similar fashion as the update equation for estimating Ĝ in
Equation 5.3. In cases where the matrix C is not known a priori, PSEA exploits the
average expression of marker genes that are exclusively expressed in one of the reference profiles as reference signals to track the variation of cell-type fractions across
multiple mixture samples.
More recently, a new class of methods, collectively referred to as convex analysis
of mixtures (CAM), have been proposed to directly infer marker genes from mixture
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profiles [25, 187, 207]. The CAM family of methods aim to use a geometric approach
to identify corners of the scatter simplex for mixed expression profiles. The key to the
success of these methods is a recently proven bijection between the scatter simplex of
mixed profiles and a transformed (rotated and compressed) version of the scatter simplex for constituent cell types [207]. Following this, “marker genes” are concentrated
around the corners of this simplex. After identifying these semi-orthogonal markers,
one can recover cell type percentages using any of the marker-based methods mentioned above, such as PSEA [101] or DSA [222]. Similar techniques have been also
proposed earlier to infer tumor phylogeny using microarray measurements of tumor
populations [161].
In addition to regression-based methods, a large class of methods is based on probabilistic modeling of gene expression. Erikkila et al. [47] introduce a method, called
DSection, which formulates the deconvolution problem using a Bayesian model. It
incorporates a Bayesian prior over the noisy observation of given concentration parameters to account for their uncertainty, and employs a MCMC sampling scheme
to estimate the posterior distribution of the parameters/latent variables, including G
and a refined version of C. The in-silico NanoDissection method [85] uses a classification algorithm based on linear SVM coupled with an iterative adjustment process
to refine a set of provided, positive and negative, marker genes and infer a ranked list
of genome-scale predictions for cell-type-specific markers. Quon et al. [149] propose
a probabilistic deconvolution method, called PERT, which estimates a global, multiplicative perturbation vector to correct for the differences between provided reference
profiles and the true cell-types in the mixture. PERT formulates the deconvolution
problem in a similar framework as Latent Dirichlet Allocation (LDA), and uses the
conjugate gradient descent method to cyclically optimize the joint likelihood function
with respect to each latent variable/parameter. Finally, microarray microdissection
with analysis of differences (MMAD) [107] incorporates the concept of the effective
RNA fraction to account for source and sample-specific bias in the cell-type fractions for each gene. They propose different strategies depending on the availability of
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Table 5.2: Best combination of choices for feature selection/regularization for different
datasets
Reference

Name

Abbas et al. (2009)

LS

Gong et al. (2011)

QP

Qiao et al. (2012)

NNLS

Method

Loss

Ordinary Least Squares (OLS)

L2

Imp

Imp

-

Quadratic Programming

L2

Exp

Exp

Non-negative Least Squares (NNLS)

L2

Exp

Imp

-

Elastic Net

L2

Imp

Imp

L1 /L2

Robust Linear Regression (RLR)

Huber

Imp

Imp

-

ν-SVR

-insensitive

Imp

Imp

L2

Altboum et al. (2014) DCQ
Newman et al. (2015)

RLR

Newman et al. (2015)

CIBERSORT

Non-negativity Sum-to-one Regularizer

x

additional data sources. In cases where no additional information is available, they
identify genes with the highest variation in mixtures as markers and assign them
to different reference cell-types using k-means clustering, and finally use these de
novo markers to compute cell-type fractions. MMAD uses a MLE approach over the
residual sum of squares to estimate unknown parameters in their formulation.
In this chapter I focus on partial deconvolution methods for recovering matrix C
using given reference profiles for constituent tissues/cell types. Table 5.2 summarizes
different combinations proposed in literature thus far. I cover all these configurations
here, as well as missing combinations that have not been studied in current literature.

5.2.4 Evaluation Measures
Let us denote the actual and estimated coefficient matrices by C and Ĉ , respectively. I first normalize these measures to ensure each column sums to one. Then,
I define the corresponding percentages as P = 100 × Cnorm and P̂ = 100 × Ĉnorm .
Finally, let rjk = pjk − p̂jk be the residual estimation error of cell-type k in sample j.
Using this notation, I can define three commonly used measures of estimation error
as follows:
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1. Mean absolute difference (mAD): This is among the easiest measures to
interpret. It is defined as the average of all differences for different cell-type
percentages in different mixture samples. More specifically:
q
p
1 XX
mAD =
|rjk |
p × q j=1 k=1

2. Root mean squared distance (RMSD): This measure is one of the most
commonly used distance functions in the literature. It is formally defined as:
v
u
p
q
X
u 1 X
r2
mAD = t
p × q j=1 k=1 jk
3. Pearson’s correlation distance: Pearson’s correlation measures the linear
dependence between estimated and actual percentages. Let us vectorize percentage matrices as p = vec(P) and p̂ = vec(P̂). Using this notation, the
correlation between these two vectors is defined as:

ρp,p̂ =

cov(p, p̂)
σ(p)σ(p̂)

(5.13)

where cov and σ correspond to covariance and standard variation of vectors,
respectively. Finally, I define the correlation distance measure as R2 D = 1−ρp,p̂ .

5.2.5 Implementation
All codes and experiments have been implemented in Matlab. To implement different formulations of the deconvolution problem, I used CVX, a package for specifying
and solving convex programs [1,63]. I used Mosek together with CVX, which is a highperformance solver for large-scale linear and quadratic programs [126]. All codes and
datasets are freely available at github.com/shmohammadi86/DeconvolutionReview.
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5.3 Results and Discussion
I now present a comprehensive evaluation of various formulations for solving deconvolution problems. Some of these algorithimic combinations have been proposed
in literature, while others represent new algorithmic choices. I systematically assess
the impact of these algorithmic choices on the performance of in-silico deconvolution.

5.3.1 Effect of Loss Function and Constraint Enforcement on Deconvolution Performance
I perform a systematic evaluation of the four different loss functions introduced
in Section 5.2.2, as well as implicit and explicit enforcement of non-negativity (NN)
and sum-to-one (STO) constraints over the concentration matrix (Ĉ), on the overall
performance of deconvolution methods for each dataset. There are 16 configurations
of loss functions/constraints for each test case. Additionally, for Huber and Hinge
loss functions, where M and  are unknown, I perform a grid search with 15 values in
multiples of 10 spanning the range {10−7 , · · · , 107 } to find the best values for these
parameters. In order to evaluate an upper bound on the “potential” performance of
these two loss functions, I use the true concentrations in each sample, c, to evaluate
each parameter choice. In practical applications, the RMSD of residual error between
m and Gĉ is often used to select the optimal parameter. This is not always in
agreement with the choice made based on known c.
For each test dataset, I compute the three evaluation measures defined in Section 5.2.4. Additionally, for each of these measures, I compute an empirical p-value
by sampling random concentrations from a Uniform distribution and enforcing NN
and STO constraints on the resulting random sample. In my study, I sampled 10, 000
concentrations for each dataset/measure, which results in a lower bound of 10−4 on
the estimated p-values. Figure 5.2 presents the time each loss function takes to compute per sample, averaged over all constraint combinations. The actual times taken
for Huber and Hinge losses are roughly 15 times those reported here, which is the
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Figure 5.2.: Average computational time for each loss function in different datasets

number of experiments performed to find the optimal parameters for these loss functions. From these results, L2 can be observed to have the fastest computation time,
whereas LHuber is the slowest. Measures L1 and LHinge fit in between these two
extremes, with L1 being faster the majority of times. I can directly compare these
computation times, because I formulate all methods within the same framework; thus,
differences in implementations do not impact direct comparisons.
Computation time, while important, is not the critical measure in my evaluation.
The true performance of a configuration (selection of loss function and constraints)
is measured by its estimation error. In order to rank different configurations, I first
assess the agreement among different measures. To this end, I evaluate each dataset
as follows: for each experiment, I compute mAD, RMSD, and R2 D independently.
Then, I use Kendall rank correlation, a non-parametric hypothesis test for statistical dependence between two random variables, between each pair of measures and
compute a log-transformed p-value for each correlation. Figure 5.3 shows the agreement among these measures across different datasets. Overall, RM SD and mAD
measures show higher consistency, compared to R2 D measure. However, the mAD
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Figure 5.3.: Agreement among different evaluation measures across different datasets

measure is easier to interpret as a measure of percentage loss for each configuration.
Consequently, I choose this measure for my evaluation in this study.
Using mAD as the measure of performance, I evaluate each configuration over
each dataset and sort the results. Figure 5.4 shows various combinations for each
dataset. The RatBrain, LiverBrainLung, BreastBlood, and CellLines datasets
achieve high performance. Among these datasets, RatBrain, LiverBrainLung, and
BreastBlood had the L2 loss function as the best configuration, with the CellLines
dataset being less sensitive to the choice of the loss function. Another surprising observation is that for the majority of configurations, enforcing the sum-to-one constraint
worsens the results. I investigate this issue in greater depth in Section 5.3.2.
For Retina, as well as both PERT datasets, the overall performance is worse
than the other datasets. In the case of PERT, this is expected, since the flow-sorted
proportions are used as an estimate of cell-type proportions. Furthermore, the reference profiles come from a different study and therefore have greater difference with
the true cell-types in the mixture. However, the Retina dataset exhibits unusually
low performance, which may be attributed to multiple factors. As an initial investigation, I performed a quality control (QC) over different samples to see if errors are
similarly distributed across samples. Figure 5.6 presents per-sample error, measured
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Figure 5.5.: Overall performance of different loss function/constraints combinations

over all datasets (lower the better)

by mAD, with median and median absolute deviation (MAD) marked accordingly.

Interestingly, for the 4th , 6th , and 8th mixtures, the third replicate has much higher

error than the rest. In the expression matrix, I observed a lower correlation be-

tween these replicates and the other two replicates in the batch. Additionally, for the

7th mixture, all three replicates show high error rates. I expand on these results in
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Figure 5.6.: Sample-based error of the Retina dataset, based on L2 with explicit NN
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later sections to identify additional reasons that contribute to the low deconvolution
performance of the Retina dataset.
Finally, I note that in all test cases the performance of L1 , LHuber , and LHinge are
comparable, while LHuber and LHinge needed an additional step of parameter tuning.
Consequently, I only consider L1 as a representative of this “robust” group of loss
functions in the rest of my study.

5.3.2 Agreement of Gene Expressions With Sum-to-One (STO) Constraint
Considering the lower performance of configurations that explicitly enforce STO
constraints, I aim to investigate whether features (genes) in each dataset respect
this constraint. Under the STO and NN constraints, I use simple bounds for identifying violating features, for which there is no combination of concentration values that can satisfy both STO and NN. Let m(i) be the expression value of the
ith gene in the given mixture, and G(i, 1), · · · , G(i, q) be the corresponding expressions in different reference cell-types. Let Gmin (i) = min{G(i, 1), · · · , G(i, q)} and
Gmax (i) = max{G(i, 1), · · · , G(i, q)}. Given that all concentrations are bound be-
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tween 0 ≤ c(k) ≤ 1; ∀1 ≤ k ≤ k, the minimum and maximum values that an
estimated mixture value for the ith gene can attain are Gmin (i) and Gmax (i), respectively (by setting c(k) = 1 for min/max value, and 0 everywhere else). Using this
notation, I can identify features that violate STO as follows:
m(i) ≤ Gmin (i)

∀1 ≤ i ≤ n

Gmax (i) ≤ m(i) ∀1 ≤ i ≤ n

{Violating reference}
{Violating mixture}

The first condition holds because expression values in reference profiles are so large
that I need the sum of concentrations to be lower than one to be able to match
the corresponding gene expression in the mixture. The second condition holds in
cases where the expression of a gene in the mixture is so high that I need the sum
of concentrations to be greater than one to be able to match it. In other words, for
feature i, these constraints identify extreme expression values in reference profiles and
mixture samples, respectively. Using these conditions, I compute the total number of
features violating STO condition in each dataset.
Figure 5.7 presents violating features in mixtures and reference profiles, averaged
over all mixture samples in each dataset. I normalize and report the percent of
features to account for differences in the total number of features in each dataset.
We first observe that for the majority of datasets, except Retina and BreastBlood,
the percent of violating features is much smaller than violating features in reference
profiles. These two datasets also have the highest number of violating features in
their reference profiles, summing to a total of approximately 60% of all features.
This observation is likely due to the normalization used in preprocessing microarray
profiles. Specifically, one must not only normalize M and G independently, but
also with respect to each other. I suggest using control genes that are expressed
in all cell-types with low variation to normalize expression profiles. A recent study
aimed to identify subsets of housekeeping genes in human tissues that respect these
conditions [45]. Another choice is using ribosomal proteins, the basic building blocks
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Figure 5.7.: Percent of features in each dataset that violate the STO constraint

of the cellular translation machinery, which are expressed in a wide range of species.
The Remove Unwanted Variation (RUV) [51] method is developed to remove batch
effects from microarray and RNASeq expression profiles, but also to normalize them
using control genes. A simple extension of this method can be adopted to solve the
normalization difference between mixtures and references.
Next, I evaluate how filtering these features affects deconvolution performance of
each dataset. For each case, I run deconvolution using all configurations and report
the change (delta mAD) independently. Figure 5.8 presents changes in the mAD estimation error after removing violating features in both m and G before performing
deconvolution. Similar to previous experiments, the Retina dataset exhibits widely
different behavior than the rest of the datasets. Removing this dataset from further
consideration, I find that the overall performance over all datasets improves, with the
exception of the RatBrain dataset. In the case of the RatBrain dataset, I hypothesize that the initially superior performance can be attributed to highly expressed
features. These outliers, that happens to agree with the true solution, result in overfitting. Finally, I note a correlation between observed enhancements and the level of
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Figure 5.8.: Performance of deconvolution methods after removing violating features

violation of features in m. Consistent with this observation, I obtain similar results
when I only filter violating features from mixtures, but not reference profiles.

5.3.3 Range Filtering – Finding an Optimal Threshold
Different upper/lower bounds have been proposed in the literature to prefilter
expression values prior to deconvolution. For example, Gong et al. [61] suggest an effective range of [0.5, 5000], whereas Ahn et al. [4] observe an optimal range of [24 −214 ].
To facilitate the choice of expression bounds, I seek a systematic way to identify an
optimal range for different datasets. Kawaji et al. [88] recently report on an experiment to assess whether gene expression is quantified linearly in mixtures. To this
end, they mix two cell-types (THP-1 and HeLa cell-lines) and see if experimentally
measured expressions match with the computationally simulated datasets. They observe that expression values for microarray measurements are skewed for the lowly
expressed genes (approximately < 10). This allows us to choose the lower bound
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based on experimental evidence. In my study, I search for the optimal bounds over
a log2 -linear space; thus, I set a threshold of 23 on the minimum expression values,
which is closest to the bound proposed by Kawaji et al. [88].
Choosing an upper bound on the expression values is a harder problem, since it
relates to enhancing the performance of deconvolution methods by removing outliers.
Additionally, there is a known relationship between the mean expression value and its
variance [188], which makes these outliers noisier than the rest of the features. This
becomes even more important when dealing with purified cell-types that come from
different labs, since highly expressed time/micro-environment dependent genes would
be significantly different than the ones in the mixture [148]. A simple argument is to
filter genes that the range of expression values in Affymetrix microarray technology is
bounded by 216 (due to initial normalization and image processing steps). Measurements close to this bound are not reliable as they might be saturated and inaccurate.
However, practical bounds used in previous studies are far from these extreme values.
In order to examine the overall distribution of expression values, I analyze different
datasets independently. For each dataset, I separately analyze mixture samples and
reference profiles, encoded by matrices M and G, respectively. For each of these
matrices, I vectorize the expression values and perform kernel smoothing using the
Gaussian kernel to estimate the probability density function.
Figure 5.9a and Figure 5.9b show the distribution of log-transformed expression
values for mixtures and reference profiles, respectively. These expression values are
greater than my lower bound of 23 . In agreement with my previous results, I observe
an unusually skewed distribution for the Retina dataset, which in turn contributes
to its lower performance compared to other ideal mixtures. Additionally, I observe
that approximately 80% of the features in this dataset are smaller than 23 , which
are filtered and not shown in the distribution plot. For the rest of the datasets, in
both mixtures and references, I observe a bell-shaped distribution with most of the
features captured up to an upper bound of 28 −210 . Another exception to this pattern
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Figure 5.9.: Distribution of gene expression values for mixtures and references

is the CellLines dataset, which has a heavier tail than other datasets, especially in
its reference profile.
Next, I systematically evaluate the effect of range filtering by analyzing upper
bounds increasing in factors of 10 in the range {25 , · · · , 216 }. In each case, I remove
all features that at least one of the reference profiles or mixture samples has a value
exceeding this upper bound. Figure 5.10 illustrates the percent of features that are
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Figure 5.10.: Percent of covered features during range filtering

retained, as I increase the upper bound. As mentioned earlier, approximately 80%
of the features in the Retina dataset are lower than 23 , which is evident from the
maximum percent of features left to be bounded by 20% in this figure. Additionally,
consistent with my previous observation over expression densities, more that 80% of
the features are covered between 28 − 210 , except for the CellLine dataset.
Finally, I perform deconvolution using the remaining features given each upper
bound. The results are mixed, but a common trend is that removing highly expressed
genes decreases performance of ideal mixtures with known concentrations, while enhancing the performance of PERT datasets. Figure 5.11a and Figure 5.11b show the
changes in mAD error, compared to unfiltered deconvolution, for the PERT dataset.
In each case, I observe improvements up to 7 and 8 percent, respectively. The red
and green points on the diagram show the significance of deconvolution. Interestingly,
while both methods show similar improvements, all data points for cultured PERT
seem to be insignificant, whereas uncultured PERT shows significance for the majority
of data-points. This is due to the weakness of my random model, which is dependent
on the number of samples and is not comparable across datasets. Uncultured PERT
has twice as many samples as cultured PERT, which makes it less likely to have any
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Figure 5.11.: Performance of PERT datasets during range filtering

random samples achieving as good an mAD as the observed estimation error. This
dependency on the number of samples can be addressed by defining sample-based
p-values. Another observation is that for the uncultured dataset, all measures have
been improved, except L1 with explicit NN and STO constraints. On the other hand,
for the cultured dataset, both L1 and L2 with the explicit NN constraint perform
well, whereas implicitly enforcing NN deteriorates their performance. Cultured and
uncultured datasets have their peak at 210 and 212 , respectively.
For the rest of the datasets, range filtering decreased performance in a majority
of cases, except the Retina dataset, which had an improved performance at 26 with
the best result achieved with L1 with both explicit NN and STO enforcement. This
changed the best observed performance of this datasest, measured as mAD, to be
close to 7. These mixed results make it harder to choose a threshold for the upper
bound, so I average results over all datasets to find a balance between improvements in
PERT and overall deterioration in other datasets. Figure 5.12 presents the averaged
mAD difference across all datasets. This suggests a “general” upper bound filter of
212 to be optimal across all datasets.
I use this threshold to filter all datasets and perform deconvolution on them. Figure 5.13 presents the dataset-specific performance of range filtering with fixed bounds,
measured by changes in the mAD value compared to the original deconvolution. As
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Figure 5.12.: Average performance of range filtering over all datasets

observed from individual performance plots, range filtering is most effective in cases
where the reference profiles differ significantly from the true cell-types in the mixture, such as the case with the PERT datasets. In ideal mixtures, since cell-types
are measured and mixed at the same time/laboratory, this distinction is negligible.
In these cases, highly expressed genes in mixtures and references coincide with each
other and provide additional clues for the regression. Consequently, removing these
highly expressed genes often degrades the performance of deconvolution methods.
This generalization of the upper bound threshold, however, should be adopted with
care, since each dataset exhibits different behavior in response to range filtering. Ideally, one must filter each dataset individually based on the distribution of expression
values. Furthermore, in practical applications, gold standards are not available to aid
in the choice of cutoff threshold.
I now introduce a new method that adaptively identifies an effective range for each
dataset. Figure 5.14 illustrates the log2 normalized value of maximal expression for
each gene in matrices M and G, sorted in ascending order. In all cases, intermediate
values exhibit a gradual increase, whereas the top and bottom elements in the sorted
list show a steep change in their expression. I aim to identify the critical points
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Figure 5.13.: Dataset-specific changes in the performance of deconvolution methods
after filtering expression ranges to fit within [23 − 212 ]

corresponding to these sudden changes in the expression values for each dataset. To
this end, I select the middle point as a point of reference and analyze the upper
and lower half, independently. For each half, I find the point on the curve that has
the longest distance from the line connecting the first (last) element to the middle
element. Application of this process over the CellTypes dataset is visualized in
Figure 5.15. Green points in this figure correspond to the critical points, which are
used to define the lower and upper bound for the expression values of this dataset.
I use this technique to identify adaptive ranges for each dataset prior to deconvolution. Table 5.3 summarizes the identified critical points for each dataset. Figure 5.16
presents the dataset-specific performance of each method after adaptive range filtering. While in most cases the results for fixed and adaptive range filtering are compatible, and in some cases adaptive filtering gives better results, the most notable
difference is the degraded performance of LiverBrainLung, and, to some extent,
RatBrain datasets. To further investigate this observation, I examine individual
experiments for these datasets for fixed thresholds. Figure 5.17 illustrates individual
plots for each dataset. The common trend here is that in both cases range filtering,
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Figure 5.14.: Sorted log2 -transformed gene expressions in different datasets
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Figure 5.15.: Example of adaptive filtering over the CellLines dataset

in general, degrades the performance of deconvolution methods for all configurations.
In other words, extreme values in these datasets are actually helpful in guiding the regression, and any filtering negatively impacts performance. This suggests that range
filtering, in general, is not always helpful in enhancing the deconvolution performance,
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Table 5.3: Summary of adaptive ranges for each dataset for deconvolution
LowerBound

UpperBound

BreastBlood

4.2842

9.4314

CellLines

5.2814

11.6942

LiverBrainLung

3.3245

9.9324

PERT Cultured

4.9416

10.9224

PERT Uncultured

5.1674

11.5042

RatBrain

3.3726

9.9698

Retina

2.4063

6.7499
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Figure 5.16.: Dataset-specific changes in the performance of deconvolution methods
after adaptive range filtering

and in fact in some cases; for example the ideal datasets such as LiverBrainLung,
RatBrain, and BreastBlood; it can be counterproductive.
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Figure 5.17.: Individual performance plots for range filtering in datasets which range
filtering exhibits negative effect on the deconvolution

5.3.4 Selection of Marker Genes – The Good, Bad, and Ugly
Selecting marker genes that uniquely identify a certain tissue or cell-type, prior to
deconvolution, can help in improving the conditioning of matrix G, thus improving
its discriminating power and stability of results, as well as decreasing the overall computation time. A key challenge in identifying “marker” genes is the choice of method
that is used to assess selectivity of genes. Various parametric and nonparametric
methods have been proposed in literature to identify differentially expressed genes
between two groups [32,80] or between a group and other groups [195]. Furthermore,
different methods have been developed in parallel to identify tissue-specific and tissueselective genes that are unique markers with high specificity to their host tissue/cell
type [14, 22, 86, 124]. While choosing/developing accurate methods for identifying
reliable markers is an important challenge, an in-depth discussion of the matter is
beyond the scope of this article. Instead, I adopt two methods used in the literature.
Abbas et al. [2] present a framework for choosing genes based on their overall differential expression. For each gene, they use a t-test to compare the cell-type with
the highest expression with the second and third highest expressing cell-type. Then,
they sort all genes and construct a sequence of basis matrices with increasing sizes.
Finally, they use condition number to identify an “optimal” cut among top-ranked
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genes that minimizes the condition number. Newman et al. [129] propose a modification to the method of Abbas et al., in which genes are not sorted based on their
overall differential expression, but according to their tissue-specific expression when
compared to all other cell-types. After prefiltering differentially expressed genes, they
sort genes based on their expression fold ratio and use a similar cutoff that optimizes
the condition number. Note that the former method increases the size of the basis
matrix by one at each step, while the latter method increases it by q (number of
cell-types). The method of Newman et al. has the benefit that it chooses a similar
number of markers per cell-type, which is useful in cases where one of the references
has a significantly higher number of markers.
I implement both methods and assess their performance over the datasets. I observe slightly better performance with the second method and use it for the rest of
my experiments. Due to unexpected behavior of the Retina dataset, as well as a low
number of significant markers in all my trials, I eliminate this dataset from further
study. In identifying differentially expressed genes, a key parameter is the q-value
cutoff to report significant features. The distribution of corrected p-values exhibits
high similarity among ideal mixtures, while differing significantly in CellLines mixtures and both PERT datasets. I find the range of 10−3 − 10−5 to be an optimal
balance between these two cases and perform experiments to test different cutoff values. Figure 5.18 shows changes in the mAD measure after applying marker detection,
using a q-value cutoff of 10−3 , which resulted in the best overall performance in my
study. I observe that the PERT Uncultured and LiverBrainLung datasets have
the highest gain across the majority of configurations, while BreastBlood and RatBrain exhibit an improvement in experiments with L1 while their L2 performance
is greatly decreased. Finally, for the PERT Cultured and CellLines datasets, I
observe an overall decrease in performance in almost all configurations.
Next, I note that the internal sorting based on fold-ratio intrinsically prioritizes
highly expressed genes and is susceptible to noisy outliers. To test this hypothesis,
I perform a range selection using a global upper bound of 1012 prior to the marker
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Figure 5.18.: Effect of marker selection on the performance of deconvolution methods

selection method and examine if this combination can enhance my previous results.
I find the q-value threshold of 10−5 to be the better choice in this case. Figure 5.19
shows changes in performance of different methods when I prefilter expression ranges
prior to marker selection. The most notable change is that both the PERT Cultured
and the CellLines, which were among the datasets with the lowest performance in
the previous experiment, are now among the best-performing datasets, in terms of
overall mAD enhancement. I still observe a higher negative impact on L2 in this case,
but the overall amplitude of the effect has been dampened in both BreastBlood and
RatBrain datasets.
I note that there is no prior knowledge as to the “proper” choice of the marker
selection method in the literature and that their effect on the deconvolution performance is unclear. An in-depth comparison of marker detection methods can benefit
future developments in this field. An ideal marker should serve two purpose: (i) be
highly informative of the cell-type in which it is expressed, (ii) shows low variance due
to spatiotemporal changes in the environment (changes in time or microenvironment).
Figure 5.20 shows a high-level classification of genes. An ideal marker is an invari-
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Figure 5.19.: Effect of marker selection, after range filtering, on the performance of
deconvolution methods

ant, cell-type specific gene, marked with green in the diagram. On the other hand,
variant genes, both universally expressed and tissue-specific, are not good candidates,
especially in cases where references are adopted from a different study. These genes,
however, comprise ideal subsets of genes that should be updated in full deconvolution
while updating matrix G, since their expression in the reference profile may differ
significantly from the true cell-types in the mixture. It is worth mentioning that
the proper ordering to identify best markers is to first identify tissue-specific genes
and then prune them based on their variability. Otherwise, when selecting invariant
genes, I may select many housekeeping genes, since their expression is known to be
more uniform compared to tissue-specific genes.
Another observation relates to the case in which groups of profiles of cell-types
have high similarity within the group, but are significantly distant from the rest. This
makes identifying marker genes more challenging for these groups of cell-types. An
instance of this problem is when I consider markers in the PERT datasets. In this
case, erythrocytes have a much larger number of distinguishing markers compared to
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Figure 5.20.: High-level functional classification of genes

other references. This phenomenon is primarily attributed to the underlying similarity
between undifferentiated cell-types in the PERT datasets, and their distance from
the fully differentiated red blood cells. In these cases, it is beneficial to summarize
each group of similar tissues using a “representative profile” for the whole group, and
to use a hierarchical structure to recursively identify markers at different levels of
resolution [124].
Finally, I examine the common choice of condition number as the optimal choice
to select the number of markers. First, unlike the “U” shape plot reported in previous
studies, in which condition number initially decreases to an optimal point and then
starts increasing, I observe variable behavior in the condition number plot, both for
Newman et al. and Abbas et al. methods. This makes the generalization of condition
number as a measure applicable to all datasets infeasible. Additionally, I note that
the lowest condition number is achieved if G is fully orthogonal, that is GT G = κI for
any constant κ. By selecting tissue-selective markers, I can ensure that the product of
columns in the resulting matrix is close to zero. However, the norm-2 of each column
can still be different. I developed a method that specifically grows the basis matrix
by accounting for the norm equality across columns. I find that in all cases my basis
matrix has a lower condition number than both the Newman et al. and Abbas et
al. methods, but it did not always improve the overall performance of deconvolution
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methods using different loss functions. Further study on the optimal choice of the
number of markers is another key question that needs further investigation

5.3.5 To Regularize or Not to Regularize
I now evaluate the impact of regularization on the performance of different deconvolution methods. To isolate the effect of the regularizer from prior filtering/feature
selection steps, I apply regularization on the original datasets. The R1 regularizer is
typically applied in cases where the solution space is large, that is, the total number of
available reference cell-types is a superset of the true cell-types in the mixture. This
type of regularization acts as a “selector” to choose the most relevant cell-types and
zero-out the coefficients for the rest of the cell-types. This has the effect of enforcing a
sparsity pattern. Datasets used in this study are all controlled benchmarks in which
references are hand-picked to match the ones in the mixture; thus, sparsifying the
solution does not add value to the deconvolution process. On the other hand, an R2
regularizer, also known as Tikhonov regularization, is most commonly used when the
problem is ill-posed. This is the case, for example, when the underlying cell-types
are highly correlated with each other, which introduces dependency among columns
of the basis matrix. In order to quantify the impact of this type of regularization
on the performance of deconvolution methods, I perform an experiment similar to
the one in Section 5.3.1 with an added R2 regularizer. In this experiment, I use L1
and L2 loss functions, as I previously showed that the performance of the other two
loss functions is similar to L1 . Instead of using Ridge regression, I implement an
equivalent formulation, k m − Gc k2 +λ k c k1 , which traces the same path but
has higher numerical accuracy. To identify the optimal value of the λ parameter that
balances the relative importance of solution fit versus regularization, I search over the
range of {10−7 , · · · , 107 }. It is notable here that when λ is close to zero, the solution
is identical to the one without regularization, whereas when λ → ∞ the deconvolu-

101
tion process is only guided by the solution size. Similar to the range filtering step in
Section 5.3.3, I use the minimum mAD error to choose the optimal value of λ.
Figure 5.21 presents changes in mAD error, compared to original errors, after
regularizing loss functions with the R2 regularizer. From these observations, it appears that PERT Cultured has the most gain due to regularization, whereas for
PERT Uncultured, the changes are smaller. A detailed investigation, however,
suggests that in the majority of cases for PERT Cultured, the performance gain
is due to over shrinkage of vector c to the case of being almost uniform. Interestingly, the choice of uniform c has lower mAD error for this dataset compared to most
other results. Overall, both of the PERT datasets show significant improvements
compared to the original solution, which can be attributed to the underlying similarity among hematopoietic cells. On the other hand, an unexpected observation is
the performance gain over L1 configurations for the BreastBlood dataset. This is
primarily explained by the limited number of cell-types (only two), combined with
the similar concentrations used in all samples (only combinations of 67% and 33%).
To gain additional insight into the parameters used in each case during deconvolution, I plot the optimal λ values for each configuration in each dataset. Figure 5.22
summarizes the optimal values of the λ parameter. Large values indicate a beneficial
effect for regularization, whereas small values are suggestive of negative impact. In
all cases where the overall mAD score has been improved, their corresponding λ parameter was large. However, large values of λ do not necessarily indicate a significant
impact on the final solution, as is evident in the CellLines and LiverBrainLung
datasets. Finally, we observe that cases where the value of λ is close to zero are
primarily associated with the L2 loss function.

5.3.6 Putting it All Together
Having analyzed each individual aspect that impacts the performance of the deconvolution process, in this section I put all of the pieces together and evaluate the overall
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Figure 5.21.: Effect of L2 regularization on the performance of deconvolution methods
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Figure 5.22.: Optimal value of λ for each dataset/configuration pair
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performance over each dataset. I remove the Retina dataset from this study due to
the observed discrepancies. For the remaining six datasets, I assess performance of
both L1 and L2 objectives with different combinations of NN/STO enforcement, for
a total of eight configurations. For each configuration, I use my previous results to
determine proper feature selection, i.e. whether or not to remove violating features
and/ or to select marker genes. Finally, I note that my results in Section 5.3.5, while
instructive, are not directly applicable here due to differences in the selected subset
of genes. Thus, for each configuration, I rerun the experiment without regularization,
as well as with regularization with λ ∈ {10−7 , . . . , 107 }.
Table 5.4 summarizes the settings used to solve each instance. There are some
general patterns to note here. First, for the RatBrain dataset, I are at the lowest
attainable mAD error, and neither removing violating features, nor selecting markers
can boost this. For this dataset, mAD is significantly lower than the rest of datasets.
This is likely due to the existence of highly expressed genes that just happen to align,
with low variation, between reference profiles and mixtures. This, however, has the
potential downfall of overfitting, in which case, the best configurations identified in
this dataset are not generalizable to other datasets.
Next, I observe that in a majority of cases, filtering violating features, on average,
either decreases mAD error or at least it does not increase it, with the previously
mentioned exception of RatBrain. Similarly, selecting marker genes, combined with
range filtering, in most cases improves deconvolution results, except in RatBrain and
BreastBlood. For the BreastBlood dataset, I argue that the quality of selected
markers might be affected because I only have two cell-types, but this needs further
validation. Finally, I note either marker selection or range filtering alone performs
much worse than combining them together.
The final results of my experiments, before and after feature selection/ regularization, are shown in Figure 5.23. Shaded bars correspond to the original performance
for each configuration, and colored bars are the final mAD errors computed. Interestingly, after suitable feature selection, the results for most of the datasets are within
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similar error ranges, approximately within the range of [5 − 7] mAD. Furthermore,
L2 seems to perform equally as good as L1 , given the proper subspace of genes to
perform deconvolution in, if not better. This is consistent with my understanding,
since L2 has higher sensitivity compared to L1 . Even in both PERT datasets, I observed only minor differences between these two objectives. Furthermore, Loss2 has
much more efficient solvers compared to L1 . Thus, in general I recommend using L2 ,
and to only resort to L1 if L2 does not perform well. However, I can not generalize
this claim to all datasets. In cases with high level of noise and/ or imperfect marker
selection, Loss1 still makes a better choice. Finally, contrary to traditional wisdom,
I observe a dataset-dependency for the effect of constraint enforcement. That is, explicitly encoding all constraints in the objective function does not always enhance the
quality of final results. A deeper understanding of this observation can guide one to
choosing the right formulation for the problem at hand.

5.3.7 Summary
Based on my observations, I propose the following guidelines for the deconvolution
of expression datasets:
1. Preprocess reference profiles and mixtures using invariant, universally expressed
(housekeeping) genes to ensure that the similar cell quantity (SCQ) constraint
is satisfied.
2. Filter violating features that cannot satisfy the sum-to-one (STO) constraint.
3. Filter lower and upper bounds of gene expressions using adaptive range filtering.
4. Select invariant (among references and between references and samples) celltype-specific markers to enhance the discriminating power of the basis matrix.
5. Solve the regression using the L2 loss function, together with an R2 regularizer,
or group LASSO if sparsity is desired among groups of tissues/cell-types.
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Figure 5.23.: Performance of deconvolution before/after applying combined feature
selection/regularization. Gray shade is mAD of the original deconvolutions (smaller
the better).
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Table 5.4: Best combination of choices for feature selection/regularization for different
datasets
L2

Loss Function
Non-negativity

+

Sum-to-One
BreastBlood

+

-

+

-

Remove violating features

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Filter markers/range

No

No

No

No

No

Yes

No

Yes

+

0

0.001

1E-06

1

10000000

100000

10000000

100000

Remove violating features

No

Yes

No

Yes

No

No

No

No

Filter markers/range

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Remove violating features

Best lambda
Remove violating features
Filter markers/range
Best lambda
PERT Uncultured Remove violating features

RatBrain

-

-

Filter markers/range

PERT Cultured

+

+

Best lambda
LiverBrainLung

-

-

Best lambda
CellLines

L1

0.0001

10

100

10

10

10000

0.001

10000

Yes

Yes

Yes

Yes

Yes

No

Yes

No

No

Yes

No

Yes

Yes

Yes

Yes

Yes

10000

10000

10000

10000

1000

1000

1000

0.0001

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10000

10000

1000

1000

10000

100000

10000

10000

No

Yes

Yes

Yes

Yes

Yes

Yes

No

Filter markers/range

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Best lambda

1000

1000

1000

1000

10000

10000

1000

100000

Remove violating features

No

No

No

No

No

No

No

No

Filter markers/range

No

No

No

No

Yes

Yes

No

No

Best lambda

0.1

100

1000

1000

1E-06

0.001

100000

100000

6. Use the L-curve method to identify the optimal balance between the regression
fit and the regularization penalty.
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6 CONSTRUCTING CELL TYPE SPECIFIC INTERACTOMES
6.1 Background
Proteins are basic workhorses of living cells. Their overall quantity is tightly regulated across different tissues and cell-types to manifest tissue-specific biology and
pathobiology. These regulatory controls orchestrate cellular machinery at different
levels of resolution, including, but not limited to, gene regulation [62, 120], epigenetic
modification [24, 121], alternative splicing [19, 46], and post-translational modifications [77, 194]. Transcriptional regulation is a key component of this hierarchical
regulation, which has been widely used to study context-specific phenotypes. In the
context of human tissues/ cell-types, genes can exhibit varying levels of specificity
in their expression. They can be broadly classified as: (i) tissue-specific (unique to
one cell-type); (ii) tissue-selective (shared among coherent groups of cell-types); and
(iii) housekeeping (utilized in all cell-types). Tissue-specific/selective genes have significant applications in drug discovery, since they have been shown to be more likely
drug targets [40]. Tissue-specific transcription factors (tsTFs) are significantly implicated in human diseases [123, 150], including cancers [197]. Finally, disease genes
and protein complexes tend to be over-expressed in tissues in which defects cause
pathology [103].
The majority of human proteins do not work in isolation but take part in pathways, complexes, and other functional modules. Tissue-specific proteins are known
to follow a similar trend. Perturbations that impact interacting interfaces of proteins
are significantly enriched among tissue-specific, disease-causing variants [155,157,208].
This emphasizes the importance of constructing tissue-specific interactomes and their
constitutive pathways for understanding mechanisms that differentiate cell-types and
make them uniquely susceptible to tissue-specific disorders. Prior attempts at re-
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constructing human tissue-specific interactomes rely on a set of “expressed genes” in
each tissue, and use this set as the baseline of transcriptional activity. The node
removal (NR) method [16] constructs tissue-specific interactomes by identifying the
induced subgraph of the expressed genes. Magger et al. [115] propose a method called
“Edge ReWeighting (ERW)”, which extends the NR method to weighted graphs. This
method penalizes an edge once, if one of its end-points is not expressed, and twice, if
both end-points are missing from the expressed gene-set.
While these methods have been used to study tissue-specific interactions, their
underlying construction relies only on the immediate end-points of each interaction
to infer tissue-specificity. Furthermore, they threshold expression values, often using
ad-hoc choices of thresholds to classify genes as either expressed or not. Finally, it is
hard to integrate expression datasets from multiple platforms, or from multiple labs,
into a single framework. These constraints are primarily dictated by limitations of
high-throughput technologies for assaying gene expression. In these technologies, one
can easily compare expression of the same gene across different samples to perform
differential analysis; however, expression of different genes in the same sample are
not directly comparable due to technical biases, differences in baseline expression,
and GC content of genes. A recently proposed method, Universal exPression Code
(UPC) [143], addresses many of these issues by removing platform-specific biases and
converting raw expressions to a unified transcriptional activity score. These scores
are properly normalized and can be compared across different genes and platforms.
Leveraging the UPC method, I propose a novel approach that uses the topological
context of an interaction to infer its specificity score. my approach formulates the
inference problem as a suitably regularized convex optimization problem. The objective function of the optimization problem has two terms – the first term corresponds
to a diffusion kernel that propagates activity of genes through interactions (network
links). The second term is a regularizer that penalizes differences between transcriptional and functional activity scores. I use these functional activity scores to compute
tissue-specificity for each edge in the global interactome, which I show, through a
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number of validation tests, are significantly better than prior methods. my method is
widely applicable and can be applied directly to single-channel, double-channel, and
RNA-Seq expression datasets processed using UPC/SCAN. Furthermore, it can be
easily adapted to cases where expression profiles are only available in preprocessed
form.
The rest of this chapter is organized as follows: In Section 6.2.1 I provide details
of the datasets used in my study. Next, I introduce a new method method, called
Activity Propagation (ActPro), and provide a consistent notation to formalize previous methods. I evaluate the effectiveness of UPC transcriptional activity scores to
predict tissue-specific genes in Section 6.3.1. Details of procedure for constructing
tissue-specific networks and their parameter choices are discussed in Section 6.3.2.
Section 6.3.3 provides qualitative assessment of my tissue-specific networks, whereas
Sections 6.3.4-6.3.6 present validation studies for tissue-specific interactions using
known pathway edges, co-annotation of proteins, and GWAS disease genes. Finally,
in Section 6.3.7, I use the brain-specific interactome constructed using my method
to identify novel disease-related pathways and use them to identify candidate targets
for neurodegenerative disorders.

6.2 Materials and Methods
6.2.1 Datasets
I downloaded the RNASeq dataset version 4.0 (dbGaP accession phs000424.v4.p1 )
from the The Genotype-Tissue Expression (GTEx) project [6, 120]. This dataset
contains 2,916 samples from 30 different tissues/cell types, the summary of which
is presented in Figure 6.1. I processed each sample using the UPC method [143],
a novel platform-independent normalization technique that corrects for platformspecific technical variations and estimates the probability of transcriptional activity for each gene in a given sample. The benefit of this method is that activation
probability scores are highly consistent across different technologies, and more im-
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Figure 6.1.: Summary of GTEx sample numbers per tissue
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portantly, they are comparable across different genes in a given sample. For each
gene, I recorded the transcript with the highest activation probability in the sample.
Finally, I averaged replicate samples within each group to construct a unique transcription signature vector for each tissue/ cell type. The final dataset contains the
expression value of 23,243 genes across 30 different tissues/ cell types.
In addition, I extracted human protein-protein interactions from the iRefIndex
database [152], which consolidates protein interactions from different databases. Edges
in this dataset are weighted using an MI (MINT-Inspired) score, which measures the
confidence of each interaction based on three different evidence types, namely (i)
the interaction types (binary/complex) and experimental method used for detection,
(ii) the total number of unique PubMed publications reporting the interaction, and
(iii) the cumulative evidence of interlogous interactions from other species. Finally,
I map transcription data to the human interactome by converting all gene IDs to
Entrez Gene IDs and only retaining genes that both have a corresponding node in
the interactome and have been profiled by the GTEx project. This yields a global in-
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teractome with 147,444 edges, corresponding to protein-protein interactions, between
14,658 nodes, representing gene products.

6.2.2 Constructing Human Tissue-specific Interactome
The global human interactome is a superset of all possible physical interactions
that can take place in the cell. It does not provide any information as to which
interactions actually occur in a given context. There are a variety of factors, including
co-expression of genes corresponding to a pair of proteins, their co-localization, and
post-translational modification, that mediate protein interactions at the right time
and place. Quantifiable expression of both proteins involved in an interaction is one of
the most important factors that determine the existence of an interaction. Different
methods have been proposed in literature to utilize this source of information to
construct human tissue-specific interactomes. Here, I briefly review existing methods,
their drawbacks, and propose a new method, called Activity Propagation (ActPro),
which addresses noted shortcomings.

Previous Methods
Let us denote the adjacency matrix of the global interatome by A, where element
aij is the weight (confidence) of the edge connecting vertices vi and vj . Let z encode
expression of genes in a tissue and z be the binarized version of z for a fixed threshold.
Finally, let diag operator applied to a given vector be the diagonal matrix with the
vector on the main diagonal. my aim is to compute a matrix Â, which is the adjacency
matrix of the tissue-specific interactome for a given expression profile. Using this
notation, I can summarize prior methods for constructing tissue-specific interactomes
as follows.
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• Node Removal (NR) This method computes the induced subgraph of the
“expressed” gene products [16].
Â = diag(z) ∗ A ∗ diag(z)

(6.1)

• Edge Re-Weighting (ERW) This method penalizes edges according to the
expression state (active/ inactive) of its end points [115]. Given a penalty
parameter 0 ≤ rw ≤ 1, ERW penalizes each edge by rw once, if only one of its
end-points is active, and twice, if both incident vertices are inactive. Formally:
Â = diag(rw(e−z) ) ∗ A ∗ diag(rw(e−z) )

(6.2)

where e is the vector of all ones.

Proposed Method
The main assumption of ERW and NR methods is that transcriptional activity
of a gene is a reliable proxy for its functional activity. While this holds in a majority
of cases, there are situations in which these scores differ significantly. First, the basis
for transcriptional activity estimation is that genes with higher expression levels have
higher chance of being functionally active in a given context. While this is generally
true, there are genes that only need a low expression level to perform their function;
i.e., their functionally active concentration is much lower than the rest of genes.
Second, there is noise associated with measurement of gene expression, and converting
measured expression values to UPC scores can over/ under-estimate transcriptional
activity. Finally, we note that there are genes whose down-regulation corresponds to
their functional activity (as opposed to the other way around).
Based on these observations, I propose a novel framework, called Activity Propagation (ActPro) to identify the most functionally active subnetwork of a given interactome. my method incorporates global network topology to propagate activity
scores, while simultaneously minimizing the number of changes to the gene activity
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scores. To this end, I first define a smoothed functional activity score defined by the
following optimization problem:


α
(1 − α)
x = argmin
xLx +
k x − z k1
|E|
|V |
x


1T x = 1
Subject to:

0 ≤ x
∗

(6.3)

In this problem, L is the Laplacian matrix, defined as A − ∆, where element δii of ∆
is the weighted degree of ith vertex in the global interactome. The Laplacian operator
L acts on a given function defined over vertices of a graph, such as x, and computes
the smoothness of x over adjacent vertices. More specifically, we can expand the
P
first term in Equation 6.3 as i,j wi,j (xi − xj )2 , which is the accumulated difference
of values between adjacent nodes scaled by the weight of the edge connecting them.
This term defines a diffusion kernel that propagates activity of genes through network
links. The second term is a regularizer, which penalizes changes by enforcing sparsity
over the vector of differences between transcriptional and functional activities. This
minimizes deviation from original transcriptome. It should be noted here that use
of norm-1 is critical, since norm-2 regularization blends the transcriptional activity
scores and significantly reduces their discriminating power. This negative aspect of
norm-2 minimization is confirmed by my experiments. Finally, constraint 1T x = 1
is known as the fixed budget. It ensures that vector x is normalized and bounded.
Parameter α determines the relative importance of regularization versus loss. We can
equivalently define a penalization parameter λ =

1−α
,
α

which is the standard notation

in optimization framework. This problem is a classical convex optimization problem
and we can solve it using efficient solvers to identify its global optimum.
After solving Equation 6.3, I first scale x∗ by |V |. These scores are centered
around 1, which allows us to perform minimal changes to the weight of interactions
in the global interactome. Using these smoothed activity scores, I can re-weight the
global human interactome as follows:
Â = diag(x∗ ) ∗ A ∗ diag(x∗ )

(6.4)
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We can also derive an alternative formulation for ActPro which, instead of using
transcriptional activity scores computed by UPC, uses expression values computed
through more common methods such as RMA or MAS5.0 [108]. I call this method
penalty propagation, or PenPro for short. In this framework, computed expression
values are not directly comparable and I need to threshold them to classify genes
as either expressed or not. Using the same notation defined previously, I can define
functional activity scores by solving the following problem:


α
(1 − α)
∗
xLx +
k x − z k1
x = argmin
|E|
|V |
x


1 T x = 1
Subject to:

0 ≤ x

(6.5)

The only difference here is that, instead of transcriptional activity vector z, I use
the binarized expression vector z. We observe similar performance for ActPro and
PenPro, with ActPro being marginally superior in all cases, and thus I will only
present results for ActPro.

6.2.3 Implementation Details
All codes used in my experiments have been implemented in Matlab. To solve the
convex problem in Equation 6.3, I used CVX, a package for specifying and solving
convex programs [63]. I used Mosek together with CVX, which is a high-performance
solver for large-scale linear and quadratic programs [126].

6.3 Results and Discussion
6.3.1 Transcriptional Activity Scores Predict Tissue-specificity of Genes
To validate the quality of UPC normalized expression values, I first analyze the
distribution of gene expressions across all tissues. Figure 6.2a shows the distribution of
transcriptional activities, averaged over all samples. The overall distribution exhibits
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a bimodal characteristic that has a clear separation point that distinguishes expressed
genes from others. I set a global threshold of 0.75 for identifying genes that are
expressed in each tissue. These genes are used in evaluating NR and ERW methods.
It should be noted that the distribution of UPC values vary across cell-types, as shown
in Figure 6.2b; however, the separation point is robust.
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Expression value of genes across tissues can be classified as specific, selective, or
housekeeping. Housekeeping (HK) genes are ubiquitously expressed across all tissues
to perform core cellular functions. On the other hand, tissue specific/selective genes
are uniquely expressed in a given tissue context to perform tissue-specific functions.
These genes typically reside in the periphery of the network, are enriched among
signaling and cell surface receptors, and highly associated with the onset of tissuespecific disorders [216]. Figure 6.3a shows the total number of genes identified in each
tissue as preferentially expressed (either specific or selective). Testis tissue exhibits
the largest number of preferentially expressed genes (I refer to these as markers), with
more that 1, 400 genes, while blood samples have the fewest markers with only ∼ 250
marker genes. In order to assess whether the sets of preferentially expressed genes can
predict tissue-specific functions, I performed GO enrichment analysis over different
sets of tissue-specific markers using GOsummaries package in R/Bioconductor [95].
This package uses g:Profiler [153] as backend for enrichment analysis and provides a
simple visualization of the results as a word cloud. The coverage of available annotations for different tissues is not uniform; that is, some tissues are better annotated
for specific terms than the others. I chose six well-annotated tissues with high, mid,
and low number of identified markers for further study. I limited terms to the ones
with at least 20 and at most 500 genes to avoid overly generic/specific terms. Finally,
I used a strong hierarchical filtering to remove duplicate GO terms and thresholded
terms at p-value of 0.05. Figure 6.3b shows the enrichment word-cloud for each tissue.
It can be seen that all terms identified here are highly tissue-specific and representative of main functions for each tissue, which supports the validity of computed
transcriptional activity scores from UPC.

6.3.2 Constructing Tissue-specific Interactomes
Node Removal (NR) and Edge ReWeighting (ERW) methods need a predefined
set of expressed genes in each tissue to construct tissue-specific interactomes (or a
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given lower bound to threshold expression values). I use the set of all genes with
transcriptional activity greater than or equal to 0.75 as the set of expressed genes
for these methods. I chose this threshold based on the averaged distribution of gene
expressions, as well as further manual curation of genes at different thresholds.
Node Removal (NR) method is known to disintegrate the network with stringent
expression values [115]. To evaluate the performance of NR over different expression
thresholds and assess its sensitivity to the choice of threshold, I computed the size
of largest connected components, while varying the value of expression threshold.
Figure 6.4 shows stable behavior up to threshold value of 0.75, after which the size of
largest component exhibit a rapid shift and the network starts to disintegrate. This
suggests that the expression value of 0.75 is also the optimal topological choice for
NR method.
For the ActPro algorithm, I evaluated the results over three different values of α
in set {0.15, 0.5, 0.85} and reported the result for each case.

6.3.3 Qualitative Characterization of Tissue-specific Interactomes
A key feature of tissue specific networks is their ability to discriminate positive
edges that manifest in each tissue from the entire set of potential interactions in the
global interactome. In case of Node Removal (NR) and Edge ReWeighting (ERW)
methods, it is easy to distinguish positive and negative edges: every edge for which at
least one of the endpoints is not expressed can be classified as a negative edge. The
latter method updates edge weights, to account for expression of their end-points,
whereas the former method sets a hard threshold to either include an edge or not.
In the case of ActPro, I first notice that the distribution of edge weights is very
different between ActPro and previous methods. Whereas NR and ERW methods
never increase the weight of an edge, in ActPro edge weights can increase or decrease.
This behavior, however, is biased towards the positive end. To decompose each
network into its HK, positive, and negative subspaces, I use the following strategy:

118
for each tissue-specific network constructed by a given method, I first compute the
relative weight change between the global interactome and the tissue-specific network.
I then normalize these changes using Z-score normalization and define positive and
negative subspaces according to the sign of normalized relative changes. I further
define and separate HK edges as the subset of positive edges that are positive in at
least half of the tissues. Figure 6.5 summarizes the average statistics for constructed
networks using different methods. As a general observation, ActPro classifies fewer
interactions as housekeeping and provides more specific positive and negative edges.
Furthermore, as I increase the α parameter, representing the diffusion depth, we
observe that these edges are more evenly distributed across vertices. To give a concrete
example, I constructed the brain-specific network using ERW and ActPro methods.
Figure 6.6 illustrates the final statistics of the constructed networks. Consistent with
the average statistics, I observe much smaller positive/negative nodes/edges in ERW.

6.3.4 Tissue-specific Interactome Predicts Context-sensitive Interactions in Known
Functional Pathways
To evaluate the power of tissue-specific interactions in capturing context-sensitive
physical interactions in known pathways, I first use Edge Set Enrichment Analysis
(ESEA) to rank pathway edges according to their gain/loss of mutual information
in each tissue context [69]. ESEA aggregates pathways from seven different sources
(KEGG; Reactome; Biocarta, NCI/Nature Pathway Interaction Database; SPIKE;
HumanCyc; and Panther) and represents them as a graph with edges corresponding
to biological relationships, resulting in over 2,300 pathways spanning 130,926 aggregated edges. It then uses an information-theoretic measure to quantify dependencies
between genes based on gene expression data and ranks edges, accordingly. Formally,
for each pathway edge, ESEA computes the differential correlation score (EdgeScore)
as follows:
EdgeScore = M I all (i, j) − M I control (i, j)

(6.6)
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where M I all is the mutual information of the gene expression profiles for genes i and
j across all cell-types. Here, M I control measures the mutual information only in the
given tissue context. Each edge can be classified as either a gain of correlation (GoC),
loss of correlation (LoC), or no change (NC) depending on the value of EdgeScore.
I use GoC edges, that is, a pair of genes with positive gain of mutual information in
the tissue context, as true positive edges in each tissue. Similarly, I use all positive
edges in all tissues but the tissue of interest as true negatives.
To assess agreement between ESEA scores over known pathway edges and computed tissue-specific interactions, I rank all edges according to the difference of their
weights in the human tissue-specific interactome compared to the global interactome
and evaluate the enrichment of true positive pathway edges among top-ranked edges.
I compute the receiver operating characteristic (ROC) curve for each tissue and average the area under the curve (AUC) gain, compared to random baseline, over all
tissues. Figure 6.7 presents the relative performance of each method. All three configurations of the ActPro algorithm are ranked at the top of the list – demonstrating
the superior performance of my proposed method.
To further investigate tissue-specific details for the top-ranked method, ActPro
with α = 0.15, I sorted AUC gain for each tissue, shown in Figure 6.8. This plot exhibits high level of heterogeneity, and surprisingly, four of the tissues had worse than
random performance. This was consistent across all of the methods. To further understand this, I investigated the ranked list of edges and identified a high enrichment
of edges with LoC among top-ranked edges. I performed enrichment analysis over
these negative edges and identified significant tissue-specific functions among them,
which suggests that the poor observed performance for these tissues is attributed to
their misclassification as negative edges.
At the other end of the spectrum, Fallopian Tube, Vagina, and Cervix Uteri had
consistently high AUC gain across different methods. Figure 6.9 shows the ROC
curve for these tissues.
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6.3.5 Tissue-specific Interactions are Enriched among Proteins with Shared Tissuespecific Annotations
I hypothesize that tissue-specific edges are enriched with proteins that participate
in similar tissue-specific functions. To evaluate my hypothesis, I collected a set of
manually curated tissue-specific Gene Ontology (GO) annotations from a recent study
[64]. I mapped tissues to GTEx tissues and identified tissue-specific GO annotations
for genes in each tissue-specific interactome. I excluded tissues with less that 100
edges with known annotations. This resulted in 10 tissues, Adipose Tissue, Blood
Vessel, Blood, Brain, Breast, Heart, Kidney, Lung, and Muscle, for which I had
enough annotations. I use the same strategy employed in previous section to identify
the mean gain of AUC for each method, which is illustrated in Figure 6.10. It should
be noted that the gain of AUC is much smaller here than the case with ESEA edges,
which can be attributed to the sparsity of tissue-specific GO annotations. Unlike
ESEA, ActPro with α = 0.5 outperforms the case with α = 0.15.
Among the ten tissues, Adipose and Muscle tissues performed marginally better
than the others with AUC of 0.59 and 0.58, respectively. On the other hand, Lung
tissue had the worst performance with lower than random AUC of 0.47.

6.3.6 Tissue-specific Interactions Densely Connect Genes Corresponding to Tissuespecific Disorders
Disease genes are densely connected to each other in the interactome, which provides the basis for a number of methods for network-based disease gene prioritization [94]. Tissue-specific interactomes have been shown to have higher accuracy in
predicting disease-related genes using the random-walk method [115]. More recently,
Cornish et al. [33] used the concept of “geneset compactness”, and showed that the average distance among nodes corresponding to a given disorder is significantly smaller
in tissue-specific networks, compared to an ensemble of random graphs.
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Here, I adopt this concept to measure how closely tissue-specific genes related
to human disorders are positioned in networks constructed using different methods.
First, I use a symmetric diffusion process instead of Random-Walk with Restart
(RWR), which is a better measure of distance. Second, I use an alternative random
model in which I hypothesize that genes corresponding to tissue-specific disorders are
strongly connected to each other, compared to random genesets of the same size.
To validate my hypothesis, I gather genes corresponding to tissue-specific disorders from a recent study [73]. These genes are extracted from the GWAS Catalog by
mapping known associations to disease-specific loci. Among a total of 99 disorders, I
focused on the gold standard set of 29 diseases with at least 10 high-quality primary
targets. I successfully mapped 27 of these diseases to GTEx tissues, which are used
for the rest of my study. Consistent with previous studies [115], I observed a small
subset of disease genes not to be expressed in the tissue in which they cause pathology. Among all disease genes, I only retained genes that are connected in the global
interactome and are expressed above 0.1 UPC score.
For a given tissue-specific interactome represented by its adjacency matrix, AT ,
1

1

I define a stochastic matrix S = ∆− 2 AT ∆− 2 , where ∆ is the diagonal matrix, with
entries δii being the degree of node i in the human tissue-specific interactome. Using
this matrix, I can compute degree-weighted random-walk scores among gene pairs as:
P = (1 − α)(I − αS)−1

(6.7)

I define the random-walk distance as dij = −log10 (pij ), after replacing zero elements
of P with  = 2−52 . Given a disease geneset Γ, I measure its compactness as the
normalized average of distances for all pairs of nodes in the geneset:
P
i6=j∈Γ dij
κΓ =

|Γ|

(6.8)

2

Finally, I sampled without replacement, 100K vertex samples of size |Γ| from the
tissue-specific interactome and computed the compactness for each of the samples,
individually. I defined an empirical p-value as the fraction of random instances with
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higher compactness (lower κ) compared to Γ. I removed disorders for which none
of the methods yield significant p-value given a threshold of 0.05. The final dataset
consists of 15 diseases with significantly compact interactions. To combine the pvalues for different disorders, I use the Edgington method [44]. This method gathers
P
a statistic S = ki=1 pi for a set of k given p-values, and computes the meta p-value
by assigning significance to S as:
bSc
X

 
k (S − j)k
−1
j
k!
j=0
j

(6.9)

The list of all individual and combined p-values is shown in Table 6.1. In these experiments, ActPro (α = 0.85) had the most significant results, closely followed by
ActPro (α = 0.5). This suggests that propagating information using diffusion kernel
in ActPro enhances its prediction power for tissue-specific pathologies. Furthermore,
there are four diseases for which the global interactome had more significant predictions compared to tissue-specific networks, among which primary biliary cirrhosis
and psoriasis had the highest difference. This difference may be attributed to misclassification of disease/ tissue in Himmelstein et al. [73], or existence of cross tissue
mechanisms of action for the disease.

6.3.7 Tissue-specific Interactome Identifies Novel Disease-related Pathways – Case
Study in Neurodegenerative Disorders
I now investigate whether tissue-specific interactomes can help in predicting novel
pathways that are involved in the progression of neurodegenerative disorders. I perform a case study of Alzheimer’s and Parkinson’s diseases, both of which were among
disorders with high compactness in brain tissue. I use Prize-Collecting Steiner Tree
(PCST) algorithm to identify the underlying pathway among disease-genes identified
by GWAS studies. Formally, PCST problem can be formulated as:
argmin
<v,e>∈T

nX
e

ce − λ

X o
bv ,
v

(6.10)
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Table 6.1: Compactness of tissue specific disease genes in their tissue-specific interactome
global

ActPro 0.15

ActPro 0.50

ActPro 0.85

ERW

NR

Alzheimer’s disease

4.12E-3

6.96E-3

5.98E-3

5.44E-3

5.32E-3

9.60E-2

breast carcinoma

1.83E-3

1.11E-3

8.40E-4

8.30E-4

4.09E-3

8.15E-2

chronic lymphocytic leukemia

8.20E-4

7.40E-4

4.80E-4

5.10E-4

8.50E-4

2.94E-2

coronary artery disease

3.95E-1

1.58E-1

1.09E-1

1.03E-1

1.33E-1

1.93E-2

Crohn’s disease

2.56E-2

1.93E-2

1.50E-2

1.44E-2

8.54E-2

4.14E-1

metabolic syndrome X

1.11E-2

1.09E-2

1.07E-2

1.12E-2

1.02E-1

7.39E-1

Parkinson’s disease

1.59E-2

1.25E-2

9.89E-3

9.50E-3

1.34E-2

9.62E-2

primary biliary cirrhosis

7.20E-4

1.32E-3

3.16E-3

3.40E-3

2.80E-2

6.86E-1

psoriasis

2.10E-4

1.10E-3

1.16E-3

9.50E-4

4.67E-3

3.24E-1

rheumatoid arthritis

1.70E-2

9.28E-3

1.06E-2

1.10E-2

6.39E-2

3.61E-1

systemic lupus erythematosus

4.98E-2

1.19E-2

7.56E-3

7.22E-3

2.55E-3

1.60E-4

type 1 diabetes mellitus

2.64E-2

3.01E-2

2.38E-2

2.40E-2

2.64E-1

9.39E-1

type 2 diabetes mellitus

1.57E-3

2.90E-4

2.40E-4

1.80E-4

5.60E-4

7.90E-3

vitiligo

1.17E-3

2.13E-3

3.04E-3

3.54E-3

1.84E-2

5.69E-1

schizophrenia

3.47E-1

2.13E-1

1.93E-1

1.84E-1

1.40E-1

4.10E-2

combined

1.53E-13

1.24E-17

6.62E-19

3.70E-19

9.03E-14

2.43E-03

where T is an induced tree of the given graph, v and e are the set of vertices and
edges in T , respectively, ce is the cost of choosing edge e, and bv is the reward/prize
of collecting node v. Similar methods have been proposed previously to connect
upstream signaling elements to downstream transcriptional effector genes [190, 191].
To identify disease-related pathways, I first prune non-specific interactions in the
network by removing vertices that have more than 500 interactions. I transform edge
confidence values (conductances) to edge penalties (resistances) by inverting each edge
weight. Node prizes are defined as the ratio of their incident edges that fall within
disease-related genes to the total degree of a node. I assigned a node prize of 1,000
to disease genes to ensure that they are selected as terminal nodes. Finally, I use a
recent message passing algorithm [8] to identify PCST rooted at each disease-related
gene and choose the best tree as the backbone of the disease-related pathway. Over
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each node, I use a maximum depth of 4 and λ = 1 as parameters to the message
passing algorithm. Figure 6.11 shows final tissue-specific pathways for Alzheimer’s
and Parkinson’s diseases.
Alzheimer’s disease (AD) network contains two distinct subnetworks, one centered
around CLTC and the other centered around ABL1. PICALM, CLU, APOE, and
SORL1 are all known genes involved in AD, which are also involved negative regulation
of amyloid precursor protein catabolic process. All four of these genes converge on
CLCT gene, but through different paths. PICALM gene is known to play a central
role in clathrin-related endocytosis. This protein directly binds to CLTC and recruits
clathrin and adaptor protein 2 (AP-2) to the plasma membrane [21]. On the other
hand, CLU, APOE, and SORL1 are linked to the CLTC through novel linker genes
XRCC6, MAPT/BIN1 and GG2A/HGS, respectively. Gamma-adaptin gene, GGA2,
binds to clathrins and regulates protein traffic between the Golgi network and the
lysosome. This network is postulated to be an important player in AD [21]. HGS gene
is a risk factor age-related macular degeneration (AMD) and has been hypothesized
to be a shared factor for AD [111]. Interestingly, MAPT, a novel marker identified
in this study, is a risk factor for Parkinson’s disease and very recently shown to
also be linked to AD [38]. A second component in AD network is centered around
ABL1 gene, which, together with CBL, INPPL1, CD2AP, and MAPT share the
SH3 domain binding function. INPPL1 gene, a metabolic syndrome risk factor, has
been hypothesized to link AD with the recently posed term “type 3 diabetes” [3].
Finally, we note that MAPT gene is one of the central genes that links these two
main components, the role of which warrants further investigation.
Parkinson’s disease (PD) network, on the other hand, contains one densely connected core centered around MAPT gene. There are two main branches converging
on MAPT. On the left, WNT3, FZD1, and GSK3B constitute upstream elements
of the WNT signaling pathway, which is known to play an important role in PD
neurodegeneration [12]. GSK3 gene product is postulated to directly interact with
MAPT (τ ) and LRKK2, while implicitly regulating SNCA (α-Syn) in a β-cat depen-
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dent manner. However, we observed direct interaction between GSK3B and SNCA,
and parallel pathways connecting it to LRRK2 via SNCA and MAPT. Both SNCA
and MAPT also take part in the right branch, together with CAV1 and RHOA,
which is enriched in reactive oxygen species metabolic process. Accumulation of ROS
contributes to mitochondrial dysfunction and protein misfolding, both of which are
linked to progression of PD. RIT2 enzyme is identified independently and confirmed
as PD susceptibility factor [133]. Pankratz et al. also suggested CALM1 as the
bridge linking RIT2 with MAPT and SNCA, which confirms my findings. Cyclin G
associated kinase (GAK ) is a known risk factor for PD. I identified HSPA8 as a key
link between GAK, WNT signaling pathway, and CSNK1E with central PD genes,
MAPT, SNCA, and LRRK2. HSPA8 gene has been proposed as a biomarker for diagnosis of PD [105]. Finally, myelin basic protein (MBP ) interacts closely with CALM1
and LRRK2. This gene has been previously shown to be differentially expressed in
PD and proposed as potential biomarker for PD [90].
In summary, I show that the brain-specific interactome derived from my method
helps in uncovering tissue-specific pathways that are involved in neurodegenerative
diseases. Similar analysis of other human tissues can potentially contribute to identification of new therapeutic targets for other human disorders.
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Figure 6.3.: Evaluation of tissue-specific markers using a threshold value of 0.75 to
define expressed genes.
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7 CONSERVATION OF CELL TYPE-SPECIFIC NETWORKS
ACROSS SPECIES
7.1 Background
Budding yeast, S. cerevisiae, is widely used as an experimental system, due to its
ease of manipulation in both haploid and diploid forms, and rapid growth compared
to animal models. Coupled with the continuous development of new experimental
methodologies for manipulating various aspects of its cellular machinery, it has served
as the primary model organism for molecular and systems biology [17]. Motivated
by the availability of its full genome in 1996 as the first eukaryotic organism to be
sequenced [59], an array of functional genomics tools emerged, including a comprehensive collection of yeast deletion mutants [56, 211], genome-wide over-expression
libraries [84], and green fluorescent protein (GFP)-tagged yeast strains [55, 76]. The
maturity of yeast’s genetic and molecular toolbox has, in turn, positioned it as the
primary platform for development of many high-throughput technologies, including
transcriptome [29, 37, 104], proteome [224], and metabolome [81, 202] screens. These
-omic datasets, all originally developed in yeast, aim to capture dynamic snapshots
of the state of biomolecules during cellular activities. With the advent of “systems
modeling”, a diverse set of methods have been devised to assay the interactions,
both physical and functional, among different active entities in the cell, including
protein-protein [78, 98, 192], protein-DNA [79, 106], and genetic [34, 184, 185] interactions. These interactions, also referred to as the interactome, embody a complex
network of functional pathways that closely work together to modulate the cellular machinery. Comparative analysis of these pathways relies on network alignment
methods, much the same way as sequence matching and alignments are used for individual genes and proteins. Network alignments use both the homology of genes, as
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well as their underlying interactions, to project functional pathways across different
species [97, 99, 163, 167]. These methods have been previously applied to detection of
ortholog proteins, projection of functional pathways, and construction of phylogenetic
trees.
Yeast and humans share a significant fraction of their functional pathways that
control key aspects of eukaryotic cell biology, including the cell cycle [71], metabolism
[142], programmed cell death [20, 127], protein folding, quality control and degradation [18], vesicular transport [15], and many key signaling pathways, such as
mitogen-activated protein kinase (MAPK) [26, 209], target of rapamycin (TOR) [36],
and insulin/IGF-I [9] signaling pathways. In the majority of cases, yeast has been
the model organism in which these pathways were originally identified and studied.
These conserved biochemical pathways drive cellular growth, division, trafficking,
stress-response, and secretion, among others, all of which are known to be associated with various human pathologies. This explains the significant role for yeast as
a model organism for human disorders [140, 141, 168]. Yeast has contributed to my
understanding of cancers [66, 138, 139] and neurodegenerative disorders [89, 137, 182].
Having both chronological aging (amount of time cells survive in post-mitotic state)
and replicative aging (number of times a cell can divide before senescence occurs),
yeast is also used extensively as a model organism in aging research. It has contributed to the identification of, arguably, more human aging genes than any other
model organism [112].
Depending on the conservation of the underlying pathways, there are two main
approaches to studying them in yeast. It has been estimated that, out of 2,271
known disease-associated genes, 526 genes (∼ 23%) have a close ortholog in the yeast
genome, spanning 1 out of every 10 yeast genes [50]. For these orthologous pairs of
disease-associated genes, I can directly increase the gene dosage of the endogenous
yeast protein by using overexpression plasmids, or decrease it, through either gene
knockout or knockdown experiments, in order to study gain- or loss-of-function phenotypes, respectively. A key challenge in phenotypic screens is that disrupting genes,
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even when they have close molecular functions, can result in characteristically different organism-level phenotypes. Phenologs, defined as phenotypes that are related by
the orthology of their associated genes, have been proposed to address this specific
problem [119]. A recent example of such an approach is the successful identification
of a highly conserved regulatory complex implicated in human leukemia [178]. This
complex, named COMPASS (Complex of Proteins Associated with Set1), was originally identified by studying protein interactions of the yeast Set1 protein, which is the
ortholog of the human mixed-lineage leukemia (MLL) gene, and years later was shown
to be conserved from yeast to fruit flies to humans. On the other hand, if the diseaseassociated gene(s) in humans does not have close orthologs in yeast, heterologous
expression of the human disease-gene in yeast, also referred to as “humanized yeast”,
can be used to uncover conserved protein interactions and their context, to shed light
on the molecular mechanisms of disease development and progression. For the majority of disease-genes with known yeast orthologs, heterologous expression of the mammalian gene is functional in yeast and can compensate for the loss-of-function phenotype in yeast deletion strains [17]. This approach has already been used to construct
humanized yeast model cells to study cancers [66], apoptosis-related diseases [31], mitochondrial disorders [147], and neurodegenerative diseases [137]. Perhaps one of the
more encouraging examples is the very recent discovery of a new compound, N-aryl
benzimidazole (NAB), which strongly protects cells from α-synuclein toxicity in the
humanized yeast model of Parkinson’s disease [180]. In a follow-up study, they tested
an analog of the NAB compound in the induced pluripotent stem (iPS) cells generated from the neuron samples of Parkinson’s patients with α-synuclein mutations.
They observed that the same compound can reverse the toxic effects of α-synuclein
aggregation in neuron cells [30]. Using this combined phenotypic screening, instead
of the traditional target-based approach, they were not only able to discover a key
compound targeting similar conserved pathways in yeast and humans, but also uncover the molecular network that alleviates the toxic effects of α-synuclein. These
humanized yeast models have also been used to study human genetic variations [41].
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Various successful instances of target identification, drug discovery, and disease
network reconstruction using humanized yeast models have established its role as a
model system for studying human disorders. When coupled with more physiologically
relevant model organisms to cross-validate predictions, yeast can provide a simple yet
powerful first-line tool for large-scale genetic and chemical screening [137, 139]. However, as a unicellular model organism, yeast fails to capture organism-level phenotypes
that emerge from inter-cellular interactions. Perhaps, more importantly, it is unclear
how effectively it can capture tissue-specific elements that make a tissue uniquely susceptible to disease. All human tissues inherit the same genetic code, but they exhibit
unique functional and anatomical characteristics. Similar sets of molecular perturbations can cause different tissue-specific pathologies given the network context in which
the perturbation takes place. For example, disruption of energy metabolism can contribute to the development of neurodegenerative disorders, such as Alzheimer’s, in
the nervous system, while causing cardiomyopathies in muscle tissues [13]. These
context-dependent phenotypes are driven by genes that are specifically or preferentially expressed in one or a set of biologically relevant tissue types, also known as
tissue-specific and tissue-selective genes, respectively. Disease genes, and their corresponding protein complexes, have significant tendencies to selectively express in
tissues where defects cause pathology [60, 103]. How tissue-selective pathways drive
tissue-specific physiology and pathophysiology is not completely understood; neither
is the extent to which I can use yeast as an effective model organism to study these
pathways.
I propose a quantitative framework to assess the scope and limitations of yeast
as a model organism for studying human tissue-specific pathways. This framework
is grounded in a novel statistical model for effectively assessing the similarity of each
tissue with yeast, considering both expressed genes and their underlying physical interactions as a part of functional pathways. To understand the organization of human
tissues, I present a computational approach for partitioning the functional space of
human proteins and their interactions based on their conservation both across species
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and among different tissues. Using this methodology, I identify a set of core genes,
defined as the subset of the most conserved housekeeping genes between humans
and yeast. These core genes are not only responsible for many of the fundamental
cellular processes, including translation, protein targeting, ribosome biogenesis, and
mRNA degradation, but also show significant enrichment in terms of viral infectious
pathways. On the other hand, human-specific housekeeping genes are primarily involved in cell-to-cell communication and anatomical structure development, with the
exception of mitochondrial complex I, which is also human-specific. Next, I identify
comprehensive sets of tissue-selective functions that contribute the most to the computed overall similarity of each tissue with yeast. These conserved, tissue-selective
pathways provide a comprehensive catalog for which yeast can be used as an effective
model organism. Conversely, human-specific, tissue-selective genes show the highest
correlation with tissue-specific pathologies and their functional enrichment resembles
highly specific pathways that drive normal physiology of tissues.
Comparative analysis of yeast and human tissues to construct conserved and nonconserved functional tissue-specific networks can be used to elucidate molecular/ functional mechanisms underlying dysfunction. Moreover, it sheds light on the suitability
of the yeast model for the specific tissue/ pathology. In cases where suitability of
yeast can be established, through conservation of tissue-specific pathways in yeast, it
can serve as an experimental model for further investigations of new biomarkers, as
well as pharmacological and genetic interventions.

7.2 Materials and Methods
7.2.1 Datasets
Protein-protein Interaction (PPI) Networks
I adopted human tissue-specific networks from Bossi et al. [16]. They integrated
protein-protein interactions from 21 different databases to create the whole human
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interactome consisting of 80,922 interactions among 10,229 proteins. Then, they
extracted the set of expressed genes in each tissue from GNF Gene Atlas and used
it to construct the tissue-specific networks, defined as the vertex-induced subgraphs
of the entire interactome with respect to the nodes corresponding to the expressed
genes in each tissue.
Additionally, I obtained the yeast interactome from the BioGRID [175] database,
update 2011 [174], version 3.1.94, by extracting all physical interactions, excluding interspecies and self interactions. This resulted in a total of 130,483 (76,282
non-redundant) physical interactions among 5,799 functional elements in yeast (both
RNA and protein). Next, I downloaded the list of annotated CDS entries from the
Saccharomyces Genome Database (SGD) [28] and restricted interactions to the set of
pairs where both endpoints represent a protein-coding sequence, i.e., protein-protein
interactions. The final network consists of 71,905 interactions between 5,326 proteins
in yeast.

Protein Sequence Similarities Between Yeast and Humans
I downloaded the protein sequences for yeast and humans in FASTA format from
Ensembl database, release 69, on Oct 2012. These datasets are based on the GRCh37
and EF4 reference genomes, each of which contain 101,075 and 6,692 protein sequences
for H. Sapiens and S. Cerevisiae, respectively. Each human gene in this dataset has,
on average, 4.49 gene products (proteins). I identified and masked low-complexity
regions in protein sequences using pseg program [212]. The ssearch36 tool, from
FASTA [135] version 36, was then used to compute the local sequence alignment of
the protein pairs using the Smith-Waterman algorithm [169]. I used this tool with
the BLOSUM50 scoring matrix to compute sequence similarity of protein pairs in
humans and yeast. All sequences with E-values less than or equal to 10 are recorded
as possible matches, which results in a total of 664,769 hits between yeast and human
proteins. For genes with multiple protein isoforms, coming from alternatively spliced
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variants of the same gene, I only record the most significant hit. The final dataset
contains 162,981 pairs of similar protein-coding genes.

7.2.2 Sparse Network Alignment Using Belief Propagation
Analogous to the sequence alignment problem, which aims to discover conserved
genomic regions across different species, network alignment is motivated by the need
for extracting shared functional pathways that govern cellular machinery in different
organisms. The network alignment problem in its abstract form can be formulated
as an optimization problem with the goal of identifying an optimal mapping between
the nodes of the input networks, which maximizes both sequence similarity of aligned
proteins and conservation of their underlying interactions. At the core of every alignment method are two key components: i) a scoring function and ii) an efficient search
strategy to find the optimal alignment. The scoring function is usually designed to
favor the alignment of similar nodes, while simultaneously accounting for the number
of conserved interactions between the pair of aligned nodes. Biologically speaking,
this translates to identifying functional orthologs and interologs, respectively.
Given a pair of biological networks, G = (VG , EG ) and H = (VH , EH ), with
nG = |VG | and nH = |VH | vertices, respectively, we can represent the similarity
of vertex pairs between these two networks using a weighted bipartite graph L =
(VG ∗ VH , EL , w), where w : EL → R is a weight function defined over edges of
L. I will denote mapping between vertices vi ∈ VG and vi0 ∈ VH with (i, i0 ) and
ii0 , interchangeably. Let us encode the edge conservations using matrix S, where
S(ii0 , jj 0 ) = 1, iff alignment of vi → vi0 together with vj → vj 0 will conserve an
edge between graphs G and H, and S(ii0 , jj 0 ) = 0, otherwise. Then, the network
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alignment problem can be formally represented using the following integer quadratic
program:
max
x

Subject to:

β
(αwT x + xT Sx)
2

 Cx ≤ 1
nG ∗nH Matching constraints;
 x 0 ∈ {0, 1}, Integer constraint.

(7.1)

ii

Here, C and w are the incidence matrix and edge weights of the graph L, respectively,
whereas x is the matching indicator vector. Vector w, which encodes the prior
knowledge of node-to-node similarity between the input pair of networks, defines the
search space of potential orthologs and can be computed using sequence, structural,
or functional similarity of the proteins corresponding to node pairs. In this study,
I chose sequence similarity of aligned protein sequences to assign edge weights in
the bipartite graph defined by L. When L is a complete bipartite graph, i.e. each
pair of vertices between G and H represents a viable ortholog candidate, I will have
S = G ⊗ H. However, Bayati et al. [10] recently proposed an efficient method, based
on the message passing algorithm, for cases where L is sparse, i.e., |EL | << nG ∗nH , by
restricting the search space to the subset of promising candidates that are provided
by EL . I will use this algorithm throughout this chapter for solving the network
alignment problem.

7.2.3 Tissue-specific Random Model (TRAM) for Generating Pseudo-random Tissues
Let us denote the global human interactome by G = (VG , EG ), and each tissuespecific network by T = (VT , ET ), respectively. Using this notation, we have nT =
|VT |, VT ⊂ VG , and ET ⊂ EG is the subset of all edges from G that connect vertices
in VT , i.e., T is the vertex-induced subgraph of G under VT . This is the formal
description of the model used by Bossi et al. [16] to construct human tissue-specific
networks. Using this construction model, we note that every tissue-specific network
inherits a shared core of interactions among housekeeping genes that are universally
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expressed to maintain basic cellular functions. Let us denote this subset of genes by
VU ⊂ VT , having nU = |VU | members, and the corresponding induced core sub-graph
using U = (VU , EU ).
In this setting, I propose a new random model to explicitly mimic the topology
of tissue-specific networks. Formally, given each human tissue-specific network, I
seed an ensemble of pseudo-random tissues denoted by RT = G(VR , ER ), in which
every instance shares two main characteristics from the original network: (i) the total
number of vertices, (ii) the shared core of housekeeping interactions. To summarize,
this random graph sampling scheme is as follows: first, I initialize the vertex set VR
using VU , which includes nU housekeeping genes. Next, to ensure that the newly
generated random instance has the same number of vertices as the seed network, we
sample nT − nU vertices without replacement from the remaining vertices, VG \ VU .
Finally, we construct the random graph as the vertex induced sub-graph of the global
human interactome imposed by VR .
It can be noted that my random model not only provides a pseudo-random network seeded on each tissue-specific network, but also provides a node-to-node similarity score between the newly generated graph and the yeast interactome. This
is a critical component of my framework, which distinguishes it from other random
graph models, such as Erdos-Renyi, network growth, or preferential attachment. The
only other effort to combine topology with the node-to-node similarity score is proposed by Sahraeian et al. [158], which fits a gamma distribution over the the known
pairs of ortholog/ non-orthologs proteins in three species (according to their KEGG
pathways), and uses the fitted distribution to sample new sequence similarity scores.
However, this model does not benefit from the structural knowledge of the tissuespecific networks. Moreover, its sequence similarity generation model loosely fits the
observed data and does not provide a fine-tuned model to assess the significance of
tissue-specific alignments. My model, one the other hand, is grounded in the same
construction model as the original tissue-specific networks, and provides enough se-
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lectivity to distinguish similarity/ dissimilarity of aligned networks with yeast and to
assign an empirical p-value to each alignment.

7.2.4 Significance of Network Alignments
For each optimal alignment of a human tissue-specific network with yeast, given by
its indicator variable x, I quantify the overall sequence similarity of aligned proteins
with the matching score of the alignment, ŵ = wT x, and the total number of conserved edges by the alignment overlap, ô = 12 xT Sx. These measures can be used to
rank different network alignments. However, without a proper reference to compare
with, it is almost impossible to interpret these values in a statistical sense. To address this issue, I sample an ensemble of kR random networks from the tissue-specific
random model (TRAM), independently align each instance to the yeast interactome,
and empirically compute a topological, a homological (sequence-based), and a mixed
alignment p-value for each alignment using Monte-Carlo simulation.
Let ŵR and ôR be the random vectors representing the weight and overlap of
aligning random tissues with yeast, respectively. First, I define individual p-values
for the conservation of network topology and sequence homology. Let us denote by
(ŵ )

(ô)

kP and kP the number of random samples that have weight and overlap greater than
or equal to the original alignment, respectively. Then, we can define the following
p-values:
(ŵ )

p − valhomolgy
p − valtopology

k
= P
kR
(ô)
k
= P
kR

(7.2)
(7.3)

Before I define the mixed p-value, I define upper and lower bounds on the p-value.
These bounds are independent of the mixing parameter. For cases where both ô ≤
ôR (i) and ŵ ≤ ŵR (i), for 1 ≤ i ≤ kR , I can report that the random alignment is at
least as good as the original alignment. Conversely, if both ôR (i) < ô and ŵR (i) < ŵ ,
we can assert that the original alignment outperforms the random alignment. Let us
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denote the number of such cases by kP and kN , respectively. Using this formulation,
I can compute the following bounds on the mixed p-value of the alignment:
δR =

kN
kP
≤ alignment p-value ≤ 1 −
= ∆R
kR
kR

(7.4)

Please note that ∆R and δR are not p-values themselves, rather, they represent αindependent bounds on the mixed p-values. I can use these bounds to estimate
the similarity of each tissue-specific network to the yeast interactome. Tissues for
which the upper-bounds on the alignment p-value are smaller than a given threshold
αu are considered similar to yeast, while tissues with lower-bounds larger than αl
are considered dissimilar. For cases where the following conditions hold: ôR (i) < ô
and ŵ < ŵR (i), or ô < ôR (i) and ŵR (i) < ŵ , the p-values are α-dependent. To
quantify this ambiguity, I define the reliability of a p-value as

kN +kP
kR

. When there

is no ambiguity, that is, both the homological and topological p-values of each case
are either concurrently significant or concurrently insignificant, the reliability score is
one. Otherwise, in cases where one of them is significant while the other is not, the
reliability score decreases, accordingly. Finally, I define an unadjusted mixed p-value
similar to the convex combination used in network alignment. Let us define a new
random variable ow
ˆ R = α ∗ ôR + β ∗ ŵR . Using this notation, I define the mixed
p-value as:
p − value = P rob(α ∗ ô + β ∗ ŵ ≤ ow
ˆ R)

(7.5)

7.2.5 Differential Expression of Genes with Respect to a Group of Tissues
Given a homogenous group of human tissues/cell types, I first identify all expressed
genes in the group, i.e., all non-housekeeping genes that are expressed in at least one
of the tissue members. Next, in order to identify the subset of expressed genes that
are selectively expressed, I use a hypergeometric random model. A gene is identified
as selectively expressed if it is expressed in significantly higher number of tissues in
the given group than randomly selected tissue subsets of the same size. Let N and n
denote the total number of tissues in this study and the subset of tissues in the given
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group, respectively. Moreover, let us represent by cN the number of all tissues in
which a given gene is expressed, whereas cn similarly represents the number of tissues
in the given group that the gene is expressed. Finally, let the random variable X be
the number of tissues in which the gene is expressed, if we randomly select subsets
of tissues of similar size. Using this formulation, we can define the tissue-selectivity
p-value of each expressed gene in the given group as follows:
p-value(X = cn ) = P rob(cn ≤ X)
= HGT (cn |N, n, cN )
min(cN ,n)

=

X
x=cn

C(cN , x)C(N − cN , n − x)
C(N, n)

(7.6)

In order to partition genes into selective and ubiquitous genesets, I derive the tissueselectivity p-value distribution of all expressed non-housekeeping genes in the given
group. I use the Gaussian kernel to smooth this distribution and then find the critical
points of the smoothed density function to threshold for tissue-selective genes. The
motivation behind my choice is that these points provide shifts in the underlying distribution, from tissue-selective to ubiquitous genes. Given the bi-modal characteristic
of the distribution, it has three expected critical points. I use the first of these points
as my cutoff point. This provides highest precision for declared tissue-selective genes,
but lower recall than the other two choices.

7.2.6 Conservation of Genesets Based on the Majority Voting Rule
Given a set of genes that are selectively expressed in a homogenous group of tissues/cell types, I am interested in tri-partitioning them into either conserved, humanspecific, or unclassified genes. Conserved genes are the subset of tissue-selective genes
that are consistently aligned in majority of aligned tissues in the given group. Conversely, human-specific genes are the subset of tissue-selective genes that are consistently unaligned in majority of tissues in the given group. Finally, unclassified genes
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are the subset of tissue-selective genes for which we do not have enough evidence to
classify them as either conserved or human-specific.
The key data-structure I use to tri-partition genesets is the alignment consistency
table. Let C be a group of homogenous tissues with n = |C|. Furthermore, let gCTS
represent the set of tissue-selective genes with respect to C, such that kCTS = |gCTS |.
The alignment consistency table is a table of size kCTS × n, represented by TCTS , in
which TCTS (i, j) is the aligned yeast partner of ith tissue selective gene under the
network alignment of j th tissue in C, or 0 −0 (gap), if it is unaligned. I find the most
common partner for each tissue-selective gene and use a consensus rate, represented by
τ , to summarize each rows of the alignment consistency table. If a gene is consistently
aligned to the same yeast partner in at least τ ∗n tissues in C, I declare it as conserved.
Similarly, if it is unaligned in at least τ ∗ n tissues in C, I classify it as human-specific.
If neither one of these conditions hold, I report it as unclassified.

7.3 Results and Discussion
In this section, I present a comparative framework for investigating the scope and
limitations of yeast as a model organism for studying tissue-specific biology in humans.
Figure 7.1 illustrates the high-level summary of my study design. We start by aligning
each of the human tissue-specific networks with the yeast interactome. I couple the
alignment module with a novel statistical model to assess the significance of each
alignment and use it to infer the respective similarity/ dissimilarity of human tissuespecific networks with their corresponding counterparts in yeast. Using a network of
tissue-tissue similarities computed using their transcriptional profile, I show that my
network alignment p-values are consistent with groupings derived from transcriptional
signatures. I use this network of tissue similarities to identify four major groups of
tissues/ cell-types. These groups; representing brain tissues, blood cells, ganglion
tissues, and testis-related tissues; are further used to identify tissue-selective genes
that are active within each group compared to the rest of tissues.
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Figure 7.1.: Main components of the analysis framework for comparing yeast with
human tissue-specific interactome

I partition both housekeeping and tissue-selective subsets of human genes separately into the conserved and human-specific subsections. I provide extensive validation for the selective genes with respect to blood cells and brain tissues. Figure 7.2
illustrates the overall partitioning of the genes and their relative subsets. I provide
an in-depth analysis of each of these subsets, and show that while conserved subsets
provide the safe zone for which yeast can be used as an ideal model organism, the
human-specific subset can shed light on the shadowed subspace of the human interactome in yeast. This subset can provide future directions for constructing humanized
yeast models.
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Figure 7.2.: A high-level classification of human genes

7.3.1 Aligning Yeast Interactome with Human Tissue-specific Networks
The global human interactome represents a static snapshot of potential physical
interactions that can occur between pairs of proteins. However, it does not provide
any information regarding the spatiotemporal characteristics of the actual protein
interactions. These interactions have to be complemented with a dynamic context,
such as expression measurements, to help interpret cellular rewiring under different
conditions.
[16] overlaid the mRNA expression level of each transcript (transcriptome) in
different human tissues [177] on top of the global human interactome, integrated from
21 PPI databases, and constructed a set of 79 reference tissue-specific networks. I
adopt these networks and align each one of them separately to the yeast interactome
that I constructed from the BioGRID database.
In order to compare these human tissue-specific networks with the yeast interactome, considering both the sequence similarity of proteins and the topology of their
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interactions, I employ a recently proposed sparse network alignment method, based
on the Belief Propagation (BP) approach. This method is described in the Materials
and methods section [10].
Genes, and their corresponding proteins, do not function in isolation; they form
a complex network of interactions among coupled biochemical pathways in order to
perform their role(s) in modulating cellular machinery. Moreover, each protein may
be involved in multiple pathways to perform a diverse set of functions. Using a
network alignment approach to project these pathways across species allows us to not
only consider their first-order dynamics, through co-expression of homologous protein
pairs, but also the context in which they are expressed.
To construct the state space of potential homologous pairs, we align all protein
sequences in human and yeast and pre-filter hits with sequence similarity E -values
greater than 10. For genes with multiple protein isoforms I only store the most
significant hit. Using these sequence-level homologies, I construct a matrix L that
encodes pairwise sequence similarities between yeast and human proteins. Entries
in matrix L can be viewed as edge weights for a bipartite graph connecting human
genes on one side, and the yeast genes, on the other side. I use this matrix to restrict
the search space of the BP network alignment method (please see Supplementary
Methods for details on E -value normalization and Materials and Methods section for
BP alignment method).
Parameters α and β(= 1 − α) control the relative weight of sequence similarity
(scaled by α) as compared to topological conservation (scaled by β) in the BP network
alignment. Using a set of preliminary simulations aligning the global human interactome with its tissue-specific sub-networks, for which we have the true alignment,
with various choices of α in the range of 0.1 to 0.9, I identify the choices of α =
and β =

5
6

1
6

to perform the best in my experiments. I use the same set of parame-

ters to align each tissue-specific network with the yeast interactome, as it provides a
balanced contribution from sequence similarities and the number of conserved edges.
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7.3.2 Investigating Roles of Housekeeping Genes and their Conservation across Species
Housekeeping genes comprise a subset of human genes that are universally expressed across all tissues and are responsible for maintaining core cellular functions
needed by all tissues, including translation, RNA processing, intracellular transport,
and energy metabolism [23,39,172]. These genes are under stronger selective pressure,
compared to tissue-specific genes, and evolve more slowly [221]. As such, we expect
to see a higher level of conservation among human housekeeping genes compared with
yeast genes. I refer to the most conserved subset of housekeeping genes between humans and yeast, computed using network alignment of tissues-specific networks with
the yeast network, as the core genes.
I identify a gene as housekeeping if it is expressed in all 79 tissues. I identify a total
of 1,540 genes that constitute the shared section of human tissue-specific networks.
These genes, while having similar set of interactions among each other, are connected
differently to the set of tissue-selective genes.
Using the alignment partners of all housekeeping genes in the yeast interactome,
I construct an alignment consistency table of size 1, 540 × 79, which summarizes the
network alignments over the shared subsection of tissue-specific networks. Then, I
use the majority voting method to classify housekeeping genes as core, which are
conserved in yeast, human-specific, which are consistently unaligned across human
tissues, and unclassified, for which we do not have enough evidence to classify it as
either one of the former cases.
Network alignments are noisy and contain both false-positive (defined as aligned
pairs that are not functionally related), as well as false-negatives (pairs of functional
orthologs that are missed in the alignment). These errors can come from different
sources, including gene expression data (node errors), interactome (edge errors), or
the alignment procedure (mapping errors). I propose a method based on majority
voting across different alignments to (partially) account for these errors. Given a
set of network alignments, I consider a pair of entities consistently aligned (either
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matched or unmatched) if they are consistent in at least 100 ∗ τ % of alignments in
the set. The parameter τ , called the consensus rate, determines the level of accepted
disagreement among different alignments. A higher value of consensus rate increases
the precision of the method at the cost of decreased sensitivity. In order to select the
optimal consensus rate parameter, I tried values in range [0.5 − 1.0] with increments
of 12 . I identified the parameter choice of τ = 0.9, equivalent to 90% agreement among
aligned tissues, to perform the best in classifying human-specific and conserved genes,
while keeping the sets well-separated. Using this approach, I was able to tri-partition
1,540 housekeeping genes into 595 conserved, 441 human-specific, and 504 unclassified
genes, respectively.
In order to investigate the conserved sub-network of core genes, I construct their
alignment graph as the Kronecker product of the subgraph induced by core genes in
the human interactome and its corresponding aligned subgraph in yeast. Conserved
edges in this network correspond to interologs, i.e., orthologous pairs of interacting
proteins between yeast and human [217].
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Figure 7.3.: Alignment graph of core human genes
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Figure 7.3 shows the largest connected component of this constructed alignment
graph. I applied the MCODE [7] network clustering algorithm on this graph to
identify highly interconnected regions corresponding to putative protein complexes.
I identified five main clusters, which are color-coded on the alignment graph, and
are shown separately on the adjacent panels. Ribosome is the largest, central cluster
identified in the alignment graph of core genes, and together with proteasome and
spliceosome, constitutes the three most conserved complexes in the alignment graph.
This complex is heavily interconnected to the eIFs, to modulate eukaryotic translation
initiation, as well as proteasome, which controls protein degradation. Collectively,
these complexes regulate protein turnover and maintain a balance between synthesis,
maturation, and degradation of cellular proteins.
In order to further analyze the functional roles of these housekeeping genes, I
use the g:Profiler [153] R package to identify highly over-represented terms. Among
functional classes, I focus on the gene ontology (GO) biological processes, excluding
electronic annotations, KEGG pathways, and CORUM protein complexes to provide
a diverse set of functional roles. I use the Benjamini-Hochberg procedure to control
for false-discovery rate (FDR), with p-value threshold of α = 0.05, and eliminate
all enriched terms with more than 500 genes to prune overly generic terms. Using
this procedure, I identify enriched functional terms for both core and human-specific
subsets of housekeeping genes.
I manually group the most significant terms (p-value ≤ 10−10 ) in core genes,
which results in five main functional classes, namely ribosome biogenesis, translation,
protein targeting, RNA splicing, and mRNA surveillance. First, we observe a one-toone mapping between enriched terms and identified putative complexes corresponding
to translation initiation (p-value = 7.1 ∗ 10−17 ) and ribosome (p-value = 5.97 ∗ 10−11 ).
In addition, translation termination and elongation are also enriched with decreasing
levels of significance. Moreover, these processes are tightly linked to SRP-dependent
co-translational protein targeting (p-value = 2.7 ∗ 10−15 ). This, in turn, suggests
protein synthesis as one of the most conserved aspects of eukaryotic cells. Next, we
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note that both mRNA splicing (p-value = 7.04 ∗ 10−10 ) and nonsense-mediated decay
(p-value = 4.66∗10−16 ) are also enriched among the most significant functional terms,
which supports my earlier hypothesis related to the role of splicesome in the alignment
graph of core genes. Finally, I find that the most significant functional term, as well as
a few other related terms, are involved in viral infection, which suggests that (a subset
of the) core genes provides a viral gateway to mammalian cells. This can be explained
in light of two facts: i) viral organisms rely on the host machinery for their key cellular
functions, and ii) housekeeping genes are more ancient compared to tissue-selective
genes, and core genes provide the most conserved subset of these housekeeping genes.
As such, these genes may contain more conserved protein interaction domains and be
structurally more “familiar” as interacting partners for the viral proteins and provide
ideal candidates for predicting host-pathogen protein interactions.
Next, I perform a similar procedure for the human-specific housekeeping genes.
This subset, unlike core genes, is mostly enriched with terms related to anatomical
structure development and proximal cell-to-cell communication (paracrine signaling),
with the exception of complex I of the electron transport chain, which is the strongest
identified term. This NADH-quinone oxidoreductase is the largest of the five enzyme
complexes in the respiratory chain of mammalian cells. However, this complex is not
present in yeast cells and has been replaced with a single subunit NADH dehydrogenase encoded by gene NDI1. Impairment of complex I has been associated with
various human disorders, including Parkinson’s and Huntington’s disease. Transfecting complex I-defective cells with yeast NDI1 as a therapeutic agent has been proposed
as a successful approach to rescue complex I defects [118, 214]. This technique, also
known as NDI1 therapy, opens up whole new ways in which yeast can contribute to
the research and development on human diseases: not only yeast can be used as a
model organism, but also can provide candidates that can be used for gene therapy
in mammalian cells.
A key observation here is that the human-specific subset of housekeeping genes is
not only associated with fewer functional terms, but is also less significantly associated
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with these terms. This effect can be attributed to two factors. First, we note that
some of the genes predicted to be human-specific might be an artifact of the method.
For example, the belief propagation (BP) method enforces sequence similarity as
a necessary, but not sufficient, condition for a pair of genes to be aligned, which
means that any human gene with no sequence similarity to yeast genes will not
be aligned, resulting in genes being artificially classified as human-specific. Second,
and more importantly, a majority of functional annotations for human genes are
initially attributed in other species, specially yeast, and transferred across ortholog
groups. Based on my construction, human-specific genes are defined as the subset of
housekeeping genes with no orthology with yeast. As such, it can be expected that
these genes span the shadowed subspace of the functional space of human genes that
is under-annotated.

7.3.3 Quantifying Similarity of Human Tissues with Yeast
Housekeeping genes are shared across all human tissues and cell types. They
provide a conserved set of functions that are fundamental to cellular homeostasis.
However, these genes do not provide direct insight into how different tissues utilize
these key functions to exhibit their dynamic, tissue-specific characteristics. To assess
the similarity of each tissue with yeast, I propose a novel statistical model, called
tissue-specific random model (TRAM), which takes into account the ubiquitous nature
of housekeeping genes and mimics the topological structure of tissue-specific networks
(please see Materials and Methods section for the details of the random model).
I use the alignment score of each tissue-yeast pair as the objective function. To
asses the significance of each alignment score, I use a Monte Carlo simulation method
to sample from the underlying probability distribution of alignment scores.
For each tissue-specific network, I sample kR = 10, 000 pseudo-random tissues of
the same size from TRAM, separately align them with the yeast interactome, and
compute the number of conserved edges and sequence similarity of aligned protein
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pairs as alignment statistics, in order to compute the empirical p-values. For each
network alignment, I compute a topological, a homological (sequence-based), and a
mixed (alignment score) p-value. Additionally, I use cases in which alignment quality
is significantly better in the original tissue alignment, both in terms of sequence and
topology, to quantify an upper bound on the alignment p-values. Conversely, cases
in which both of these measures are improved in the random samples can be used to
define a lower bound on the alignment p-value.
First, we note that all tissues with significant mixed p-values also have both significant topological and homological (sequence-based) p-values. For a majority of
tissues with insignificant mixed p-values, we still observe significant homological, but
insignificant topological p-values. I summarize the most and the least similar tissues
to yeast by applying a threshold of αl = αu = 10−2 to the p-value upper and lower
bounds, respectively. Using the p-value upper bound (∆R ) of 10−2 , I identify a total
of 23 out of 79 tissues with high similarity to yeast. These are listed in Table 7.1.
Among them, blood cells consistently show high significance, without even a single
instance from 10, 000 samples having either the alignment weight or the edge overlap of the random sample exceeding the original alignment. Similarly, immune cell
lines and male reproductive tissues also show significant alignment p-values, but with
lower reliability scores. Conversely, there are 19 out of 79 tissues that have δR > 10−2 .
These are least similar to yeast. Among these tissues, listed in Table 7.2, ganglion tissues consistently show the least similarity to yeast. An interesting observation is that
tissues and cell types at either end of the table (either the most or the least similar)
usually have very high reliability scores, that is both their topology and homology
p-values are consistent.

7.3.4 Identifying Groups of Coherent Tissues
Next, I investigate the correlation between the similarity of human tissues among
each other and how it relates to their corresponding alignment p-values with yeast
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Table 7.1: Tissues with the most significant similarity to the yeast interactome
Name

pval lower bound

overall pval

pval upper bound

reliability

Myeloid Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Monocytes

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Dentritic Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

NK Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

T-Helper Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Cytotoxic T-Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

B-Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Endothelial

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Hematopoietic Stem Cells

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

MOLT-4

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

B Lymphoblasts

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

HL-60

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

K-562

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Early Erythroid

< 1.00e-04

< 1.00e-04

< 1.00e-04

1

Bronchial Epithelial Cells

< 1.00e-04

< 1.00e-04

0.0002

0.9998

Colorectal Adenocarcinoma

< 1.00e-04

< 1.00e-04

0.0004

0.9996

Daudi

< 1.00e-04

< 1.00e-04

0.0009

0.9991

Testis Seminiferous Tubule

< 1.00e-04

< 1.00e-04

0.0012

0.9988

Smooth Muscle

< 1.00e-04

< 1.00e-04

0.0016

0.9984

Blood (Whole)

< 1.00e-04

< 1.00e-04

0.0053

0.9947

Thymus

< 1.00e-04

0.0001

0.0062

0.9938

Testis Interstitial

< 1.00e-04

0.0004

0.0086

0.9914

in order to better understand the transitivity of this relationship. I expect that
similar tissues should exhibit consistent alignment p-values, resulting in groups of
homogenous tissues with coherent alignments scores.
To this end, I first construct a network of tissue-tissue similarities (TTSN) using
the global transcriptome of human tissues from the GNF Gene Atlas, including 44,775
human transcripts covering both known, as well as predicted and poorly characterized
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Table 7.2: Tissues with the least significant similarity to the yeast interactome
Name

pval lower bound

overall pval

pval upper bound

reliability

Trigeminal Ganglion

0.9947

0.9994

1

0.9947

Superior Cervical Ganglion

0.9847

0.9991

1

0.9847

Ciliary Ganglion

0.9407

0.9813

0.9964

0.9443

Atrioventricular Node

0.8746

0.9792

0.9921

0.8825

Skin

0.8355

0.9297

0.9809

0.8546

Heart

0.7934

0.9585

0.9815

0.8119

Appendix

0.7596

0.9371

0.973

0.7866

Dorsal Root Ganglion

0.7065

0.933

0.9717

0.7348

Skeletal Muscle

0.3994

0.5902

0.7866

0.6128

Uterus Corpus

0.233

0.7736

0.8769

0.3561

Lung

0.0771

0.3853

0.5544

0.5227

Pons

0.0674

0.5201

0.6983

0.3691

Salivary Gland

0.0639

0.3449

0.5173

0.5466

Liver

0.0600

0.6857

0.8519

0.2081

Ovary

0.0388

0.2735

0.4481

0.5907

Trachea

0.0259

0.2376

0.4146

0.6113

Globus Pallidus

0.0206

0.2471

0.4336

0.587

Cerebellum

0.0127

0.1950

0.3783

0.6344

genes. For each pair of tissues/ cell types, I compute a similarity score using the
Pearson correlation of their transcriptional signatures and use the 90th percentile of
similarity scores to select the most similar pairs. I annotate each node in the TTSN
with its corresponding alignment p-value as a measure of similarity with the yeast
interactome. This meta-analysis allows us to investigate how linear measurements of
gene/protein activity project to the space of protein interactions, in order to re-wire
the underlying interactome in each human tissue.
Figure 7.4 presents the final network. In this network, each node represents a
human tissue/cell type and each weighted edge illustrates the extent of overall tran-
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Figure 7.4.: Projection of alignment p-values on the network of tissue-tissue similarities

scriptional similarity between pairs of tissues. This network is filtered to include only
tissue pairs with the highest overlap with each other. In order to assign color to each
node, I use z -score normalization on the log-transformed alignment mixed p-values.
Green and red nodes correspond to the highly positive and highly negative range of
z -scores, which represent similar and dissimilar tissues to yeast, respectively.
Preliminary analysis of this network indicates that the alignment p-value of tissues highly correlates with their overall transcriptional overlap. Furthermore, these
high-level interactions coincide with each other and fall within distinct groups with
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consistent patterns. I manually identified four such groups and separately annotated
them in the network. These groups correspond to brain tissue, blood cells, ganglion
tissues, and testis tissues. Among these groups, blood cells and testis tissues exhibit
consistent similarity with yeast, whereas brain and ganglion tissues bear consistent
dissimilarity.
The existence of homogenous group of tissues with consistent similarity with yeast
suggests an underlying conserved machinery in these clusters. This raises the question
of what is consistently aligned within each tissue group and how it relates to the
computed alignment p-values? I address this question, and relate it to the onset of
tissue-specific pathologies in the remaining subsections.

7.3.5 Dissecting Tissue-selective Genes with Respect to Their Conservation
In this subsection, I investigate the subset of non-housekeeping genes in each
homogenous group of human tissues and partition them into sets of genes, and their
corresponding pathways that are either conserved in yeast or are human-specific.
Next, I analyze how these pathways contribute to the overall similarity/ dissimilarity
of human tissues with yeast.
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Figure 7.5.: Membership distribution of non-housekeeping genes in human tissues
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Figure 7.5 presents the probability density function for the membership distribution of non-housekeeping genes in different human tissues. The observed bi-modal
distribution suggests that most non-housekeeping genes are either expressed in a very
few selected tissues or in the majority of human tissues. I use this to partition the
set of expressed non-housekeeping genes, with the goal of identifying genes that are
selectively expressed in each group of human tissues.
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Figure 7.6.: Distribution of tissue-selectivity p-values in different tissue groups

I start with all expressed non-housekeeping genes in each tissue group, i.e., genes
that are expressed in at least one of the tissue members. Next, in order to identify the
subset of expressed genes that are selectively expressed in each group, I use the tissue-

159
selectivity p-value of each gene. In this formulation, a gene is identified as selectively
expressed if it is expressed in a significantly higher number of tissues in the given group
than randomly selected tissue subsets of the same size (see Materials and Methods
section for details). Figure 7.6 illustrates the distribution of tissue-selectivity p-values
of expressed genes with respect to four major groups in Figure 7.4. Each of these
plots exhibit a bi-modal characteristic similar to the membership distribution function
in Figure 7.5. This can be explained by the fact that membership distribution is a
mixture distribution, with the underlying components being the same distribution for
the subset of genes that are expressed in different tissue groups. I use critical points
of the p-value distributions to threshold for tissue-selective genes. The motivation
behind this choice is that these points provide shifts in the underlying distribution,
from tissue-selective to ubiquitous genes. Given the bi-modal characteristics of these
distributions, they all have three critical points, the first of which I use as the cutoff
point. This provides highest precision for declared tissue-selective genes, but lower
recall than the other two choices.
Having identified the subset of tissue-selective genes with respect to each tissue
group, I use the majority voting scheme to tri-partition these sets based on their
alignment consistency with yeast. Similar to the procedure I used to tri-partition
housekeeping genes, I tried different choices of consensus rate parameter from 50% to
100% with increments of 5%. The percent of unclassified genes decreases linearly with
the consensus rate, while relative portions of human-specific/ conserved genes remain
the same. I chose 90% for my final results, as it leaves the least number of genes as
unclassified, while keeping human-specific and conserved genes well-separated.
Table 7.3 presents the number of expressed genes, selectively expressed genes, and
the percent of tissue-selective genes that are conserved, human-specific, or unclassified
within each group of tissues. There is a similar relationship between the ratio of
conserved/human-specific genes within each group of tissues and their alignment pvalues, suggesting that alignment p-values are highly correlated with the conservation
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Table 7.3: Summary of tissue-selective gene partitioning
Cluster name

# expressed genes

# TS genes

# CG (%)

# HS (%)

Brain Tissues

5936

891

273 (30.64 %) 401 (45.01 %)

217 (24.35 %)

Blood Cells

6092

1093

460 (42.09 %)

385 (35.22 %)

248 (22.69 %)

Testis Tissues

5358

328

119 (36.28 %) 126 (38.41 %)

83 (25.30 %)

Ganglion Tissues

5278

274

76 (27.74 %)

62 (22.63 %)

136 (49.64 %)

# unclassified (%)

of tissue-selective genes and their corresponding pathways. Figure 7.7 illustrates the
relative sizes of each subset of genes identified in this study.
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Figure 7.7.: Summary of gene classifications. Housekeeping and tissue-selective genes,
in four main groups of human tissues, which are classified into three main classes based
on their conservation in yeast

Conserved genes and their corresponding pathways comprise the functional subspace in which we can use yeast as a suitable model organism to study tissue-specific
physiology and pathophysiology. On the other hand, human-specific genes provide a
complementary set that can be used to construct tissue-engineered humanized yeast
models. They also provide promising candidates for tissue-specific gene therapies in a
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similar fashion to NDI1 therapy, in cases where an alternative functional mechanism
can be found in yeast. To further investigate these subsets, I focus on blood cells and
brain tissues, which illustrate the clearest separation between their tissue-selective
and conserved genes in their TSS distribution, and subject them to more in depth
functional analysis in next subsections.

7.3.6 Elucidating Functional Roles of the Brain and Blood Selective Genes
I use g:ProfileR on both human-specific and conserved genes to identify their enriched functions. These two subsets share many common terms, due to the underlying
prior of both being subsets of tissue-selective genes. To comparatively analyze these
functions and rank them based on their human-specificity, I use the log of p-value
ratios between human-specific and conserved genes to filter terms that are at least
within 2-fold enrichment. I focus on GO biological processes, KEGG pathways, and
CORUM protein complexes and remove all genesets with more than 500 genes to filter
for overly generic terms. Finally, to group these terms together and provide a visual
representation of the functional space of genes, I use EnrichmentMap (EM) [122], a
recent Cytoscape [171] plug-in, to construct a network (map) of the enriched terms. I
use the log ratio of p-values to color each node in the graph. Figures 7.8 and 7.9 illustrate the final enrichment map of unique human-specific and conserved blood-selective
and brain-selective functions, respectively.
Conserved blood-selective functions, shown in Figure 7.8 (A), are primarily enriched with terms related to DNA replication, cellular growth, and preparing cell for
cell-cycle. Among these terms, DNA replication-is tightly linked to both DNA repair
and telomere maintenance related terms. Telomere maintenance, specially via telomerase enzyme, is one of the cellular functions that is known to be conserved in yeast,
but only active in a selected subset of differentiated human tissues and cell types,
including hematopoietic stem cells and male reproductive tissues [109]. Functional
terms involved in DNA conformation changes, including condensin complex, as well

162
A

B
Cell cycle phase transition

Telomere maintenance
DNA replication

Lymphocyte proliferation

regulation of
transcription involved
in G1/S transition of
mitotic cell cycle

telomere maintenance

cell cycle DNA
replication

leukocyte proliferation

DNA replication

T cell activation

G1/S transition of
mitotic cell cycle

telomere organization

nuclear cell cycle
DNA replication

positive regulation of
leukocyte
proliferation

mitotic recombination

DNA replication

DNA strand
elongation involved in
DNA replication

lymphocyte
proliferation

13S condensin
complex

DNA geometric
change

DNA packaging

regulation of cell
activation

membrane
disassembly

Cytokine production

T cell mediated
cytotoxicity

PCNA-MutS-alpha-DNA
initial complex

leukocyte mediated
cytotoxicity

cytokine production

cell killing

regulation of cytokine
production

T cell receptor
signaling pathway

T-cell mediated cytotoxicity

DNA ligase
IV-condensin
complex

mitotic nuclear
envelope
disassembly

DNA repair
ncRNA processing

Pantothenate and
CoA biosynthesis

TNF signaling
pathway

SRCAP-associated
Ribosome biogenesis
cell cycle checkpoint chromatin remodeling
in eukaryotes
complex

positive regulation of
leukocyte activation

positive regulation of
cell activation

regulation of cell
killing

DNA conformation change

nuclear envelope
disassembly

PCNA-MSH2-MSH6
complex

regulation of
lymphocyte activation

regulation of
leukocyte
proliferation

positive regulation of
lymphocyte
proliferation

regulation of T cell
mediated cytotoxicity

DNA repair

RNA transport

lymphocyte activation

Condensin I complex
PCNA-MSH2-MSH6
complex

Base excision repair

regulation of T cell
proliferation

positive regulation of
T cell activation

positive regulation of
T cell proliferation
leukocyte activation

DNA conformation
change
Mismatch repair

positive regulation of
lymphocyte activation

regulation of
leukocyte activation

mononuclear cell
proliferation

regulation of
mononuclear cell
proliferation

Condensin
I-PARP-1-XRCC1
complex

Condensin I complex

DNA duplex
unwinding

regulation of T cell
activation

T cell proliferation

positive regulation of
mononuclear cell
proliferation

regulation of
lymphocyte
proliferation

DNA-dependent DNA
replication

DNA strand
elongation

Lymphocyte activation

cell cycle G1/S phase
transition

telomere
maintenance via
telomere lengthening

Apoptosis

antigen
receptor-mediated
signaling pathway

positive regulation of positive regulation of
protein
activated T cell
oligomerization
proliferation

Inflammatory bowel
disease

B cell activation

Intestinal immune
network for IgA
production

Hematopoietic cell
lineage

Cytokine-cytokine
receptor interaction

Cell cycle

Figure 7.8.: Enrichment map of unique blood-selective functions
A

B

Neuron-neuron transmission
neuron-neuron
synaptic transmission

Brain development

positive regulation of
synaptic
transmission,
glutamatergic

negative chemotaxis
chemorepulsion
involved in postnatal
olfactory bulb
interneuron migration
postnatal olfactory
bulb interneuron
cerebral cortex
migration
tangential migration
using cell-cell
interactions
substrate-dependent
cerebral cortex
tangential migration

Regulation of nervous system development

regulation of
neurogenesis

brain development

sterol biosynthetic
process

cholesterol
biosynthetic process

semaphorin-plexin
signaling pathway
involved in bone
trabecula
morphogenesis

membrane biogenesis

anatomical structure
maturation

regulation of action
potential

regulation of nervous
system development

positive regulation of
sterol transport

positive regulation of
cholesterol transport

Cholesterol biosynthesis and transport

dADP metabolic
process

peroxisome
membrane
biogenesis

glutamate receptor
signaling pathway

Peroxisome biogenesis
Glutamatergic
synapse

mTORC2 complex
(mTOR/FRAP1,
LST8,
mAVO3/RICTOR)

ion transmembrane
transport

guanosine-containing
compound catabolic
process

regulation of ion
transmembrane
transport

guanosine-containing
compound metabolic
process

negative regulation of
alkaline phosphatase
activity

mTOR-RICTOR
complex

mTORC2 complex

microtubule
polymerization or
depolymerization

microtubule
polymerization

Microtubular structure and
tubulin polymerization

AKAP250-PKA-PDE4D protein localization to
complex
plasma membrane

cell division

negative regulation of
synapse organization
cytoskeleton
organization

Circadian entrainment

Glutamate receptor signaling pathway
embryonic organ
development

microtubule
depolymerization
deoxyribonucleoside
diphosphate
metabolic process

purine
deoxyribonucleoside
diphosphate
metabolic process

neuronal ion channel
clustering

neuron maturation

mTORC2 complex
(mTOR/FRAP1,
LST8,
mAVO3/RICTOR,
SIN1)

positive regulation of
cholesterol efflux

developmental
maturation

Neuron maturation
Voltage-dependent
calcium channel

forebrain cell
migration

cholesterol metabolic
process

axon ensheathment

semaphorin-plexin
signaling pathway

positive regulation of
neurogenesis

telencephalon cell
migration

regulation of
excitatory
postsynaptic
membrane potential

regulation of action
potential in neuron

positive regulation of
cell development

pallium development

bone trabecula
morphogenesis

ossification involved
in bone maturation

Seaphorin signaling pathway
regulation of
membrane potential

positive regulation of
axonogenesis

regulation of cell
morphogenesis
involved in
differentiation

regulation of
alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionate selective
glutamate receptor
positive regulation of
activity
excitatory
postsynaptic
membrane potential

neuron homeostasis

regulation of cell
projection
organization
regulation of neuron
projection
development

regulation of cell
morphogenesis

telencephalon
development

cerebral cortex
development

Axon ensheathment

ensheathment of
neurons

regulation of
axonogenesis

olfactory bulb
development

cerebral cortex cell
migration

bone development

positive regulation of
cell projection
organization

positive regulation of
neuron projection
development

olfactory bulb
interneuron
differentiation

olfactory lobe
development

membrane
depolarization

trabecula
morphogenesis

sensory organ
development

trachea cartilage
development

cartilage
morphogenesis

neuron migration

potassium ion
transport

negative regulation of
DNA-dependent
transcription, initiation

RICH1/AMOT polarity
complex, Flag-Amot
precipitated

diencephalon
development

trachea cartilage
morphogenesis

Organ development

Figure 7.9.: Enrichment map of unique brain-selective functions

as cell cycle phase transition, specifically from G1 to S phases, are two other groups
of conserved functional terms that are highly conserved from yeast to human. On
the other hand, human-specific blood-selective functions, shown in Figure 7.8 (B),
are mainly involved in lymphocyte proliferation and activation. Terms in these two
groups are also tightly related to each other and form a larger cluster together. In
addition, cytokine production and T-cell mediated cytotoxicity also exhibit human-
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specific, blood-selective characteristics. This is partially expected, as these functions
are highly specialized immune-cell functions that are evolved particularly in humans
to ensure his survival in less-favorable conditions.
Figure 7.9 (A) shows the functional space of conserved brain-selective functions.
Many of these terms correspond to various aspects of brain development, including
olfactory bulb, telencephalon, pallium, and cerebral cortex development, as well as
the regulatory circuit that controls nervous system development. Considering the
unicellular nature of yeast, the exact mechanisms in which orthologs of these pathways modulate yeast cellular machinery is less studied. An in-depth analysis to
identify matching phenologs can help us use yeast to study various disorders related
to brain development. Another functional aspect that exhibits high conservation is
the mTOR complex 2. The target of rapamycin (TOR) signaling is a highly conserved pathway, which forms two structurally distinct protein complexes, mTORC1
and mTORC2. The former complex has a central role in nutrient-sensing and cell
growth, and as such, has been used extensively to study calorie restriction (CR)
mediated lifespan extension. On the other hand, mTORC2 has been recently proposed to modulate consolidation of long-term memory [75]. Cholesterol biosynthesis
and transport is another conserved functional aspect that differs significantly from
other human tissues. As the most cholesterol-rich organ in the body, expression of
genes corresponding to lipoprotein receptors and apolipoproteins is tightly regulated
among different brain cells and plays an important role in normal brain development.
Dysregulation of these metabolic pathways is implicated in various neurological disorders, such as Alzheimer’s disease [132].Finally, microtubular structure and tubulin
polymerization also shows significant conservation and is known to play a key role in
brain development [189]. These cytoskeletal proteins have recently been associated
with brain-specific pathologies, including epilepsy [87].
Finally, we study human-specific brain functions, which are shown in Figure 7.9
(B). One of the key functional aspects in this group is the semaphorin-plexin signaling
pathway. This pathway was initially characterized based on its role in the anatomical
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structure maturation of the brain, specifically via the repulsive axon guidance, but
later was found to be essential for morphogenesis of a wide range of organ systems,
including sensory organs and bone development [223]. Another human-specific signaling pathway identified in brain is the glutamate receptor signaling pathway, which
also cross-talks with circadian entrainment, as well as neuron-neuron transmission.
This pathway plays a critical role in neural plasticity, neural development and neurodegeneration [128]. It has also been associated with both chronic brain diseases,
such as schizophrenia, as well as neurodegenerative disorders, such as Alzheimer’s
disease [210].
Both conserved and human-specific genes play important roles in tissue-specific
pathologies. In addition, these genes, which are enriched with regulatory and signaling
functions, cross-talk with housekeeping genes to control cellular response to various
factors. As such, a complete picture of disease onset, development, and progression
can only be achieved from a systems point of view. From this perspective, we study
not only the genes (or their states) that are frequently altered in disease, but also
the underlying tissue-specific and housekeeping pathways in which they interact to
exhibit the observed phenotype(s). In the next subsection, I further investigate this
hypothesis. I study the potential of different subsets of the identified tissue-selective
genes for predicting tissue-specific pathologies.

7.3.7 Assessing the Significance of Tissue-specific Pathologies among Conserved and
Human-specific Tissue-selective Genes
To further study the predictive power of tissue-selective genes for human pathologies, I use the genetic association database (GAD) disease annotations as my gold
standard [11]. This database collects gene-disease associations from genetic association studies. Additionally, each disease has been assigned to one of the 19 different
disease classes in GAD database. I use DAVID functional annotation tool for disease
enrichment analysis of tissue-selective genes [74].
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Table 7.4: Enriched disease classes of tissue-selective genes
Conserved genes
Disease class

Human-specific genes
p-value

Disease class

p-value

Blood cells

Cancer

9.3 ∗ 10−4

Immune

1.2 ∗ 10−5

Brain tissues

Psych

3.6 ∗ 10−4

Psych

5.7 ∗ 10−8

Chemdependency

2.6 ∗ 10−3

Neurological

3.0 ∗ 10−2

Pharmacogenomic

9.7 ∗ 10−2

First, I seek to identify which disease classes are significantly enriched among each
set of tissue-selective genes. Table 7.4 shows the disease classes enriched in each group
of brain and blood selective genes. Conserved blood-selective genes are predominantly
enriched with cancers, whereas human-specific blood-selective genes are mainly associated with immune disorders. This can be linked to the previous results indicating that
conserved subset is mainly involved in regulating growth, DNA replication, and cell
cycle, whereas human-specific genes are primarily involved in lymphocyte proliferation and activation. Conversely, brain-selective genes show higher similarities in terms
of disease classes that they can predict. Both conserved and human-specific brainselective genes can predict psychiatric disorders, but human-specific subset seems to
be a more accurate predictor. On the other hand, neurological disorders are only
enriched in human-specific subset of brain-selective genes, whereas disorders classified as pharmacogenomic and chemdependency show higher enrichment in conserved
genes.
To summarize the specific disorders that are enriched in each subset of brainselective genes, I integrate all identified diseases and rank them based on their enrichment p-value, if it is only enriched in one set, or their most significant p-value,
if it is enriched in both sets. Table 7.5 shows the top 10 disease terms enriched
in either human-specific or conserved brain-selective genes. In majority of cases,
human-specific genes are more significantly associated with brain-specific pathologies
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Table 7.5: Comparative analysis of brain-specific pathologies
Disorder

Conserved genes

Human-specific genes

schizophrenia

0.008573

8.4905E-06

autism

0.048288

0.00077448

dementia

0.0014356

-

-

0.0021433

0.0051617

-

epilepsy

0.071562

0.0064716

seizures

-

0.020381

bipolar disorder

0.048288

0.022016

attention deficit disorder conduct disorder opposi-

0.032444

0.023865

schizophrenia; schizoaffective disorder; bipolar disorder
myocardial infarct; cholesterol, HDL; triglycerides;
atherosclerosis, coronary; macular degeneration;
colorectal cancer

tional defiant disorder

than conserved genes. In addition, there are unique disorders, such as schizophrenia,
bi-polar disorder, and seizures, that are only enriched among human-specific genes.
In conclusion, both conserved and human-specific subsets of tissue-selective genes
are significantly associated with different human disorders. However, the humanspecific subset shows higher association with tissue-specific pathologies. To this end,
they guide us to appropriate molecular constructs (gene insertions) in yeast to explore molecular/functional mechanisms that cause tissue-specific dysfunction. Such
mechanisms can be tested in humans, and if validated, yeast can serve as an experimental model for further investigations of biomarkers and pharmacological and
genetic interventions.
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8 CONCLUSION AND FUTURE DIRECTIONS
In this dissertation, I developed computational methods coupled with statistical models to analyze human transcriptomics and interactomics datasets from single cell level
up to complex tissues. These methods lay the foundation to study cell type-specific
biology and pathobiology at a scale that has not been possible before. To this end,
I have proposed a novel algorithms to (i) measure similarity of cells, (ii) identify cell
types from single cell datasets, (iii) separate cell types from complex tissues, (iv)
reconstruct tissue-specific interactomes, and (v) assess conservation of these tissuespecific pathways.
One major direction for extending this work is to combine gene expression deconvolution with single cell analysis. Single cell transcriptomics can provide a rough
sketch of what each cell type should look like. This cell type-specific expression panel
then can be used to perform supervised deconvolution. On the other hand, one major
challenge in single cell analysis is the lack of ability to estimate underlying fractions
in complex mixtures, such as tumor microenvironment. Deconvolution techniques
provide these cellular decompositions, which can be additionally incorporated into
single cell analysis to correct for sampling biases, among other confounding factors.

LIST OF REFERENCES

168

LIST OF REFERENCES

[1] CVX, Matlab Software for Disciplined Convex Programming, Version 2.1. http:
//cvxr.com/cvx, March 2014.
[2] Alexander R Abbas, Kristen Wolslegel, Dhaya Seshasayee, Zora Modrusan, and
Hilary F Clark. Deconvolution of Blood Microarray Data Identifies Cellular
Activation Patterns in Systemic Lupus Erythematosus. PLOS ONE, 4(7):e6098,
January 2009.
[3] Giulia Accardi, Calogero Caruso, Giuseppina Colonna-Romano, et al. Can
Alzheimer Disease Be a form of Type 3 Diabetes? Rejuvenation Research,
15(2):217–221, 2012.
[4] Jaeil Ahn, Ying Yuan, Giovanni Parmigiani, et al. DeMix: Deconvolution
for Mixed Cancer Transcriptomes Using Raw Measured Data. Bioinformatics
(Oxford, England), 29(15):1865–71, August 2013.
[5] Z. Altboum, Y. Steuerman, E. David, et al. Digital Cell Quantification Identifies
Global Immune Cell Dynamics during Influenza Infection. Molecular Systems
Biology, 10(2):720–720, 2014.
[6] K. G. Ardlie, D. S. Deluca, A. V. Segre, et al. The Genotype-Tissue Expression (GTEx) Pilot Analysis: Multitissue Gene Regulation in Humans. Science,
348(6235):648–660, May 2015.
[7] Gary D Bader and Christopher W V Hogue. An Automated Method for Finding
Molecular Complexes in Large Protein Interaction Networks. BMC Bioinformatics, 4:2, January 2003.
[8] M. Bailly-Bechet, C. Borgs, A. Braunstein, et al. Finding Undetected Protein
Associations in Cell Signaling by Belief Propagation. Proceedings of the National
Academy of Sciences, 108(2):882–887, January 2011.
[9] Michelangela Barbieri, Massimiliano Bonafè, Claudio Franceschi, and Giuseppe
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